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Abstract 
 
In biochemistry, sulfur-containing biomolecules enrich the chemical diversity in cells. 
This occurs via their participation in several reactions including disulfide formation, 
metal-binding and redox catalysis. Since sulfur occurs in various oxidation states, it 
exhibits interesting chemistry and reactivity. In this Dissertation computational modeling 
techniques have been used to investigate several aspects of sulfur's unique chemistry.  
Chapter 1 provides a brief introduction summarizing the importance of sulfur in 
biochemistry. In particular it discuss the chemical diversity and redox chemistry of sulfur 
in biology. Chapter 2 provides an overview of the computational methods commonly 
used in studying enzymatic reactions. 
Chapter 3 discusses the reduction mechanism of S-methionine sulfoxide (Met-O) to 
methionine via a ubiquitous antioxidant enzyme known as methionine sulfoxide reductase 
A (MsrA). We used a wide range of computational methods including docking, molecular 
dynamics simulations and QM/MM calculations. Our results have proposed new roles for 
active site residues such as Asp87. In addition, the activation mechanism of the catalytic 
cysteine was revealed. Furthermore, the effect of active site tyrosyl residues after 
mutation were also considered and found in agreement with experimental results. The 
formation and reduction mechanism of sulfenic acid intermediate was computationally 
elucidated. It showed that sulfenic acid is formed via the activation of a water molecule in 
accordance with a new experimental study. Notably, our results support that sulfenic acid 
is readily reduced upon proper positioning of the second cysteinyl residue solving the 
controversy in experimental studies regarding this step.  
! VI!
In Chapter 4, we discuss our computational investigation on the last step in the 
reductase step of the catalytic mechanism of methionine sulfoxide reductase B (MsrB), 
the formation of disulfide directly or via sulfenic acid intermediate. Our previous work on 
MsrB showed that, unlike MsrA, sulfenic acid is not formed in the catalytic mechanism. 
Due to a disagreement with experimentalists, we considered investigating the effect of 
level of theory, the effect of model choice QM-cluster vs. QM/MM and the effect of 
choosing a starting structure from X-ray vs. MD. Our QM/MM results based on MD 
show that sulfenic acid occurs in the mechanism. We also considered running MD 
simulations throughout the reaction coordinates to test the effect of substrate binding on 
the distance between the two catalytic cysteinyl residues. 
In Chapter 5, we discuss our synergistic use of docking, MD simulations and virtual 
screening to investigate the mechanism of MsrA activation via small ligands. The 
possibility of their direct molecular interaction with MsrA was tested using docking 
techniques identifying a novel allosteric site. Furthermore, the effect of ligand-MsrA 
binding was elucidated using MD simulations. Our MD results suggest that their binding 
facilitates the unfolding of two-stranded antiparallel β–sheet revealing the active site for 
subsequent reduction by thioredoxin (Trx). Finally, virtual screening was employed to 
identify other potential ligands to act as MsrA activators.  
Chapter 6 discusses our computational investigation on the second step (formation 
sulfenyl-amide intermediate from sulfenic acid) in protein tyrosine phosphatase 1B 
(PTP1B). We propose an alternative pathway to the previously suggested high-energy 
barrier mechanism proposing new roles for active site residues. Furthermore, the role of 
non-covalent interactions was highlighted and supported using QTAIM and NBO 
analysis.  
In Chapter 7 the reduction mechanism of peroxide via the archaeal peroxiredoxin 
(ApTPx) antioxidant enzyme was discussed. In addition, the formation of the previously 
proposed hypervalent intermediate from sulfenic acid was tested.  The nature of 
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interactions in this highly coordinated species was elucidated using QTAIM and NBO 
analysis. Furthermore, the transferability of this unique sulfenic acid protection 
mechanism to other enzymes was also considered. Moreover, the overoxidation 
mechanism of sulfenic acid to sulfinic acid was examined for the first time.  
Chapter 8 describes our MD and ONIOM investigation on the unique reduction 
mechanism of the 2-Cys perxoiredoxins (Prxs) sulfinic acid via sulfiredoxin (Srx). The 
previously suggested sulfinic acid phosphoryl ester and thiosulfinate intermediate were 
characterized in the active site. Understanding the generally irreversible sulfinic acid 
intermediate reduction mechanism can potentially enable the development of new 
antioxidant drugs. 
In Chapter 9 we discuss our investigation of the cis-trans isomerization mechanism of 
maleate to fumarate via maleate isomerase (MI) enzyme. Small DFT models, QM-cluster 
approach, QM/MM and MD were employed to investigate previously proposed 
mechanisms. Previous X-ray and mass spectrometry studies have suggested a novel 
mechanism in the racemase family in which an active site cysteinyl residue covalently 
bonds to the substrate forming either a succinyl-cysteinyl or enediolate intermediate. Our 
calculations show that the enediolate intermediate is unstable and succinyl cysteine 
intermediate occurs in the mechanism. Also, proton affinities calculations of active site 
cysteinyl residues and substrate in protein environment indicated different roles for active 
site cysteinyl residues from the proposed ones. Notably, our QM/MM calculations of both 
pathways (experimental and proton affinities-based) have confirmed our conclusion. 
These results highlights that the mutation of active site residue might mislead the 
conclusion of the enzymatic mechanism. 
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1.1 Introduction: 
The importance of sulfur in biochemistry has been recognized as early as the first half 
of the 20th-century with the discovery of insulin.1 Subsequently it has been found to play 
a key role in all major classes of biomolecules such as proteins, nucleic acids, and 
carbohydrates, as well as cofactors and many metabolites.2 In fact, sulfur is the only 
element other than N, C, and H that occurs in the 20 genetically encoded amino acids, 
being found in both cysteine (Cys) and methionine (Met).3 Sulfur-containing 
biomolecules greatly enrich the chemical diversity in cells in part as they can undergo a 
diverse variety of chemical reactions including nucleophilic substitution (e.g. 
thioredoxin), electron transfer (e.g. glutathione reductase (GR)), proton, hydrogen or 
hydride transfer (e.g. NADH peroxidase (Npx)), and oxygen atom transfer (e.g. NADH 
oxidase (Nox)).4,5  
This versatile chemistry of sulfur containing-biomolecules partially originates from 
being in the chalcogens group of the periodic table wherein sulfur and oxygen share 
similar chemical reactivity.6,7 However, being in lower position in the periodic table, 
sulfur has a lower electronegativity.6 As a result, sulfur-containing biomolecules are often 
better nucleophiles than oxygen-containing biomolecules. Additionally, disulfide bonds 
(RS–SR) are generally more stable than the peroxide bonds (RO–OR).6,7  
Another important contributing reason for sulfur's distinct reactivity is its electronic 
configuration of [Ne]3s23p43d0, which contains an energetically accessible d-orbital that 
can be involved in bonding.8 Indeed, this electronic configuration enables sulfur to exhibit 
a range of oxidation states.8 Notably, in biochemistry, the oxidation states of sulfur have 
been found to vary from -2 to +6.5,8,9 Interestingly, it has been noted that there appears to 
be a correlation between the complexity of a cell and its sulfur content. For instance, in 
archaea the average occurrence of Cys in proteins is 0.4%-0.5% while in mammalian 
cells it is 2.26%.6  
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Thiol (–SH) is a common sulfur containing functional group within biochemical 
systems. Indeed, the unique R-group of Cys contains a thiol. At physiological pH it 
predominantly exists in its neutral form (i.e., RSH). For example, as the pKa of the R-
group thiol of Cys is around 9.8 However, the reactivity of a thiol can be increased by its 
deprotonation to form a thiolate anion (RS–). The latter is a much better nucleophile, and 
can react with soft or hard electrophiles such as carbonyl and phosphoryl groups.8 
Notably, the high reactivity of RS– plays key roles in a range of cellular functions such as 
catalysis, post-translational modifications, protein structure, metal binding, and 
detoxification of xenobiotics.4,5,10 
The R-group of Met contains a divalent sulfur atom (RSCH3). Notably, Met has been 
found to play a number of crucial cellular roles, especially in redox signaling.11,12 This is 
due in part to the fact that it is one of the most readily oxidized amino acids.13 Indeed, due 
to its ability to undergo reversible oxidation under some conditions it has been suggested 
to play a role as a protein 'oxidation sink' or antioxidant.12,14 It is also noted that Met is the 
initiating amino acid in eukaryotic protein synthesis.15 In addition, upon its metabolism, 
Met can act as a methyl group donor, and form other sulfur containing amino acids such 
as homocysteine and cysteine.16 
Unlike other redox reactions in biochemistry, Cys mediated redox systems are unique 
as they do not require metal ions or cofactors (e.g. NAD+ or FAD).4,17 In Cys the sulfur is 
in its fully reduced oxidation state of -2 and can readily undergo several redox 
reactions.4,18 This is due to the low oxidation/reduction potential of the Cys side chain; 
E°! -0.27 to -0.125 V.8 In general, higher oxidation states of Cys, specifically from -1 to 
+4, are less stable and a larger amount of energy is required for their further oxidation.6 
Regardless, a diverse array of thiol-derived species' can be obtained via redox reactions in 
biochemical systems including sulfenic, sulfinic and sulfonic acids, thiosulfinate, 
thiosulfonate, disulfide trioxide, disulfone and disulfide (Figure 1.1).4,6,19 It is noted that 
the formation of a disulfide is the most common thiol redox modification.5,17 
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Figure 1.1. Schematic illustration of some thiol-derived species obtained via redox in 
biochemical systems. 
 
With a sulfur oxidation state of 0, sulfenic acid (RSOH) has both nucleophilic and 
electrophilic character. As such, it is a chief intermediate in thiol redox chemistry with 
broad biological roles in signal transduction, non-enzymatic protein folding, protection 
against reactive oxygen species' (ROS) and modulating gene transcription.6,20,21 It is also 
now proposed to be an essential precursor intermediate for disulfide bond formation.22 
RSOH can be formed via the direct oxidation of Cys by reactive oxygen or nitrogen 
species' (ROS/RNS), peroxynitirite, or hypochlorous acid. Alternatively, it can be formed 
indirectly either during some enzymatic mechanisms, or xenobiotic metabolism.21,23  
Sulfenic acid is highly reactive and unstable,6,19 and can be irreversibly oxidized to form 
sulfinic or sulfonic acid.20 Hence, it generally occurs as an intermediate along a reaction 
pathway. 
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Figure 1.2. Schematic illustration of sulfenic acid proposed reactions in biochemistry. 
 
The protection of sulfenic acid against overoxidation is crucial to maintaining cellular 
health.20,21 In fact, the presence of high oxidation state intermediates are hallmarks for 
many diseases.6 Consequently, many reactions in biochemical systems have been 
identified as protective mechanisms for sulfenic acid. The most common mechanism is its 
reduction to disulfide. However, some mechanisms involve the formation of unusual and 
unique species'.6,19,24 For instance, using X-ray crystallography a sulfenyl-amide 
intermediate was identified in the enzyme protein tyrosine phosphatase 1B.25 In archaeal 
peroxiredoxin (ApTPx) a unique electron density was identified in the crystal structure 
that was suggested to be a hypervalent sulfurane intermediate.26 The oxidation of sulfenic 
acid to a sulfinic intermediate in some Prx's was found to be reversible via interactions 
with sulfiredoxin and an ATP cofactor.27-29 
Despite its importance to biochemical systems, much of sulfur's redox chemistry, for 
example that of sulfenic acid, remains unknown or unclear. Notably, some of the above 
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proposed intermediates have not been experimentally or computationally characterized. In 
this thesis several computational modeling approaches have been applied, at times 
synergistically, to investigate sulfur-related biochemistry, in particular the redox 
chemistry of Cys and Met including the formation and chemistry of sulfenic acid. 
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2.1 Introduction 
In 1888 J. L. Gay-Lussac wrote, “We are perhaps not far removed from the time when 
we shall be able to submit the bulk of chemical phenomena to calculation”.1 Almost 40 
years after Gay-Lussac's prophecy, Schrodinger and Dirac independently established the 
foundation of quantum chemistry conveying his dream to reality. However, the 
application of quantum chemical calculations remained limited; for decades only the 
investigation of simple systems involving one or a few atoms were practical. Later, the 
advent of computers together with the work of many scientists such as John Pople and 
Walter Kohn (Nobel Prize winners in chemistry 1998)2 have pushed the limits of 
chemical calculations to deal with more complex systems. More recently, Karplus, Levitt 
and Warshel were awarded the Nobel Prize in chemistry 20133 “for the development of 
multi-scale models for complex chemical systems”. As a result, the application of 
quantum chemical calculations has been extended to deal with complex systems not only 
in chemistry but also biology, enzymology, genetics, and engineering. 
 
2.2 Computational Enzymology 
Enzymes are remarkable natural biological catalysts that speed up chemical reactions 
dramatically to maintain cellular life. Elucidating the origin of enzymes' catalytic power 
as well as their mechanism of action is central to gaining a more complete understanding 
of biochemistry, as well as fundamental chemical principles. Indeed, such information 
could be used for several applications such as designing new catalysts as well as new 
therapeutic drugs (e.g. enzyme inhibitors).4 Enzymes are very versatile and utilize 
numerous mechanisms of action, making their characterization challenging.5,6 In addition, 
due to the nature of transition states and the fact that many reaction intermediates are 
highly reactive and transient,6 traditional experimental methods are generally unable to 
determine all atomistic-level details involved in their chemical reactions.7,8 
! 10!
In the last two decades, computational modeling techniques have been established as a 
powerful tool to dissect in detail enzymatic chemical reactions describing the nature of 
intermediates and transition states.7,9,10 More importantly, several fundamental questions 
could be answered such as the origin of the enzyme catalytic power, the important 
catalytic residues and their mutations, the mode of ligand binding in the protein as well as 
the dynamics of its structure and energetics of the reaction.7,8 Thus, currently, the 
synergistic use of chemical modeling and laboratory experimentation is essential to study 
these powerful catalysts.6,8  
Computational enzymology (Figure 2.1) is a growing field of study with potential 
contributions in pharmaceutical, chemical and biotechnology industries.11,12 Several 
computational chemistry methods have been developed to help answer questions in 
enzymology. These methods include quantum mechanics (QM)-cluster, hybrid quantum 
mechanical/molecular mechanical (QM/MM), empirical valence bond (EVB), molecular 
dynamics simulations (MD) and Car-Parrinello molecular dynamics (CPMD).9,13-15 
Notably, the aforementioned methods can achieve high accuracy when studying chemical 
systems. For example high-level QM-based methods can accomplish chemical accuracy 
near 1 kcal mol-1,16 while parameterized-empirical based methods have also been shown 
to be able to provide good agreement with experiment.17  
 
2.3 Protein Dynamics and MD Simulations 
MD simulations are one of the fundamental tools in molecular modeling.18 They 
enable one to simulate the time dependent behavior of a molecular system by integrating 
Newton's laws of motion, providing insights into for example protein dynamics, protein-
ligand and protein-protein interactions as well as conformational fluctuation. In 
computational enzymology, MD simulations can also be used to generate a number of 
plausible conformers of the initial reactive complex (RC).19 Subsequently the generated 
conformers can be analyzed to select either a single average structure to represent the 
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reactive complex or in some cases, several starting structures could be used to examine 
the effect of conformer variation on the mechanism.19,20 Notably, choosing an accurate 
RC is important to obtaining meaningful results in subsequent mechanistic 
calculations.10,21 
 
 
Figure 2.1. Graph indicating the results of a search on ISI Web of Science using the 
criteria: Topic = computational and Topic = enzyme sorted by publication year. 
 
A large number of conformers are needed to calculate the free energy of an enzymatic 
system.22 This can be achieved by calculating molecular trajectories using several 
simulation methods, such as potential of mean force (PMF).23 In general, understanding 
protein dynamics is important as many enzymes undergo large conformational changes 
during their catalytic cycle.19 Protein dynamics is involved in both substrate binding and 
product release, which could be the rate-limiting step of the mechanism.7  
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In biological systems, the size of the required chemical model is often quite large and 
complex. Similarly, the time scale required for their simulation is prolonged. Therefore, a 
cheaper level of theory is usually used to run the simulation. Typically, a molecular 
mechanical (MM) force field is used in simulating the trajectories of these systems. There 
are several computational programs to preform MD simulations such as AMBER, 
CHARMM, GROMOS and NAMD.24-27 The simulation starts by calculating the forces at 
particular time for a finite time period via solving the Newton equation of motion 
numerically. 
 
2.4 Molecular Mechanics (MM) Force Fields 
These methods use classical mechanics to predict the total energy of molecules as a 
function of their conformation. As a consequence, in MM force fields electrons are 
ignored and the system is expressed using empirical parameters derived from experiment 
or at times high-level conventional ab initio results. Hence, they are most applicable to 
ground state and covalent structures. Thus, processes that includes bond breaking or 
formation can not be described using MM.28 However, MM force field is very useful in 
investigating energy changes upon structural rearrangements as in MD simulations. 
Additionally, the total energy is calculated using simple functions,28 an example of 
which is shown in equation 2.1.  
 !!! = !!"# + !!"#$ + !!"#$ + !!"# + !!" (2.1) 
 
In the above example the total MM energy of the system (EMM) is written as the sum of 
simple harmonic terms of bond stretching (Estr) and valence angle bending (Ebend), a 
periodic term to represent the torsional angles (Etors), while Van der Waals (Evdw) and 
electrostatic (Eel) interaction contributions are calculated using Lennard-Jones potentials 
and Coulomb's law, respectively (equation 2.2). 
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!!"# = !!"!!" !" − !!!!" ! !!" = !!!!!!!!!!!!" (2.2) 
 
The terms !!" and !! are the repulsion and attraction parameters respectively, !! is the 
atomic partial charge, !!" is the interatomic distance, and !! and !!!are the unit charge 
and dielectric constant, respectively. 
Many force fields have been developed for biomolecules (e.g. protein and DNA). This 
includes all atom force fields that represent all atoms in the system such as AMBER, 
CHARMM22-27 and OPLS/AA.24,26,29 Other force fields only deal with heavy atoms and 
polar hydrogen. In this case nonpolar hydrogens are represented as part of the carbon 
atom to which they are bonded. It is important to mention that atomic partial charges in 
most force fields are kept constant and do not change in response to environmental and/or 
conformational changes. Thus, electronic polarization is only included in an average way. 
Recently, there has been great interest and research into generating new polarizable force 
fields which would include electron polarization.30,31  
Although MD simulations based on MM methods are a well-established tool to 
simulate protein motion and dynamics, the size and the complexity of the biological 
systems generally allows for only relatively short simulations in the nanosecond (ns) time 
scale to be performed.32 Many biological problems would need much longer MD 
simulations (in micro to millisecond time scale) to be executed allowing for better 
sampling of the system.33 In atomistic classical MD simulations the high barriers between 
minima often cannot be crossed. Several approaches have been developed to overcome 
these limitations. For instance, steered molecular dynamics allows the system to cross 
barriers by applying a force to the system forcing it to deviate from its initial 
conformational state.34 This approach is very useful especially in studying the (un)folding 
of proteins and transportation of molecules through membrane proteins.35,36 Another 
! 14!
approach that has been fast growing is the generation of coarse-grained (CG) force 
fields.32 These force fields reduce computational cost by representing a small group of 
atoms as a single particle and thus allow for much longer simulation times. CG-MD has 
been successfully applied to study lipids and membrane proteins.37,38 Several CG force 
fields have been developed such as the all atom MRTINI force field.39 Finally, other 
approaches are also been used such as targeted MD simulations and Monte Carlo MD 
simulations.40,41  
 
2.5 Quantum Mechanical (QM) Methods 
Unlike MM methods, QM methods allow one to describe bond(s) formation/breaking 
processes in chemical systems.13,16 Thus in order to study the catalytic reactions in 
enzymes, generally, QM is the method of choice to obtain all detail including the 
geometries and energies of the unstable transition states and intermediates. To date, 
several different QM methods have been developed which can be categorized into three 
main types: 1) wavefunction-based (ab initio), 2) density functional theory (DFT) and 3) 
semiempirical methods. Each of these aim to find an approximate solution to the time-
independent Schrödinger equation as it cannot be solved exactly for system containing 
more than one electron. The Hamiltonian of the non-relativistic time-independent 
Schrödinger equation of a molecular system is represented in equation 2.3. 
 Ĥ = − !!∇! − !!!! ∇! −!!!! !!!!" +!!!!!!!!!!!! !!!" + !!!!!!"!!!!!!!!!!!!!!!! !!!!!(2.3) 
 
The first two terms represent the kinetic energies of the electrons and nuclei, 
respectively. The following three terms describe the potential energy of electron-nuclei 
attraction, electron-electron repulsion and nuclei-nuclei repulsion, respectively. In 
addition, α and β represent the nuclei, i and j represent the electrons, and N and n 
represent the total number of electrons and nuclei in the system, respectively.  
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In order to address the complexity of the time-independent Schrödinger equation, 
several approximations must be made. Two of the most widely applied and common 
approximations are the (i) Born-Oppenheimer approximation in which the nuclei are 
assumed from the perspective of the electrons to be stationary, and (ii) orbital 
approximation in which the motions of the electrons are assumed to be independent of 
each other and hence each electron can be assigned its own spin orbital. In fact, QM 
methods differ based on the approximations applied. For example, the simplest ab initio 
method is based on Hartree Fock (HF) theory, which assumes that each electron can be 
considered as moving through an average field generated by the other electrons. As a 
result, the HF method is said to be an uncorrelated method. Unfortunately, the error in HF 
energies due the neglect of electron correlation can lead to significant errors in describing 
molecular and electronic properties of the system. Therefore, several post-HF methods 
have been developed to account for electron correlation. These methods include Møller-
Plesset perturbation theory (e.g. MP2), coupled cluster theory (CC), complete active 
space SCF (CASSCF) and Configuration interaction techniques (CI). Although all 
previous mentioned methods significantly improve the accuracy of the calculation, they 
cannot be applied to large systems due to their high computational cost. 
DFT provides an alternative method that retains chemical accuracy at lower 
computational cost. It can calculate electronic and molecular properties using the 
molecules electron density. This reduces the computational cost dramatically as the 
electron density is a function of three variables instead of the wavefunctions dependence 
on 3N variables. The main basis of DFT theory is that the energy of the system is a 
functional of the electron density.42 Unfortunately, the exact functional correlating the 
two is not known. Thus, numerous approximate functionals have been proposed and 
parameterized based on experimental results or high level ab initio calculations. These 
functionals can be categorized into: pure DFT (e.g. Local Density Approximate (LDA) 
methods),43 generalized gradient approximation (GGA) (e.g. PBE),44 hybrid-GGA 
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functionals (e.g. B3LYP)45,46 in which part of the exchange energy is calculated using HF, 
meta-GGA functionals (e.g. M06L) and hybrid-meta-GGA (e.g. M06-2X).47 B3LYP was 
the most commonly employed functional in enzymology.6 However in the recent years 
other functionals have started to gain increasing use such as the M06 series.47 
Semiempirical methods are the least computationally demanding as they involve a 
number of approximations that aim to simplify the calculation, for instance, entire types 
of integrals. Therefore, they are also on average the least accurate among QM methods. 
Despite such drawbacks, they allow for the study of larger systems and are widely used in 
studying protein dynamics (e.g. QM/MM MD).48 Therefore, several semiempirical 
methods have been developed based on different approximations. For instance, the 
modified neglect of diatomic differential overlap (MNDO) approximation includes some 
of the most widely used semi-empirical methods, AM1 and PM3.49 Furthermore, a 
semiempirical DFT based method, self-consistent charge density functional tight-binding 
(DFTB) has been recently developed and has been successfully applied to enzymatic 
systems.50 
 
2.6 Choosing a Starting Structure 
For most computational studies the choice of the starting chemical structure is very 
important. Typically, the primary model of the enzyme is obtained from a high-resolution 
X-ray structure of the protein in complex with the substrate, substrate analogue or 
inhibitors.6,9 Alternatively, docking techniques can be used to model the binding of the 
substrate in the active site. Although abovementioned approach is very useful, it suffers 
from limitations such as lacking protein dynamics and conformational variability. 
Therefore, another alternative is to use NMR structures as they provide information on 
protein dynamics. However, in general, NMR structures suffer from low resolution on 
atomic positions especially with respect to the flexible parts of the protein.10 In addition, 
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in some cases if there is no X-ray or NMR structure, homology modeling could be used to 
generate the starting structure. 
Notably, in order to address the limitations of the generated structures, preparation 
steps need to be used to generate a more reliable representation of the in vivo structure of 
the enzyme-substrate complex via MD simulations. Once a representative structure is 
chosen, the mechanistic details of the reaction can be elucidated using several approaches. 
In enzymology, two main approaches are usually used to study chemical reactions: QM-
cluster and quantum mechanical/molecular mechanical (QM/MM). It is noted that other 
methods can also be used such as empirical valence bond (EVB).9,13,15,28  
 
2.7 Quantum Mechanical (QM)-Cluster Approach 
QM-cluster is one of the main approaches to study chemical reactions. It has been 
successfully used for many years to study enzymatic reactions with good accuracy, 
especially for metalloenzymes.51,52,53 In part, this is due to the fact that most enzymatic 
reactions occur within a small region (e.g. enzymes active site). In fact, using small 
models of the active site allows one to apply highly accurate QM methods, which cannot 
be used with larger models due to prohibitive computational cost. Furthermore, it 
provides an efficient tool to test the accuracy of several levels of theories against highly 
accurate methods and subsequently to select a suitable method for further calculations 
using larger models. 
The initial model is usually derived from a high-resolution X-ray structure of an 
enzyme complex with substrate/substrate analogue or from the generated conformers of 
an enzyme-substrate complex using MD simulation. The enzyme-substrate complex is 
truncated to include a minimal number of atoms in the QM model that adequately 
describe or mimic the active site chemistry. In the case of using DFT, which is commonly 
used to study enzymes, a chemical model consisting of between 150-200 atoms is 
chosen.9,10 The selection of the active site atoms is quite crucial and might affect the 
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obtained results. Therefore it is important to include certain residues and interactions in 
the active site including:9,10 1) the catalytic amino acids involved in the reactions, 2) 
residues that are responsible for substrate binding and conformation in the active site, 3) 
residues that can alter catalysis via their interactions (e.g. hydrogen bond, charge 
stabilization) with the catalytic residues or the substrate and 4) minimal part of the 
substrate without affecting its binding or properties. Generally, only models of the 
selected residues are included and only those parts of them that are necessary (e.g., R-
groups). For instance, histidine and aspartate are often modeled by imidazole and acetate, 
respectively. Furthermore, a minimal number of peripheral atoms are usually fixed during 
the optimization to keep the active site conformation similar to the native enzyme 
structure. 
If all important interactions and residues are maintained in the model, the QM-cluster 
can offer very useful and accurate insights in the reaction including stationary points on 
the potential energy surface (PES) (intermediates and transition states) and energetics. In 
general, a PES describes the relation between the system coordinates and its energy, 
which is important for a complete understanding of their chemical reactions. In fact, QM-
cluster can be used as an efficient tool to compare between alternative catalytic pathways 
by obtaining their PESs ruling out those pathways whose activation energies are too high. 
Furthermore, free energies can be also estimated using frequency calculations, which are 
commonly done on the optimized structure. Moreover, since the QM-cluster model does 
not include the surrounding residues, the effect of enzymatic environment is modeled 
using a solvation model method and an appropriately chosen dielectric constant. Several 
implicit solvation approaches are usually used including IEF-PCM, COSMO and 
CPCM.54 The values of the dielectric constant to mimic protein environments vary 
between 2-20 with a value of 4 being commonly used.9  
Although a QM-cluster approach is very useful in revealing reaction chemical 
insights, in some cases this approach might fail.9 For instance, if the long-range 
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interactions are important for the reaction, truncating the surrounding residues can affect 
the calculated results dramatically. Furthermore, the dynamics of the enzyme are 
neglected and the investigated reaction is elucidated using a single model, which might 
not represent the reaction effectively.55  
 
2.8 Quantum Mechanical/Molecular Mechanical  (QM/MM) Approach 
QM/MM is a hybrid approach that allows for high accuracy calculations using QM 
methods, combined with the simplicity of cheap MM calculations.13,28 This combination 
enables the study of large enzymatic systems in which the core region (active site) where 
the bond(s) breaking/formation occur is described using QM calculations. The remainder 
is described using MM force field allowing for environmental effects and interactions to 
be accounted for in the calculations (see Figure 2.2). As in the QM-cluster approach, the 
QM layer should include catalytic residues, reactive region of the substrate and important 
interactions that can directly affect the catalytic mechanism. The MM layer can either 
include the rest of the enzyme/solvent atoms or part of the enzyme, e.g., all those residues 
within15 Å from the center of the QM layer.  
The beginning of the QM/MM era started with the pioneering work of Warshel and 
Levitt (Nobel prize winners in chemistry 2013) in 1976.56 However, this method started 
to become widespread only in 1990 after the work of Field, Bash and Karplus who 
described in detail the coupling between the QM (using semiempirical method) and the 
MM layers (CHARMM forcefield) and compared the accuracy of the method against ab 
initio calculations and experimental data.57 Since then QM/MM approaches have become 
established as an important tool for the study of bimolecular systems.58 In general, 
transition states, intermediate, activation energies, zero point corrections and tunneling all 
can be elucidated using this approach.28 There are several QM/MM implementations 
available in various computational chemistry programs. 
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Figure 2.2. Schematic representation of QM/MM partitioning model.  
 
The use of QM/MM has expanded and has been applied to study of 
inorganic/organometallic and solid-state systems.28,59 In addition it is currently also being 
used in free energies simulations allowing for better determination of ligand-protein 
binding.60 A more recently developed extension of QM/MM is QM/MM-MD. It can, for 
example, be performed using a cheap QM method (e.g. DFTB) allowing for simultaneous 
modeling of the effects of protein dynamics.48  
 
2.8.1 QM/MM Additive Scheme 
One of the main differences in QM/MM schemes is how the total energy of the system 
is calculated. In the additive scheme, the total energy is calculated by adding the 
individual energies of the QM layer, the MM layer and their coupling energy.58 The full 
effective Hamiltonian (Ĥ!"")!of the QM/MM system is: 
 Ĥ!"" = Ĥ!",!""#$!!"#$% + Ĥ!!,!"#$%!!"#$% + Ĥ!"/!!/!"#$%&'( (2.4) 
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In which the first term is the  quantum Hamiltonian of the inner layer (see equation 2.3) 
and the second term is the molecular mechanical Hamiltonian representing the MM layer 
(see equation 2.1). Finally, the third term in the equation represents the coupling between 
the two regions including electrostatic and van der Waals interaction. In this term, the 
MM atoms are described using point charges and van der Waals parameters (see equation 
2.5). 
 
 Ĥ!"/!!/!"#$%&'( = − !!!!"!" + !!!!!!"!" + !!"!!"!" − !!"!!"!!"  (2.5) 
 
In equation 2.5, !, ! and !!represent the MM atoms, the QM layer electrons and the 
QM layer nuclei, respectively. Furthermore, the first term represents the electrostatic 
interactions between the MM atoms and the QM layer electrons while the second term 
accounts for MM and QM layer nuclei electrostatic interactions. The last term represents 
the van der Waals interactions between the two layers. In general, the calculation of the 
QM/MM coupling term is problematic especially upon using link atoms and/or upon 
electrostatic embedding as will be discussed later in this chapter. The total energy of the 
system can be written as: 
 E!"/!! = E!",!""#$!!"#$% + E!!,!"#$%!!"#$% + E!"/!!/!"#$%&'( (2.6) 
 
The additive scheme is a widely used approach in QM/MM and has been implemented in 
many software packages. 
 
2.8.2 QM/MM subtractive scheme  
Unlike the additive scheme, in QM/MM subtractive schemes the total energy of the 
system is obtained via addition and subtraction of component energy terms. More 
specifically, the total energy is calculated through three individual calculations: 1) the 
QM energy of the inner layer, 2) The MM energy of the entire system and 3) the MM 
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energy of the isolated inner layer. By subtracting the MM energy of the inner layer form 
the entire system, the coupling between the two layers is mainly calculated at the MM 
level of theory. The total energy of the system is the result of the subtraction of the MM 
inner system energy from the MM energy of the whole system, which is subsequently 
added to the QM energy of the inner layer as follow: 
 E!"/!! = E!",!""#$!! !"# + E!!,!"#$%!!!"!#$% − E!!,!""#$!!"#$% (2.7) 
 
In principle, this scheme can be used to extrapolate the energy of a system composed 
of n layers. Three different methods based on this scheme have been developed by 
Maseras and Morokuma including:61,62 1) IMOMM, 2) IMOMO and 3) ONIOM. The 
latter allows for several layers to be used as well as numerous combinations of level of 
theories. It is important to mention that ONIOM is the method of choice in our studies. In 
addition, the following sections mainly discuss the interactions in ONIOM. 
Although the subtractive QM/MM scheme does not require any parameterization of 
the coupling region, it still needs parameterization of the inner layer, which might be 
problematic to obtain accurately in certain cases (e.g. metal ions). However, all 
systematic errors are cancelled in the calculations. In addition, its implementation is 
straightforward as no coupling term to represent the interaction between the MM and the 
QM calculations is required. 
 
2.8.3 QM/MM Electrostatic Interactions  
One of the main challenges in QM/MM is to accurately describe the coupling between 
the two layers, including bonded and non-bonded interactions. More specifically 
electrostatic interactions are one of the effects that one may need to describe accurately. 
There are four different formalisms to evaluate QM/MM: A) mechanical embedding in 
which there is no polarization between the two layers, B) electrostatic embedding where 
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QM is polarized by MM, C) polarized embedding wherein MM is polarized by QM and 
D) Iterative polarization between QM and MM layers.  
Mechanical embedding is the most computationally efficient as the QM layer is 
isolated during the calculations, that is, it is in a sense in the gas-phase. The coupling 
between the QM and MM layers is calculated at the MM level of theory that could be 
included in the force field. Since the QM inner system is evaluated in the absence of the 
MM layer, the MM layer only provides a mechanical/steric effect in the optimization of 
the QM layer. Furthermore, the interaction between the two regions is calculated based on 
fixed charges, which might change during the reaction during bond(s) formation/breaking 
in the inner layer. Thus in certain cases the partial charges of the QM inner layer should 
be calculated at each step along the reaction pathway. Similarly, Lennard-Jones 
parameters are usually kept constant in the calculations. All these limitations in the 
mechanical embedding formalism might affect the accuracy of some calculations.  
Another alternative to improve the way electrostatic interactions are calculated is to 
use electrostatic embedding.63 The affects of the electrostatic environment of the protein, 
surrounding the QM-region, can be modeled via the use of electrostatic embedding (EE). 
In this formalism, the charged MM atoms polarize the electron density of the QM layer. 
This is introduced into the calculation by adding a one electron operator to the QM 
Hamiltonian (equation 2.8). 
 Ĥ!",!"#$%&'() = Ĥ!" − !!!!!!!! !!!!!!!  (2.8) 
 
The MM point charges are represented as !!. !!and !! !represent the MM atom (!)! and 
the electron (!)! position, respectively.  
Since the electronic Hamiltonian has an extra term, electrostatic embedding 
calculations are more computationally demanding.13,58 Therefore, it is commonly 
implemented via single point calculations on the structures optimized within the 
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mechanical embedding formalism. Indeed, the use of electrostatic embedding can provide 
more experimentally reliable results as the QM/MM coupling is now evaluated at the QM 
level of theory. Subsequently, no parameterization of the inner system is required. 
Despite all these advantages, electrostatic embedding might not be the best method to be 
used in all cases as the presence of the MM point charges can lead to the overpolarization 
of the QM inner layer, especially near the boundary region, in some cases. This mainly 
occurs upon using large basis set to describe the system leading to electrons spilling into 
the MM region.  
In model C, the QM density polarizes the MM atoms but the polarized MM does not 
then polarize the QM layer.31 This requires the development of new force fields with 
flexible charges. Several approaches have been developed to model the polarization of 
MM atoms including the induced dipole model and the fluctuating charge models. Finally 
in model D both layers polarize each other via an iterative process. This requires the 
calculation of the MM polarization at every step of the self-consistent field iteration. Such 
calculations are very demanding and impractical to use with large QM/MM models. 
Unfortunately, such polarizable forcefield for bimolecular system is not available yet. 
 
2.8.4 QM/MM Boundary  
Since the QM and the MM layer are connected by covalent bonds, the partitioning of 
the two layers creates unpaired electrons in the QM subsystem, which is an artifact of the 
method. Several approaches have been developed to remedy this problem and saturate the 
valence of the frontier atoms. 
The most straightforward approach and one that is commonly used, especially in 
ONIOM calculations, is the addition of monovalent link atoms to the QM subsystem. 
Hydrogen is the most commonly used link atom, however, in principle other atoms or 
even a group of atoms (e.g. methyl group) could be employed.58 These atoms are only 
added during the calculation of the inner QM layer. Despite the simplicity of this 
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approach, it has several disadvantages:58 1) it complicates the energy expression, 2) it 
generates three extra degree of freedom for each link atom, 3) the generated bond is 
artificial and different from the original bond, and 4) it might lead to the overpolarization 
of the QM layer. Some of these problems are already addressed in chemical software 
packages. For instance, the extra degree of freedom is canceled by fixing the link atom 
along the partitioned bond between the QM and the MM atoms. Furthermore, in order to 
avoid overpolarization of the subsystem, many schemes have been developed 
including:31,58 1) deleting MM charges atoms (e.g. Z1 scheme), 2) redistribution of the 
point charges around the link atom, and 3) deletion of one electron integrals of the link 
atom.  
An alternative approach is the use of localized orbitals in which a doubly-occupied 
molecular orbital is used. Two commonly used such approaches are the: 1) hybrid orbital 
method, which introduces a molecular orbital at the boundary QM atom, and 2) 
generalized hybrid orbital approach (GHO)64 which instead places a molecular orbital on 
the MM atom. In the hybrid orbital method (e.g. LSCF)65 a hybrid occupied orbital is 
added at the QM atom and pointed towards the MM atom of the broken bond and kept 
frozen during the optimization. To apply this method the coefficient of the frozen orbital 
has to be calculated, which is usually done using small models assuming its 
transferability. Although this method does not cause overpolarization, it is more 
complicated than using link atoms. In GHO,64 Gao and co-workers suggested the addition 
of the hybrid orbitals to the MM atom. This allows for the hybrid orbital linking the 
broken bond to be optimized while other auxiliary orbitals on the MM atom are fixed. 
Nevertheless, extensive parameterization is still needed. In general localized orbital 
approaches are more complicated. Comparative studies have shown that they can give 
slightly better results compared to the use of link atoms.  
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2.8.5 Setting-up QM/MM Model  
In order to set-up a QM/MM model, special care is always required in choosing the 
boundary between the two layers. For instance, all atoms involved in bond breaking and 
formation must be included in the inner layer. Aromatic or conjugated systems cannot be 
divided between the two layers. Atoms that change hybridization during the reaction 
should also be included in the high layer. A general practice is to start the calculations 
with a minimum QM layer, and then to systematically increase it in order to examine the 
selection of model on the obtained energies.66 
As mentioned earlier the accurate description of the boundary and coupling between 
the two layers is important for obtaining reliable and accurate results. Therefore, it is 
always important to partition the layer by cutting non-polar bonds. Replacing C-C bonds 
by C-H when using link atoms also helps minimize any errors due to the need to partition. 
Each MM atom of the broken bonds has to be replaced by only one single link atom. It is 
also important to always cut single bonds to minimize the error. Furthermore, in the 
subtractive approach, the broken bonds have to be at least three bonds away from bond 
formation/breaking in the QM subsystem. This maintains the same MM parameters at the 
boundary region to be used during the reactions.  
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3.1 Introduction 
Of the standard 20 genetically encoded amino acids methionine (Met) is one of the 
most easily oxidized.1 In particular, oxidation at its R-group sulfur can lead to formation 
of methionine sulfoxide (Met-O).1 Remarkably, Met-O can be reduced to give Met.2 This 
uncommon amino acid redox chemistry has increasingly been shown to be critical for 
many biological processes including protein regulation, the calcium-induced signal 
transduction pathway and immune responses.1,3-6 However, such post-translational 
modifications induced by oxidative stress are also known to be involved in aging and age 
related diseases including cancer and Alzheimer’s disease.7-9 
Methionine sulfoxide reductases (Msr’s) are a family of ubiquitous enzymes that 
reduce Met-O to Met.10,11 These enzymes have been shown to be important, for example, 
in cellular responses to oxidative stress,12-14 bacterial virulence,15,16 and against amyloid 
b-protein toxicity.17 There are two main classes of Msr’s, A and B, which are 
stereospecific for the S- and R-Met-O epimers respectively.18,19 Both classes are thought 
to utilize the same overall reaction despite having quite distinct active site compositions 
and being structurally unrelated.20 The few shared similarities include an active site 
cysteinyl and tryptophanyl that are thought to act as a nucleophile and help orient the 
substrate, respectively. In addition, both have several hydrogen bond donors that interact 
with the Met-O sulfoxide oxygen. However, the nature of these donors differs: MsrB has 
multiple ionizable and polar residues21 while MsrA contains two tyrosyl and a glutamyl 
residue.22 In vitro studies2 of recombinant MsrA have shown it to be 10-fold more active 
than MsrB. Furthermore, for several species it has been found that knocking it out 
enhances their susceptibility to oxidative stress23-25 while its overexpression results in 
longer lifespans.26,27 Meanwhile, its down regulation in human breast cancer cells 
increased the disease's aggressiveness both in vivo and in vitro.28 
Several experimental kinetic studies on MsrA have examined the possible roles of 
various active site amino acid residues. For instance, substitution of the Cys51 in 
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Escherichia coli MsrA by serine deactivated the enzyme, thus confirming its essential 
catalytic role.29 Similarly, substitution of the active site glutamyl (Glu94 in Neisseria 
meningitidis), thought to be important both in activation of Cys51 and as a proton donor 
to the substrate, by alanine drastically reduced the rate of catalysis 36500-fold.22 In 
contrast, mutation of either active site tyrosyl (Tyr82 or Tyr134 in Neisseria meningitidis) 
by Phe appeared to have little effect on the rate of reaction.22 However, simultaneous 
substitution of both by Phe decreased the catalytic rate significantly by ~10000-fold.22 In 
addition, using chemical probes and mass spectrometry a catalytic cysteine-derived 
sulfenic acid was detected in a wild type MsrA from Escherichia coli.29 The ionization 
states of Cys51 (the catalytic cysteine) and a second active site cysteine Cys198, known 
as the recycling cysteine, have also been experimentally measured. In particular, it was 
observed that upon substrate binding the pKa of Cys51 was reduced significantly from 9.5 
to 5.7 in Neisseria meningitidis.22 However, it was only decreased to 8.0 if Glu94 was 
replaced by Gln or if both Tyr82 and Tyr134 were replaced by Phe. This was suggested to 
indicate that these three residues are important for polarizing the sulfoxide S=O bond 
which also leads to a decrease in the pKa of Cys51.22 
Based on these and related experimental studies, several possible catalytic 
mechanisms for MsrA and by extension Msr's in general were proposed and are 
summarized in Scheme 3.1.18,30,31 Specifically, upon activation of Cys51 by some as yet 
unclear process to give the Cys51S– thiolate, the proposed mechanisms A and B in 
Scheme 3.1 commonly begin with formation of a sulfurane via nucleophilic attack of 
Cys51S– at the Met-O sulfur.32 However, two alternate mechanisms were suggested for 
the subsequent reactions of the sulfurane: (A) it undergoes a 1,2-shift of the sulfurane's –
OH group from the substrate sulfur to the adjacent Cys51 sulfur to give the sulfenic acid 
Cys51SOH and the desired Met product or, (B) it is protonated at its oxygen to give a 
sulfonium. In the former the resulting catalytic cysteine-derived sulfenic acid 
intermediate readily reacts with the recycling cysteine, which itself has been activated and 
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is in its thiolate form, to give an intra-molecular disulfide bond. In contrast, in the latter 
proposed mechanism B the recycling cysteine thiolate directly attacks the Cys51S center 
of the sulfonium to give an intra-molecular disulfide bond and the reduced Met product, 
i.e., without formation of the sulfenic acid.14 In both cases, the active site is then 
ultimately regenerated via reduction of the disulfide bond by Thioredoxin (Trx).33  
 
Scheme 3.1. Proposed30,31 reductase mechanisms for MsrA via (A) a sulfenic acid 
intermediate, or (B) via direct attack. 
 
 
However, more recently Lim et al.18 using mass spectrometry and isotope labeling 
identified peptide modifications formed during the catalytic mechanism of mouse MsrA. 
To prevent other modifications such as disulfide bond formation they mutated Cys107, 
Cys218 and Cys227 to serine. They observed that the catalytic cysteine was converted to 
a sulfenic acid (CysSOH) during the course of the mechanism. Importantly, and in 
contrast to that previously proposed, the CysSOH oxygen was not derived from the initial 
Met-O substrate but instead from the aqueous solvent. Consequently, they proposed a 
modified mechanism for MsrA involving sulfonium and sulfenic acid intermediates 
highlighted in Scheme 3.2. 
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Computationally, there have been very few studies on the catalytic mechanism of 
Msr's. Recently, Thiriot et al.34 used a DFT-cluster approach to gain insights into the 
reductase mechanism of MsrA. Specifically, the substrate was modeled by dimethyl 
sulfoxide (DMSO) and the R-groups of the active site residues Tyr134 and Tyr82, Glu94 
and Cys51S– by phenol and water, CH3S– and acetic acid respectively. In addition, 
general environment effects were included via use of a PCM solvation method with a 
dielectric constant (e) of 2. Importantly, they showed that formation of a sulfonium 
intermediate may occur via nucleophilic attack of Cys51S– at the substrate's sulfur with 
stepwise protonation of its sulfoxide oxygen by Glu94 and Tyr134. Furthermore, a 
sulfenic acid intermediate was calculated to lie quite low in energy. Unfortunately, a 
reaction pathway between the sulfonium ion and sulfenic acid was not elucidated. 
However, they suggested it may involve dissociation of the sulfonium with the H2O 
moiety released then attacking the catalytic cysteinyl's sulfur to give a sulfenic acid. 
 
Scheme 3.2. Proposed18 catalytic reductase mechanism for MsrA involving formation of 
a sulfenic acid intermediate via attack of a solvent water at the catalytic cysteine's sulfur 
centre. 
 
 
Previously, we performed a computational investigation on the complete catalytic 
reductase mechanism of MsrB using a large DFT-cluster model and with the general 
protein environment modeled by a PCM solvation method with e = 4 as common in such 
approaches.35 In particular, we showed that the mechanism may be initiated by 
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nucleophilic attack of the catalytic Cys at the substrate's sulfur with concomitant proton 
transfer from a nearby histidyl residue to form a sulfurane. A sulfonium cation was then 
formed via transfer of a proton from a second histidyl residue onto the sulfurane's oxygen. 
However, within the computational model used, two possible enzymatically feasible 
mechanisms were then obtained by which the Met product could be formed: (i) direct 
attack of the recycling cysteine thiolate at the sulfonium's catalytic cysteinyl sulfur, or (ii) 
via a sulfenic acid intermediate. The latter was found to not be feasible via intramolecular 
rearrangement of the sulfurane as previously suggested. Instead, it required a solvent 
water to attack the sulfonium's catalytic cysteinyl sulfur as experimentally observed in 
MsrA.18 
A clearer elucidation of the catalytic mechanism of Msr's is central to a greater 
understanding of their role in aging, oxidative stress and other important physiological 
processes. In addition, due to their use of a diverse variety of sulfur compounds and 
chemistry, they represent a tremendous opportunity to obtain greater insights into the 
important area of sulfur biochemistry, in particular that of highly reactive species such as 
sulfenic acids. We have thus performed a detailed systematic computational investigation 
into the catalytic mechanism of MsrA. More specifically, we have complementarily 
applied Docking, Molecular dynamics (MD) simulations and an extensive ONIOM 
QM/MM approach to investigate activation of the catalytic cysteinyl and the subsequent 
reductase mechanism that leads to formation of Met and the intra-molecular disulfide 
bond. 
 
3.2 Computational Methods  
Docking and MD Studies. These calculations were performed using the Molecular 
Operating Environment (MOE) program.36 The X-ray crystal structure (PDB ID: 1NWA) 
of MsrA from Mycobacterium tuberculosis (MsrAMtb) complexed with protein-bound 
methionine was used as a template for docking.37 The substrate and all crystal structure 
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waters were removed then the substrate methionine sulfoxide (Met-O) docked into its 
active site where all residues within the first interaction shell of the catalytic cysteine 
(Cys13) were considered as in the active site. The London dG scoring function was used 
in conjunction with a force field refinement method in order to obtain the top 30 scoring 
structures. These were visually examined to choose the most suitable starting structure for 
further calculations. A molecular dynamics (MD) simulation was then performed on the 
chosen structure to allow for thermal relaxation. More specifically, the enzyme-substrate 
complex was spherically solvated up to 15 Å from the substrate. Then MD simulations 
were performed for 1 ns using a time step of 2 fs in a same manner as has been 
previously38 described. The structures generated during the simulation were analysed and 
clustered according to the distance between the sulfur's of the catalytic cysteine and 
substrate into 10 clusters. The overlay of the 10 average structures of the generated 
clusters show similar interactions (See Appendix Figure A1); furthermore, the RMSD of 
the QM-region moieties (QM-RMSD) of the 10 structures was 0.12 Å, indicating a very 
consistent structure. The average structure of the most populated cluster was then 
optimized using the AMBER99 force field,39 and the resulting structure (structure A') 
being used to construct a QM/MM chemical model to examine the catalytic mechanism 
of MsrA up to and including formation of a sulfenic acid intermediate. 
A second MD simulation was performed to model possible rearrangements in the 
active site upon sulfenic acid formation. Similar to the protocol detailed above the X-ray 
crystal structure PDB ID: 1NWA was modified to remove the substrate and all 
crystallographic waters. The catalytic cysteine was then modified to form a sulfenic acid 
(CysSOH) and the resulting intermediate spherically solvated up to 15Å from the sulfur 
of the CysSOH moiety. The complex was equilibrated for 0.5 ns followed by a 1 ns 
production run as previously described.40 The S-O bond of the CysSOH moiety was 
constrained to its optimized length as obtained at the B3LYP/6-31G(d) level of theory. 
Partial charges for the sulfenic acid were also obtained via a Mulliken population analysis 
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of IC3 performed at the below QM/MM level of theory. The resulting structures obtained 
were cluster-analyzed based on the sulfenic acid hydrogen-bonding network into 10 
clusters (see above). Similarly, the 10 average structures were overlaid ((See Appendix 
Figure A2) and analyzed and found to have a QM-RMSD of 0.24 Å. Again, the average 
structure of the most populated cluster was chosen and optimized using the AMBER99 
force field.39 The resulting complex, structure B', was used to construct a QM/MM 
chemical model to examine the catalytic mechanism of MsrA for formation of the final 
product from the sulfenic acid intermediate. 
QM/MM models and calculations. All QM/MM calculations were performed within 
the ONIOM formalism41 using the Gaussian 0942 suite of programs. The density 
functional theory method B3LYP; a combination of Becke’s three parameter exchange 
functional43 and Lee, Yang and Parr’s correlation functional44 was used for the high-layer 
(QM) while the AMBER9645 force field was used for the low-layer (MM) 
parameterization. Optimized geometries (the default convergence criteria of Gaussian 
0942 was used throughout) were obtained using the 6-31G(d) basis set for the high-layer 
and within the mechanical embedding (ME) formalism, i.e., at the ONIOM(B3LYP/6-
31G(d):AMBER96)-ME level of theory. Frequency calculations were also obtained at 
this same level of theory in order to characterize the nature of the stationary points 
obtained (i.e., minima or transition structures) and to calculate Gibbs energy corrections 
(ΔGcorr). The single imaginary and first real frequencies for the optimized TSs are 
reported (See Appendix Table B1). Relative energies were then obtained via single point 
energy calculations at the ONIOM(B3LYP/6-311+G(2df,p):AMBER96) level of theory 
within the electrostatic embedding (EE) formalism on the above optimized structures, and 
with inclusion of the appropriate ΔGcorr. All atoms in the QM layer were unfixed while 
for the MM layer only the Cα centres were kept fixed at their final MD positions. This and 
similar QM/MM approaches have been successfully used to explore a range of enzymatic 
systems.46-52 
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The chemical models used were obtained by truncating structures A' and B' to only 
include those residues in the first- and second-shell centered on the sulfur of the catalytic 
cysteine and where appropriate the substrate. The resulting two active sites models, A and 
B, enabled us to more effectively consider the different stages in the overall mechanism 
and are shown in Figure 3.1. More specifically, models A and B were used to investigate 
possible catalytic mechanisms of MsrA resulting in (i) formation of a enzyme-derived 
sulfenic acid intermediate and (ii) conversion of a sulfenic acid intermediate to the final 
products, respectively. In model A the Met-O substrate was modeled by ethylmethyl-
sulfoxide. It should be noted that in model A (Figure 3.1A) the catalytic and recycling 
cysteinyls (Cys13 and 154), three tyrosyl (Tyr 92, 44 and 152), three charged residues 
(Glu52, Asp87, His155), three H2O and the backbone of Trp15, Phe14 and Cys154 were 
included in the QM layer. The R-groups of Phe14 and Trp15 were kept in the low (MM) 
layer as DFT does not take into account Van der Waals interactions which are important 
for their interactions with the Met-O substrate.53 It is worth noting that several QM/MM 
models were also tested that contained a smaller QM-region, e.g., lacking residues near 
the catalytic and recycling cysteinyl residues. However, these were found to not 
adequately describe the chemistry of the reactions that would likely occur as part of the 
mechanism. For model B (Figure 3.1B) the QM-layer included the catalytic and recycling 
cysteinyls (Cys13 and 154), two charged residues (Asp87 and His155), three H2O and the 
backbone of Trp15 and Phe14. 
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Figure 3.1. The QM/MM models used to examine the catalytic mechanism of MsrA for 
(A) formation of an enzyme-derived sulfenic acid intermediate from the initial enzyme-
substrate complex and (B) reaction of the enzyme-derived sulfenic acid intermediate to 
give the final products. The inner circles represent the QM layer while the outer represent 
the MM layer. Color key for MM residues: included in their entirety (black); R-group 
replaced by hydrogen (red); R-group included in the MM layer while backbone is in the 
QM layer (blue). 
 
3.3 Results and Discussion 
3.3.1 Substrate binding and activation of the catalytic cysteine. 
As noted in the introduction, all previously proposed mechanisms involve 
nucleophilic attack of the sulfur of the thiolate form of the catalytic cysteine (Cys13 in 
MsrAMtb) at the sulfur center (Ssub) of the Met-O substrate.18,31,33 In order for this to occur, 
however, Cys13 must be activated by deprotonation of its thiol. Indeed, as noted 
previously it has been shown experimentally22 that in the absence of the substrate the pKa 
of the thiol of the catalytic cysteine is 9.5, but decreases to 5.7 upon substrate binding. X-
ray crystal structures of MsrA's from different species have revealed that there is no basic 
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residue in close proximity to the catalytic cysteine,22 the closest being a glutamyl (Glu52 
in MsrAMtb) ~5 Å away.37 Nevertheless, Glu52 has been suggested to play a role in 
activating Cys13 and lowering the pKa of its thiol.22 
In the optimized structure of the pre-reactive complex (PRC) in which the substrate is 
bound within the active site and Cys13 is neutral a water molecule forms a hydrogen 
bond bridge between the Cys13 thiol and the R-group carboxyl of Glu52 with distances of 
2.55 and 1.67 Å, respectively (Figure 3.2). In the MD simulations on the PRC complex, a 
water is also observed to consistently be similarly positioned and hydrogen bonded (See 
Appendix Figure A3). Meanwhile, the backbone amide -NH- moiety of W15 forms a 
weak hydrogen bond with the Cys13SH sulfur with a length of 3.07 Å.54 Meanwhile, the 
substrates sulfoxide oxygen (Osub) is observed to form shorter, stronger hydrogen bonds 
with the phenol hydroxyls of Tyr92 and Tyr44 with lengths of 1.76 and 1.78 Å, 
respectively. As a result, the substrates Ssub=Osub bond lengthens markedly upon binding 
by 0.08 Å to 1.55 Å (See Appendix Table B1). It is noted that the distance between the 
sulfurs of Cys13 and the substrate, r(Cys13S…Ssub), is quite long in PRC at 3.79 Å. 
The structure and in particular hydrogen bond network within PRC suggests that 
Cys13SH may be able to transfer a proton via a bridging H2O onto the R-group 
carboxylate of Glu52. At the B3LYP/6-31G(d) level of theory the proton affinities (PAs) 
of methylthiolate and acetate, models of the ionized R-groups of cysteine and glutamate, 
are calculated to lie just 34.3 kJ mol–1 apart, with the former being the more basic (See 
Appendix table B1). Indeed, Cys13SH is able to formally transfer a proton through a H2O 
onto the carboxylate of the Glu residue. This step proceeds via TSAct at a cost of just 38.5 
kJ mol–1 (Figure 3.3). The slightly lower relative energy of TSAct (10.8 kJ mol-1) with 
respect to RC is an artifact of the use of free energy corrections and indicates that at 298 
K RC can effectively convert back to PRC without a barrier. It indicates that the reverse 
reaction, i.e., proton transfer from Glu51COOH via a water to Cys13S–, effectively 
occurs without a barrier. As can be seen in the structure of TSAct (Figure 3.2) the thiol's 
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proton lies approximately midway between the sulfur of Cys13 and the water's oxygen. 
Meanwhile, the water has almost wholly transferred its proton onto the glutamyl's 
carboxylate, r(Glu52COO–…H-OH)  = 1.08 Å. This process may be facilitated by the 
moderately strong hydrogen bond between the H2O and the backbone -NH- of Phe14 in 
PRC and TSAct which would help stabilize negative charge build-up on the water's 
oxygen and thus enhance the water's acidity. It should be noted that possible alternate 
mechanisms were also examined involving proton transfer from Cys13SH via a H2O (i) 
directly onto the sulfoxide oxygen of the Met-O substrate and, (ii) to the glutamyl with 
concomitant nucleophilic attack of Cys13S– at the substrate's sulfur centre. However, 
both mechanisms were found to be enzymatically unfeasible. 
 
 
Figure 3.2. Schematic illustration of the optimized structures of the pre-reactive complex 
(PRC), activated reactive complex (RC) and the transition structure (TSAct) for their 
interconversion. For simplicity, only selected residues, functional groups and bond 
lengths (Angstroms) are shown. 
Two mechanistically relevant conformers of the reactive complex (RC) were 
optimized that differed only in the nature of the hydrogen bond formed by Glu52COOH. 
In one (RC', not shown), it is hydrogen bonded via the H2O with the now deprotonated 
thiol of Cys13. However, a low barrier rotation of the glutamyl's R-group about its Cβ—
Cγ bond, i.e., a change in its ∠CαCβCγO angle, from -86.6° to -62.4° gives rise to the 
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alternate conformer RC shown in Figure 3.3 lying slightly higher in energy than RC' by 
3.7 kJ mol-1 and just 49.3 kJ mol-1 higher in energy than PRC. In RC, the Glu52COOH 
group is now directly hydrogen bonded to the substrate's sulfoxide oxygen with 
r(Glu52COOH…OsubS) = 1.82 Å (Figure 3.2). The two phenol hydroxyl's (Tyr92OH and 
Tyr44OH) also remain strongly hydrogen bonded to the substrate's sulfoxide oxygen with 
distances of 1.80 and 1.75 Å, respectively. As a result, the sulfoxide's Ssub=Osub bond has 
now elongated further to 1.60 Å, increasing the negative charge on Osub and enhancing 
the susceptibility of Ssub to nucleophilic attack. In addition, in RC the distance between 
the sulfur's of Cys13 and Met-O has decreased significantly by 0.53 to 3.26 Å, such that 
they are now more suitably positioned for reaction. 
 
 
Figure 3.3. Free energy surface (kJ mol-1) obtained (see Computational Methods) for 
activation of the catalytic cysteine (Cys13) by proton transfer via a bridging H2O to the 
active site glutamate (Glu52). 
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3.3.2 Reduction of the substrate with formation of a sulfenic acid intermediate. 
Following activation of the catalytic cysteine (Cys13) via proton transfer to the 
carboxylate of the glutamate (Glu52) residue, the latter is then able to transfer the proton 
onto the substrate's sulfoxide oxygen. Concomitantly, the now anionic sulfur of Cys13 
nucleophilically attacks the substrate's sulfoxide sulfur center thus generating a sulfurane. 
This step proceeds via the transition structure TS1 with a quite low activation energy of 
only 11.8 kJ mol–1 while the sulfurane intermediate formed, IC1, lies decidedly lower in 
energy than RC by 47.0 kJ mol–1 (Figure 3.4). 
 
 
Figure 3.4. Free energy surface (kJ mol-1) obtained (see Computational Methods) for 
formation of a sulfenic acid intermediate (Cys13SOH) involving the proton donors (A) 
Glu52COOH and Tyr92OH and (B) Glu52COOH and Tyr44OH. 
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The optimized structures of the reactant and product complex, intermediates and 
transition structures obtained, with selected bond and interaction distances in angstroms 
(Å), are schematically illustrated in Figure 3.5. As can be seen, in TS1 the proton 
transferring from the Glu52COOH group is roughly equidistant to the substrates sulfoxide 
oxygen (Osub) with r(Glu52COO…H+) and r(Osub…H+) = 1.23 and 1.22 Å respectively. 
More importantly, however, the substrates S—O bond has lengthened markedly to 1.74 Å 
while the key Cys13S…Ssub distance has shortened significantly by 0.51 Å to 2.75 Å. In 
the sulfurane intermediate IC1 the S—O bond has lengthened even further to 2.31 Å 
while the Cys13S—Ssub disulfide bond has now formed as indicated by its length of 2.23 
Å. It is noted that these bond lengths are in reasonable agreement with a sulfurane 
intermediate we obtained previously35a as part of a computational study on the 
mechanism of an MsrB using a DFT-large active site chemical model approach. In 
contrast, the S–OH and S–S lengths are considerably longer and shorter respectively than 
obtained by Thiriot et al.34 in a computational study using more modest active site 
models. This suggests that the structure of the active site and its environment in MsrA and 
Msr's in general may act to help to stabilize a more polarized sulfurane intermediate. 
In IC1 the sulfurane's oxygen now forms even shorter and stronger hydrogen bonds 
with the phenol hydroxyls of both Tyr44 and Tyr92 compared to that observed in RC 
with distances of 1.60 and 1.56 Å, respectively (Figure 3.5). As noted previously, 
experimental22 mutation studies involving the two active site tyrosyl's suggest that 
substitution of either alone reduces the rate of the reaction only slightly while mutation of 
both has a severe negative effect on the rate. Previous computational studies34,35a have 
suggested that the sulfurane hydroxyl (Ssub-OsubH) can accept a proton from an acidic 
residue. This is likely facilitated in part by the sulfurane's oxygen Osub greater basicity35a 
than that of the sulfoxide oxygen in Met-O, which is likely further enhanced by the 
sulfurane's polarized nature within the active site. Thiriot et al.34 suggested that one of the 
active site tyrosyl's may be able to act as such an acid and protonate the sulfurane's –
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OsubH oxygen. Given the similar distances for the hydrogen bond interactions between 
Osub and Tyr44OH and Tyr92OH (Figure 3.5), we considered the feasibility of either 
tyrosyl acting as the second mechanistic acid. 
 
 
Figure 3.5. Schematic illustration of the optimized structures with selected bond lengths 
(in Angstroms) of the minima and transition structures obtained for MsrA catalysed 
reduction of Met-O to Met with concomitant formation of an enzyme-derived sulfenic 
acid intermediate. 
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The phenol hydroxyl of Tyr92 is able to transfer its proton essentially without a 
barrier onto the sulfurane's oxygen Osub via TS2a to give the sulfonium cation 
intermediate IC2a (Figure 3.4). The latter lies slightly lower in energy than IC1 by 7.0 kJ 
mol-1 (i.e., –54.0 kJ mol-1 with respect to RC). The fact that TS2a (upon adding free 
energy corrections) is lower in energy than IC1 and IC2a suggests that these 
intermediates should be able to readily interconvert. In TS2a the proton is almost 
equidistant between the sulfurane and tyrosyl oxygen's as indicated by the fact that the 
r(Tyr92O…H) and r(Tyr92OH…Osub) distances are 1.23 and 1.20 Å, respectively (Figure 
3.5). In the sulfonium complex IC2a the Ssub…OH2 interaction has been effectively 
cleaved as indicated by its distance of 2.74 Å, while the Cys13S—Ssub disulfide bond has 
shortened to 2.13 Å (Figure 3.5). 
Alternatively, Tyr44 can act as the second mechanistic acid. More specifically, it is 
able to transfer its phenolic proton onto the sulfurane's oxygen Osub via TS2b without a 
barrier (Figure 3.4). In contrast to that observed when Tyr92 acts as an acid, the resulting 
sulfonium complex formed, IC2b, is calculated to lie decidedly lower in energy than IC1 
by 40.4 kJ mol-1 (i.e., –87.4 kJ mol-1 with respect to RC). This greater stabilization of the 
sulfonium may reflect in part enhanced stabilization of the positive charge on the 
Cys13S—Ssub disulfide by the now anionic phenol oxygen of Tyr44 at a distance of 2.80 
Å. In contrast, the Ssub…OH2 distance in IC2b is markedly longer than observed in IC2a 
with a length of 3.30 Å (Figure 3.5). 
Based in part on a previous computational study by Balta et al.,55 Thiriot et al.34 
suggested that the sulfurane, upon protonation, may dissociate to a sulfonium cation and 
water molecule. The water moiety may then attack at the Cys13 sulfur center of the 
cationic disulfide to generate methionine (Met) and an enzyme-derived sulfenic acid 
(Cys13SOH). Indeed, for MsrA a catalytic cysteine-derived sulfenic acid has been 
detected in mutant and wild-type enzymes using chemical probes and mass 
spectrometry.29 Unfortunately, they were unable to locate a pathway and barrier for this 
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process. Also, it has previously been suggested that the sulfurane intermediate could 
undergo an analogous 1,2-sigmatropic shift of its –OsubH group to generate Met and the 
sulfenic acid derivative.14 However, we previously showed that the barrier for such a 
process was enzymatically unfeasible.35a Recently, experimental labeling studies have 
suggested that the oxygen of the sulfenic acid is in fact derived from the aqueous solvent 
and not the Met-O substrate.18 Notably, in the optimized structures of both IC2a and IC2b 
(see Figure 3.5) and in an X-ray crystal structure of the wild-type enzyme, a H2O is 
positioned within the active site and oriented such that its oxygen is directed towards the 
Cys13S center of the sulfonium disulfide moiety. Specifically, in IC2a and IC2b the 
distance between the water oxygen (Ow) and sulfonium's Cys13 sulfur center is 3.42 and 
3.25 Å respectively. Simultaneously, the water acts as a hydrogen bond donor to the 
sulfur of the recycling cysteine Cys154 with r(OH2…SCys154) = 2.34 and 2.35 Å in 
IC2a and IC2b, respectively (Figure 3.5). 
However, for nucleophilic attack of the water at Cys13S to occur, the H2O needs to be 
either be first deprotonated or be able to donate a proton to a suitable base. In our present 
model Cys154 has been modeled as neutral based on its experimentally measure pKa 
value of 9.5.22 Thus, in order to be able to act as a suitable base its thiol must itself be 
able to transfer its proton to a suitable base. Importantly, during the initial MD 
simulations on the initial active site-bound substrate complex (see Computational 
Methods) the thiol of Cys154 was observed to consistently be directly hydrogen bonded 
to the R-group carboxylate of a spatially adjacent aspartyl (Asp87). In the QM/MM 
optimized structures of both IC2a and IC2b the Cys154SH group forms a short and strong 
hydrogen bond to Asp87; r(Cys154SH…–OOC-Asp87) = 1.95 Å. Consequently, the 
Cys154S—H bond itself is elongated now having a length of 1.37 Å in both complexes 
compared to 1.33 Å (at the B3LYP/6-31G(d) level of theory) in an isolated methylthiol. 
Thus, it appears that Cys154 may indeed be able to act as a suitable base to facilitate 
sulfenic acid formation. It is noted that within the active site region the only other residue 
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that may be able to act as base is His155. However, the distance between the nearest 
nitrogen of its R-group imidazole and H2O is quite large (~4.85 Å). Hence, it would seem 
less likely to be a suitable a base to facilitate sulfenic acid formation. 
In the present study, for both situations in which Tyr92 or Tyr44 acts as the second 
mechanistic acid, the H2O is able directly attack at the Cys13 sulfur center of the 
sulfonium's disulfide bond. Importantly, this occurs with concomitant proton transfer 
from the attacking H2O onto the thiol of Cys154 which itself has transferred its proton to 
the adjacent R-group carboxylate of Asp87. For the case in which Tyr92 acted as an acid, 
this step proceeds via TS3a at a cost of 32.6 kJ mol-1 with respect to IC2a. In the resulting 
intermediate complex obtained, IC3a, the desired methionine (modeled by 
ethylmethylsulfide) product is bound within the active site. In particular, it is positioned 
such that its methyl is directed towards the R-group of the active site tryptophanyl residue 
(Trp15). Furthermore, however, the catalytic cysteine (Cys13) has now been oxidized to a 
sulfenic acid (Cys13SOH). Thermodynamically, the complex IC3a lies significantly 
lower in energy than IC2a by 168.4 kJ mol-1 which is -222.4 kJ mol-1 with respect to RC. 
Structurally, in TS3a it can be seen that the Cys154SH proton is essentially wholly 
transferred onto the carboxylate of Asp87, r(Cys154S…H+) = 2.08 Å (Figure 3.5). In 
contrast, the proton being abstracted from the attacking H2O lies between the Cys154S 
and Ow centers with distances of 1.76 and 1.16 Å respectively (Figure 3.5). In contrast, 
for the pathway in which Tyr44 acted as an acid this process occurs via TS3b with a 
markedly higher cost of 85.6 kJ mol-1 with respect to IC2b (Figure 3.4). In fact, the 
relative energy of TS3b is higher than that of TS3a by 19.6 kJ mol-1. As obtained for 
IC3a, in the resulting sulfenic acid-containing active site complex IC3b, the desired 
ethylmethylsulfide product is again positioned within the active site such that its methyl is 
oriented towards the R-group of Trp15. In addition, IC3b also lies considerably lower in 
energy than IC2b and RC, though now by 120.9 and 208.3 kJ mol-1, respectively. 
Notably, while IC3b lies slightly higher in energy than IC3a by 14.1 kJ mol-1 (see Figure 
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3.5), they can interconvert with each other. This could occur by a proton transfer via the 
H2O that is simultaneously hydrogen bonded to the carboxylate of Glu52 and the phenolic 
oxygen's of both Tyr92 and Tyr44 (see Figure 3.5). Structurally, TS3b is very similar to 
TS3a and hence is not discussed in detail herein. 
We have also considered the catalytic pathway from RC to IC2 in which either Tyr92 
or 44 is substituted by a pheylalanyl (i.e., for the mutated enzymes Y92F or Y44F). 
Structurally, mutating either tyrosyl leads to a strengthening of the Met-O S—O bond 
(i.e., decreased polarization of the S–O bond via hydrogen bonds with the Tyr-OH 
groups) and concomitantly longer –S—S– bond in the sulfurane (IC1). Furthermore, a 
slight reduction is observed in the barrier for formation of IC1; specifically, it decreases 
from 14.6 kJ mol-1 in the wild-type to 12.8 and 4.6 kJ mol-1 in the Y44F and Y92F 
mutated enzymes, respectively (See Appendix Figure A4). It is noted that the magnitude 
of these energy changes are within the expected error margins of our calculations. 
Furthermore, these mutations lead to similar destabilizations of the resulting sulfurane 
(IC1) from -52.1 kJ mol-1 (with respect to RC) to -21.0 and 22.4 kJ mol-1, respectively. 
The subsequent sulfonium intermediates (IC2) are also destabilized, although now with a 
marked difference in magnitude between the two mutations, as indicated by the increase 
in its relative energy from -53.7 kJ mol–1 (wild-type) to -51.8 (Y92F) and -28.7 (Y44F) kJ 
mol–1. It is noted that this change in the relative energies of the subsequent sulfonium 
intermediates has little effect on the barrier for proton transfer from the remaining tyrosyl 
to the sulfurane's oxygen. For instance in the wild-type system the barrier for reaction via 
TS2a is 0.9 kJ mol–1 while in Y92F and Y44F it is 0.8 and 3.0 kJ mol–1, respectively. 
Importantly, however, assuming that the tyrosyl's have no effect on the activation of 
Cys13 (proton transfer from Cys13-SH via a H2O to Glu52COO–), the rate-limiting step 
in the reductase stage remains formation of the sulfurane from RC (See Appendix Figure 
A5). 
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The above results may also give insights into observations from experimental22 
mutagenesis studies in which the substitution of Tyr92 or Tyr44 (Tyr134 or Tyr82 in 
Neisseria meningitidis) by Phe was shown to have little effect on the catalytic rate. In 
particular, the experimentally measured difference in rates between the two mutations 
corresponded to a difference in rate-limiting barrier heights of ~6 kJ mol–1. The results of 
the present study emphasize the ability of either active site tyrosyl to act as a mechanistic 
acid. Furthermore, they also suggest only minor changes within the error margins of the 
present calculations in the thermodynamics of formation of the enzyme-sulfenic acid 
intermediate upon mutation of either tyrosyl. 
It should be noted that alternative mechanistic pathways were also considered. In 
particular, the direct nucleophilic attack of the sulfur of the recycling cysteine (Cys154) at 
the catalytic cysteine's (Cys13) sulfur center was investigated. That is, the direct reaction 
of the sulfonium intermediate to give the final product complex (PC), bound Met with 
formation of an intramolecular Cys13S–SCys154 disulfide bond (see Scheme 3.1B), 
without formation of a sulfenic acid intermediate (see below). Previous computational 
studies have shown that if a thiolate is suitably positioned it can readily react with a 
sulfonium to give a disulfide, e.g., CysS—CysS, and a alkylated sulfide, e.g., Met.56 
However, in the sulfonium complexes IC2a and IC2b the sulfurs of the two active site 
cysteinyl residues are at least 5.1 Å apart and with a Cys13Cα—CαCys154 distance of 
7.14 Å. Thus, direct nucleophilic attack of the thiol of Cys154 at the Cys13S center in 
either sulfonium complex appears unlikely to occur. It is noted that larger distances 
between the catalytic and recycling cysteines has been observed in the X-ray crystal 
structures of MsrA's from several species. For example, for an MsrA from E. coli the 
distance between the Cα carbons of the catalytic and recycling cysteinyl residues is 
approximately 11.0 Å!37 However, if the Cys13S—Ssub bond was first cleaved, Cys13 
would then be free to undergo a conformational change that reorients its sulfur closer to 
that of the recycling cysteine. 
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3.3.3 Reduction of the sulfenic acid with formation of an intramolecular disulfide bond 
As noted for both of the above IC3 complexes (IC3a and IC3b), the initial Met-O 
substrate has now been reduced to Met. Importantly, however, with cleavage of the 
sulfonium's Cys13S—Ssub bond and formation of the sulfenic acid Cys13SOH, the Met 
moiety is now free to leave the active site. This would likely enable water(s) to enter the 
active site, the anionic tyrosyl residue (Tyr44 or Tyr92) to regain a proton and may result 
in some changes in the hydrogen bonding network and possibly some repositioning of the 
active site residues. Hence, as detailed in the Computational Methods, in order to better 
model such changes an MD simulation was performed on a "resolvated Met-free" 
Cys13SOH-containing active site complex. The QM/MM optimized structure obtained at 
the same level of theory as above and hereafter referred to as IC3', is shown in Figure 
3.7. 
In IC3', both Tyr92 and Tyr44 are modeled as neutral while the R-group carboxylate 
of Asp87 is modeled as anionic. That is, the two former residues have regained or kept 
their proton while the latter has been deprotonated. It is noted that in both the average 
structure obtained from MD simulations and in the QM/MM optimized structure, a chain 
of waters was observed to interconnect the R-groups of Asp87 and the two tyrosyl 
residues. It thus appears possible that regeneration of the neutral tyrosyl residues could 
occur via proton transfer along a water chain from the Asp87COOH moiety generated 
during or possibly after sulfenic acid formation (See Appendix Figure A6). 
Structurally, in IC3' the hydroxyl of the Cys13SOH sulfenic acid acts as a hydrogen 
bond donor to an active site H2O that is itself simultaneously hydrogen bonded to the 
backbone carbonyl oxygen of Cys13, the R-group imidazole of His155 and the sulfur of 
Cys154. The thiol of Cys154 is also hydrogen bonded via another water molecule to the 
R-group carboxylate of Asp87. Due in part to this hydrogen bond network arrangement 
the hydroxyl of the Cys13SOH moiety sits approximately between the sulfur's of Cys13 
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and Cys154. Consequently, these two mechanistically important sulfur centers are not 
suitably positioned for the required nucleophilic attack of the Cys154S center at the 
sulfenic's acid sulfur to form an intramolecular Cys154S—SCys13 disulfide bond. 
Therefore, a rotation about the C—SOH bond of Cys13SOH (i.e., a change in its dihedral 
angle ∠CαCβSO) with a slight alteration to the active site hydrogen bonding network is 
required in order to suitably position the sulfurs of Cys13S and Cys154 for further 
reaction. More specifically, a change in ∠CαCβSO from 243.9° to 110.0° leads to 
formation of the alternate conformer IC3" lying just slightly higher in energy than IC3' 
by 14.0 kJ mol-1 (Figure 3.6). As can be seen in Figure 3.7, in IC3" the Cys13SOH 
hydroxyl now acts as a hydrogen bond donor with a water that is itself hydrogen bonded 
to the R-group carboxylate of Asp87. That is, the sulfenic acid is no longer hydrogen 
bonded via a water molecule with the thiol of Cys154. Importantly, as a result of this 
rotation, the sulfurs of the catalytic and recycling cysteine are now better positioned with 
respect to each other for reaction and are closer than in IC3' by 0.39 Å with a 
Cys154S…SCys13 distance of 4.54 Å. Furthermore, the sulfenic acids S—OH bond has 
lengthened slightly from 1.69 (IC3') to 1.72 Å. Unfortunately, within the present 
computational model we were unable to optimize a transition structure (TS4) for 
interconversion of IC3' and IC3". However, for isolated ethanesulfenic acid 
(CH3CH2SOH) at the B3LYP/6-31G(d) level of theory the analogous rotational barrier is 
very low at around 4.0 kJ mol-1. Thus, while the active site sterics and the hydrogen bond 
network may increase the barrier for this step, it is still unlikely to be significant or rate-
limiting. It is also important to note that sulfenic acid orientation in IC3" is in agreement 
with a sulfenic acid-containing X-ray crystal structure of MsrA from N. meningitides 
(PDB ID: 3BQG).33 Furthermore, two water molecules were also found to be positioned 
in the crystal structure such that they may be able to form a hydrogen bond bridge 
between the sulfenic acid's –SOH oxygen and a carboxylate oxygen of Asp87. In 
addition, a third water molecule was positioned such that it may form a hydrogen bond 
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bridge between the sulfenic acid's sulfur and the R-group of His155. However, the X-ray 
crystal structure as well as our MD structure also shows a chain of waters connecting the 
sulfenic acid oxygen to Glu52, Tyr44 and Tyr92, suggesting the possibility that one or 
more of these residues might also be able to play a role as proton donor's in the disulfide 
formation step. 
The nucleophilicity of the Cys154S sulfur center, and hence its ability to attack at the 
sulfur of Cys13, would be facilitated by deprotonation of the Cys154 thiol. In the present 
computational model this can be achieved by proton transfer from Cys154SH via a water 
molecule onto the R-group carboxylate of Asp87. This step proceeds via TS5 to give the 
Cys154S– thiolate-containing complex IC4 just 37.8 kJ mol-1 higher in energy than IC3". 
In IC4 the Asp87COOH group remains hydrogen bonded via a water with the Cys154S– 
thiolate while the Cys154S…SCys13 distance has decreased further by 0.13 Å to 4.41 Å 
(Figure 3.6). The slightly lower relative energy of TS5 (17.8 kJ mol-1) with respect to IC4 
is an artifact of the use of single-point energy calculations and free energy corrections. It 
indicates that the reverse reaction, i.e., proton transfer from Asp87COOH via a water to 
Cys154S–, occurs without a barrier. 
In order for the hydroxyl of the sulfenic acid to be a better leaving group for disulfide 
bond formation, it needs to gain a proton at some point and become H2O. The now 
neutralized Asp87 residue could act as a suitable proton donor. In particular, it needs to 
act as a hydrogen bond donor either directly or indirectly (e.g., via water) with the 
Cys13SOH oxygen center. This can be achieved by rotation of its carboxylate's –OH 
moiety, i.e., rotation about the aspartyl's Cβ—OH bond, such that it no longer hydrogen 
bonds indirectly with Cys154S–. This step proceeds via TS6 with a barrier of 39.4 kJ mol-
1 with respect to IC4. This is only slightly higher by 28.0 kJ mol-1 than that obtained for 
the analogous rotation in isolated propanoic acid at the B3LYP/6-31G(d) level of theory. 
This likely reflects in part general effects of the active site and the cleaving of the 
negatively charged Asp87COOH…OH2…–SCys154 hydrogen bonding interaction. The 
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resulting alternate conformer formed, complex IC4', lies 29.8 kJ mol-1 lower in energy 
than IC4. The Cys154S…SCys13 distance is only marginally affected by this rotation 
being 4.43 Å in IC4', while the sulfenic acids S—OH bond has lengthened marginally to 
1.74 Å (Figure 3.7). 
 
 
Figure 3.6. Free energy surface (kJ mol-1) obtained (see Computational Methods) for the 
reduction of sulfenic acid-containing complex to give an intramolecular disulfide bond 
with formation of H2O. 
 
The final step of the overall mechanism is nucleophilic attack of the anionic sulfur of 
Cys154 at the sulfur center of the Cys13SOH sulfenic acid to give a Cys154S—SCys13 
disulfide bond, and proceeds via TS7. As illustrated in Figure 3.7, formation of the 
disulfide bond occurs with concomitant transfer of the proton from Asp87COOH via a 
bridging water onto the leaving –OH group of the sulfenic acid to give a H2O molecule. It 
is noted that this reaction has been computationally investigated previously using density 
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functional theory in combination with small chemical models.56 Similar to the present 
results it was also found that disulfide bond formation involved an SN2 mechanism in 
which S—S bond formation occurred with concomitant proton transfer onto the leaving –
OH group.56 Within the present extensive QM/MM approach, however, the relative 
energy of TS7 is lower than that of IC4' (Figure. 3.6). This suggests that upon 
rearrangement of the Asp87COOH…OH2…HOSCys13 hydrogen bond network within 
the active site environment of MsrA, the reduction of the sulfenic acid to give a disulfide 
bond can effectively occur without a barrier. The resulting final product complex (PC) 
formed lies considerably lower in energy than IC3' by 133.1 kJ mol-1. The overall highly 
exothermic mechanism for sulfenic acid formation and its subsequent reduction supports 
the common experimental observation of the high reactivity of sulfenic acid and 
challenges in detecting its occurrence in the presence of the recycling cysteine. 
It is noted that within the present computational model the rate-limiting step of the 
overall mechanism appears to occur after formation of the sulfenic acid and corresponds 
to rotation within the Asp87COOH moiety.57 However, this approach is necessarily 
'static' and does not include free energy corrections. In contrast, the hydrogen bond 
network within the active site is likely quite dynamic. Thus, the presently calculated 
results for this stage of the overall mechanism likely represent an upper thermodynamic 
value. Indeed, the approximate rate-limiting barrier obtained from experimental kinetic 
studies on the wild-type enzyme in the absence of Trx is 56.6 kJ mol-1.30 This is in good 
agreement with the rate-limiting barriers presently calculated for the two possible 
pathways for sulfenic acid (IC3) formation from PRC: 61.1 and 85.6 kJ mol-1 in the case 
of Tyr92 and Tyr44 acting as the second mechanistic acid, respectively. 
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Figure 3.7. Schematic illustration of the optimized structures for sulfenic acid reduction 
and formation of disulfide bond 
 
In the mechanism described above for sulfenic acid reduction after methionine 
formation, the active site model used began with an initially anionic Asp87 (i.e., 
Asp87COO–) and protonated His155 (i.e., His155-H+). That is, these residues were in 
their usual charge states at pH 7. Experimentally, Gand et al.58 have examined the kinetic 
effects of mutating either Asp87 or His155 and concluded that a main role of Asp87 is in 
substrate binding. Our above MD simulations on the pre-reactive complex are in 
agreement as suggested by the observation of a consistent direct interaction between 
Asp87 and the substrate. However, the results of Gand et al. also found that mutating 
either Asp87 or His155 had similar kinetic effects. 58 We examined the effect of mutating 
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Asp87 to Alanine. More specifically, we replaced Asp87 by Ala in the pre-reactive 
complex (PRCAsp87Ala), then resolvated the complex using the same procedure as detailed 
in the Computational Methods. This was followed by a 1 ns MD simulation and the 
results obtained analyzed via cluster analysis. Notably, it was observed that in the 
PRCAsp87Ala the thiol of Cys154 consistently hydrogen bonds to the imidazole of His155 
either directly or via a water molecule (See Appendix Figure A6) This suggests the 
possibility of a Cys154-activation pathway involving His155 that is analogous to that we 
have previously described involving Asp87. Hence, for completeness and given that the 
pKa of the R-group of His lies near 7 and can be modified by the environment, we also 
considered an alternate mechanism in which the imidazole of His155 is neutral and thus 
able to act as a base. For this mechanism the R-group of Asp87 was modeled as neutral as 
it could still have participated in sulfenic acid formation by accepting a proton from 
Cys154SH. It should be noted that in the case of His155 facilitating Cys154 activation, no 
rotation of the hydroxyl in Asp87COOH would be necessary (i.e., IC4 →  IC4'). 
Importantly, His155 was indeed able to act as a base and accept a proton from the thiol of 
Cys154 in the activation of the latter residue (i.e., IC3' →  IC4) with a calculated reaction 
barrier of 65.1 kJ mol-1 (See Appendix Table B1). While this is enzymatically feasible, it 
is higher than obtained for the above mechanism via TS5. This suggests that mutation of 
Asp87 may not significantly affect sulfenic acid reduction as either basic residue near the 
thiol of the recycling cysteine could potentially facilitate its activation. 
 
 
Figure 3.8. Schematic illustration of our computationally suggested mechanism. 
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3.4 Conclusion  
The overall mechanism(s) by which methionine sulfoxide reductase A (MsrA) from 
Mycobacterium tuberculosis catalyzes the reduction of S-methionine sulfoxide (Met-O) 
to methionine (Met), i.e., the reductase stage, have been investigated via the 
complementary application of docking, molecular dynamics (MD) simulations and 
ONIOM (QM/MM) calculations. More specifically, docking and MD simulation were 
used to obtain solvated structures for the initial active site-bound substrate complex in 
which the catalytic cysteine (Cys13SH) is not yet activated (PRC), i.e., neutral. An 
ONIOM QM/MM approach in combination with a large active site model has been used 
to examine the mechanism of Cys13 activation and subsequent pathway(s) leading to 
formation of a sulfenic acid intermediate. In particular, Cys13SH is able to transfer its 
proton via a bridging water molecule onto the R-group carboxylate of the active site 
glutamate (Glu52) with a modest energy cost of 49.3 kJ mol-1, to give the activated active 
site-bound substrate complex, RC. The now anionic Cys13S– sulfur then nucleophilically 
attacks the sulfur of the Met-O substrate. This occurs with concomitant proton transfer 
from the now neutral Glu52COOH group onto the substrate sulfoxide oxygen. The 
resulting sulfurane intermediate is "polarized" by the active site environment. 
Consequently, the sulfurane's oxygen can readily accept a proton from the phenol 
hydroxyl of either of the active site tyrosyl residues, Tyr44 and Tyr92, with a negligible 
barrier or without a barrier, to give a sulfonium cation and water. The water formed is 
hydrogen bonded to the R-groups of both active site Tyr44 and Tyr92, and Glu52. 
It was found that a water moiety was then able to directly and readily attack the 
sulfonium cation at its Cys13S center, i.e., the sulfur of the catalytic cysteine, to give a 
sulfenic acid Cys13SOH and methionine in one step. In the active site chemical model 
used, the recycling cysteine (Cys154) was neutral, i.e., Cys154SH. It is found that a 
neutral Cys154SH group is able to facilitate sulfenic acid formation by accepting a proton 
from the attacking H2O while simultaneously transferring its proton via a water to the 
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nearby R-group carboxylate of Asp87. For the case in which Tyr92 acted as the second 
mechanistic acid this step occurs with a barrier of 32.6 while for the alternate case in 
which Tyr44 acted as an acid the barrier is higher but still enzymatically feasible at 85.6 
kJ mol-1. The resulting sulfenic acid intermediate complexes formed, IC3a and IC3b 
respectively, are calculated to lie significantly lower in energy than RC by -222.4 and -
208.3 kJ mol-1. 
Reduction of the sulfenic acid to give an intramolecular Cys154S—SCys13 disulfide 
bond, with formation of H2O, was found to occur via series of low barrier steps. 
Primarily, these steps involve the rearrangement of the active site hydrogen bond network 
and suitable positioning of the sulfur centers of Cys154 and Cys13 for reaction. It is 
found that nucleophilic attack by the sulfur of the neutral thiol of Cys154SH is facilitated 
by the R-group carboxylate of Asp87. In particular, the latter is able to accept the thiol 
proton and then transfer it via a H2O onto the leaving –OH group of sulfenic acid 
(Cys13SOH) concomitant with formation of the disulfide bond. Further, our results 
suggest an SN2 mechanism for disulfide bond formation, and that it would happen 
spontaneously after activation of Cys154 and suitable positioning of the Cys13SOH 
sulfur for nucleophilic attack by the thiolate sulfur of Cys154. 
Thus, the present results also suggest that both active site cysteines can at least 
initially be neutral. During the course of the reaction they can be activated for formation 
of the sulfurane or reduction of the sulfenic acid via direct or indirect proton transfers to, 
for instance, the R-groups of some active site residues including Glu52 and Asp87. 
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4.1 Introduction 
In the last two decades, the applications of quantum chemistry have been extended 
from small molecules to protein and DNA.1-4 More specifically, the introduction of 
density functional theory (DFT) methods as well as the vast growing of computational 
resources allowed for further applications in biochemistry.2,5 Enzymatic reactions are one 
of the main field were quantum chemistry have been applied successfully providing 
detailed information for numerous catalytic mechanisms.6-10 In order to model these 
proteins, there are two main approaches:1,3 1) quantum cluster approach in which the 
active site is basically extracted from the crystal structure of the substrate analogue bound 
proteins; the structure is truncated including only models of the catalytic residues; mostly, 
the quantum model is less than 200 atoms. 2) Quantum mechanics/molecular mechanics 
(QM/MM) approach in which docking and molecular dynamic (MD) simulations are used 
to prepare the model; then the MM minimized structure is truncated up to 10-20Å from 
the active site and partitioned into two layers where the catalytic residues are only 
included in the quantum layer and the rest of the model is calculated using molecular 
mechanics force field. Both approaches have been successfully used to investigate several 
enzymatic mechanisms,11-14 however they also have some downsides.1,9,15  
Earlier, we investigated in details the catalytic mechanism of Methionine sulfoxide 
reductase B (MsrB) using a quantum mechanical (QM)-cluster approach.16 The two 
previously experimentally proposed mechanisms were considered: (1) release of Met via 
sulfenic acid intermediate followed by nucleophilic attack of the recycling cysteine 
thiolate at sulfenic acid (–SOH) sulfur forming disulfide, (2) direct attack of the recycling 
cysteine thiolate at the sulfonium catalytic sulfur. Both mechanisms were found to be 
feasible! However, the direct sulfur attack was found to be energetically more favorable. 
More interestingly, it occurs via low barrier transition state of 23.8 kJ mol-1 which is 
almost half the barrier for sulfenic acid formation, 54.6 kJ mol-1. However, this energy 
difference is still small compared to computational error raising an important question, as 
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it is unclear if this difference is an artifact of the employed computational method or 
model. It is also important to mention that, there was a debate with experimentalists as 
they accept that a sulfenic acid intermediate would occur in the mechanism.17,18   
MsrB is subclasses of ubiquitous group of enzymes that play crucial roles in cellular 
protection mechanism against oxidative stress, Methionine sulfoxide reductase (Msr's), 
via reducing methionine sulfoxide (MetSO) back into methionine.19,20 MsrA, another 
subclass of the same group of enzymes, and MsrB are stereospecific to MetSO S- and R- 
epimers, respectively.21 Initially, the same reduction mechanism was proposed for both 
subclasses in which sulfenic acid was proposed to occur as a precursor intermediate to 
disulfide bond formation.22,23 In contrast, a direct sulfur attack on sulfonium cation 
intermediate mechanism was also suggested.24 More importantly, sulfenic acid 
intermediate was only detected in wild type of MsrA.25 However for MsrB, it was only 
detected upon mutating the second Cys.26 
Sulfenic acid is a fundamental key intermediate involved in redox chemistry of 
proteins.27,28 Its role in biochemistry diverge from signal transduction, non-enzymatic 
protein folding, protection against ROS and modulating gene transcription.29-34 It occurs 
either via direct oxidation of Cys by ROS, peroxynitirite and hypochlorous acid or 
indirectly during several enzymes catalytic reactions and xenobiotic metabolism.27,29,35-37 
Furthermore, it has been also proposed to occur as an essential precursor intermediate for 
disulfide bond formation in several enzymes.25,31,38-40 Since sulfenic acid has both 
nucleophilic and electrophilic characters, it is highly reactive and unstable species.27,28 
Therefore, once formed several fate reactions have been proposed to occur, such as 
overoxidation to sulfinic and sulfonic acids.29,41 Both reactions considered to be 
irreversible as their reduction require a very low pH.29 Furthermore, sulfiredoxin (Srx) is 
the only enzyme that has been shown to reduce sulfinic acid in Prx.42  
In contrast, several reversible protection mechanisms have also been also proposed. 
For instance, Nakamura et al. suggested the formation of a hypervalent sulfur 
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intermediate in archaeal peroxiredoxin via forming S–N covalent bond between –SOH 
and neighboring His.43 Likewise, it is protected in PTPs and OhrR via formation of 
sulfenyl-amide intermediate by forming a covalent bond with backbone nitrogen of the 
adjacent residue.44,45 More importantly, it could be stabilized and recycled via S-
thiolation forming a mixed disulfide bond with Trx, Grx and GSH or using an 
intramolecular Cys as in Msr's.46,47  
Lately, we also investigated the formation and reduction mechanisms of sulfenic acid 
during the reduction mechanism of MetSO via MsrA in which sulfenic acid was found to 
form through a concerted TS via a low barrier of 30.7 kJ mol-1. Furthermore, the 
reduction to disulfide was found to occur via several low barrier steps suggesting 
spontaneous reduction via an SN2 mechanism upon the activation of second Cys and 
rotation of sulfenic acid to be in a proper position for nucleophilic attack explaining its 
high reactivity. In MsrA, no direct sulfur attack mechanism was obtained due to the large 
distance between the two sulfurs. More importantly, the C∝…C∝ distance of the two 
cysteine was found to be around 11Å in most MsrA crystal structures.48 
 In contrast, in the MsrB crystal structure of N.gonorrhoeae pilB (PDB: 1L1D,49 the 
one used in our previous DFT study), the distance between the two sulfurs is 3.29 Å. 
More importantly, the C∝…C∝ distance is around 7.41 Å. Similar distances were also occur 
in other crystal structures such as in streptococcus pneumonia (PDB: 3E0M) and 
Neisseria meningitidis PilB (PDB: 3HCG) with a C∝…C∝ distance of 8.29 Å and 8.47 Å, 
respectively. 50,51 Earlier, Ranaivoson et al. suggested the presence of high degree of 
flexibility in the MsrB's second Cys containing loop, β2-β3.51 Since a distance of 13 Å 
were found to occur between the two C∝ in X. campestris (PDB: 3HCI).51 This implies the 
need for conformational change prior to disulfide bond formation. More importantly, 
Trp65 lies in between the two Cys preventing the formation of disulfide bond. However, 
kinetically, these expected drastic conformational changes did not change the rate-
limiting step. Furthermore, the C∝…C∝ distance in the NMR structure of Bacillus subtilis 
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MsrB (PDB: 2KZN) is found to be 9.25 Å as well the distance between the two sulfurs is 
7.46 Å.52 Hence, all solved crystal structures of MsrB suggest the high flexibility in the 
free, complex-like and sulfenic acid forms. However, the driving force for these changes 
are still unclear. 
In this study, we reinvestigate the last step of the reductase step in MsrB via studying 
the effect of method selection, functional and basis sets on the catalytic mechanism. 
Further, we also investigate the effect of model preparation comparing quantum cluster 
approach to QM/MM. Furthermore, several MD studies have been used to understand the 
driving force for any of the suggested pathways. More importantly, investigating a series 
of conformational changes in the active site along the catalytic mechanism.  
 
4.2 Computational Methods 
4.2.1 DFT Calculations 
All calculations were performed using Gaussian 09 suite of program.53 The hybrid 
density functional theory method B3LYP; a combination of Becke’s three parameter 
exchange functional and Lee, Yang and Parr’s correlation,54-56 was used. Two basis sets 
including 6-31G(d) 5d, 6-31G(d,p) 5d were chosen for structures optimization. In 
addition, the HM-GGA M06-2X functional57 was also used in accordance with the 6-31G 
(d) 5d basis set. Relative energies were obtained via single point energy calculations on 
the optimized structures using the 6-311G(d,p) 5d and the 6-311+G(2df,p) 5d basis sets. 
Frequency calculations were only used to characterize the optimized structures as minima 
or transition structures The same active site model as in our previous study,16 extracted 
from the MsrB crystal structure of N.gonorrhoeae pilB (PDB: 1L1D)49, was chosen to 
test the effect of functional and basis set choice. This model as previously described 
includes main active site residues.16 
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4.2.2 QM/MM Models  
All QM/MM calculations were performed using Gaussian 09 suite of program using 
the ONIOM formalism.53,58 Truhlar's HDFT M06-2x was chosen for the QM layer 
calculations for better description of the hydrophobic interactions between the substrate 
and Trp442.57 Furthermore, the AMBER96 force field was used for the MM layer as 
implemented in Gaussian.59 The 6-31G(d) 5d basis set was chosen for structures 
optimization. However relative energies were obtained via single point energy 
calculations on the optimized structures at the ONIOM (M062X/6-
311+G(2df,p):AMBER96) using the electronic embedding formalism to account for the 
polarization of the environment. One monomer of the same MsrB crystal structure of 
N.gonorrhoeae pilB (PDB: 1L1D)49 was used to generate QM/MM models, in order to 
test the effect of model selection. Furthermore, two QM/MM models were used during 
calculations.  
To mimic our previous DFT model we used the same crystal structure without running 
molecular dynamic simulations to keep the same starting distance between the two sulfur 
atoms. We isolated one of the monomers that include a cacodylate molecule in the active 
site. Then, the cacodylate was manually modified into Met. Likewise, two seleno-
methionine 509 and 464 were mutated back to Met. A PFROSST force field was used to 
parameterize and optimize the overall structure as implemented in MOE suite of program. 
Then, the QM/MM model was built using the whole monomer. No atoms were kept fixed 
during the calculations. A large QM model around the second Cys was chosen including 
Asp437, Ser438, Ala439, Cys440, Ala441, Trp442, Pro443, Ser444, Arg493, Asp412, 
Cys495 , 3 water molecules and the substrate Met. In the QM/MM starting structure a 
bond was formed between Cys495 sulfur and the substrate forming a sulfonium cation 
intermediate as our starting structure.  
The second QM/MM model was built using the same monomer but after minimizing 
and running an MD simulation for the sulfonium cation for 5 ns, simulation details are 
 72 
explained in details in the following MD section. First, similar to previous model the 
cacodylate and MSE were mutated to Met. Then the catalytic Cys sulfur was bonded to 
the substrate sulfur forming a sulfonium cation intermediate. Afterwards, the whole 
system was solvated via adding 3434 water molecule to the system. Next, the system was 
minimized using the PFROSST force field until the root mean square gradient of the total 
energy become less than 0.1 Kcal mol-1 Å-1.  Subsequently, we performed a 5 ns 
simulation after performing a 100 ps equilibration step. The distance between the two 
sulfur of the catalytic and the second Cys, was used to cluster the resultant structures into 
5 Clusters. Then an average structure was obtained from the highest populated cluster. 
Similar to previous QM/MM model, a large model around the second Cys including the 
same residues and 4 water molecules. Likewise, the whole monomer was used with no 
fixed atoms. 
 
4.2.3 Molecular Dynamics Simulations 
The MOE suite of program was used to prepare, minimize and analyze all structures. 
However, the NAMD program was used to run the MD simulations. An all atom force 
field PFROSST were used to parameterize all structures. It uses AMBER10 for 
macromolecules and for small molecules it uses parm@forsst parameters and AM1-BCC 
for charges. Four different stages in the catalytic mechanism were considered for 
simulations including the substrate free active site, the Michaelis complex with 
methionine sulfoxide, the sulfonium cation intermediate and sulfenic acid intermediate. 
All investigated structures were manually generated via modifying the MsrB 
N.gonorrhoeae pilB (PDB: 1L1D) crystal structure. Prior to simulations, all residues were 
solvated using the whole monomer as solute adding a layer of water up to 6 Å from the 
residues. The S–O bond in sulfenic acid were restrained to previous DFT measured value.  
 Solvated structures were minimized using PFROSST force field until the total 
energies become less than 0.1 Kcal mol-1 Å-1. Next, 500 ps simulating annealing 
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simulations with time step of 2 fs were performed on the minimized structures allowing 
for thermal relaxation. All simulations were done under constant pressure however the 
temp varied during the annealing process. Starting by heating the system form 150° to 
300° for 25ps followed by an equilibration step for another 25 ps. Then, it was heated 
again from 300° to 400° for 25 ps followed by a longer time equilibration step for 350 ps. 
Afterwards, it allowed to cool down to 300° for 25ps followed by a final equilibration for 
50 ps. Subsequently, a production run for 15.5 ns, with time step of 2 fs were performed 
at constant temp (300°), in the case of wild, Michaelis complex, sulfonium cation and 
sulfenic acid intermediates.  
 
 
Figure 4.1. The second QM/MM model for MsrB sulfonium cation intermediate 
optimized structure. The QM layer atoms are highlighted in sticks to the right of the 
Figure. 
 
Generated trajectories were then analyzed. Three main criteria were used to analyse 
the generated structures, the change in the C∝…C∝ distance of the catalytic and second Cys 
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as well the change in the S…S distance. Furthermore, the RMSD of the active site QM 
residues were also obtained. Then, generated structures were clustered into five clusters in 
which the average structure was further investigated. The first 1.5 ns of the simulations 
were excluded from our analysis as it considered as equilibration period.  
 
4.3 Results and Discussions 
4.3.1 QM-cluster Approach 
In order to determine the effect of the level theory on the energy difference between 
the two pathways, sulfenic acid and direct disulfide formation, several combinations of 
functionals and basis sets have been used, see Figure 4.2 and 4.3. Relative energies were 
compared at optimization level as well as single points calculations in gas phase. It is 
important to mention that all following discussed optimized TSs are enzymatically 
feasible. In our previous study, optimized structures were obtained at quite small basis set 
using the B3LYP/3-21G* 5d level of theory and the direct disulfide bond formation, 
before corrections, was slightly favoured by 2.0 kJ mol-1. However this difference was 
significantly changed upon using a larger single point calculations at the B3LYP/6-
311G(d,p) level of theory to 55.0 kJ mol-1. Upon adding solvation and dispersion 
corrections, this difference was reduced to 30.2 kJ mol-1. Therefore, we investigated the 
effect of using a larger basis set for optimization using polarization functions as well as 
adding f and diffuse function in the single points calculations.  
Using the same model as in our previous paper, we optimized the two pathways 
starting from 3Large, the sulfonium cation intermediate, using B3LYP/6-31G (d) level of 
theory. Surprisingly, the energy difference between the two TSs increased to 60.5 kJ mol-
1 which is in agreement with our previous single point results emphasizing that a direct 
sulfur attack on the sulfonium sulfur is more favourable than forming sulfenic acid 
intermediate. This difference was slightly decreased upon adding p functions to the 
hydrogen atoms, 56.8 kJ mol-1. 
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Figure 4.2. Potential energy surface (PES) for direct disulfide bond formation pathway 
from optimization and single point calculations at several level of theory. Relative 
energies in kJ mol-1  
 
Single points on previous optimized structure using the same level of theory as in 
previous paper B3LYP/6-311G(d,p) have not changed the difference between the barriers, 
60.5 and 55.2 kJ mol-1 for the B3lYP/6-31G(d) and B3lYP/6-31G(d,p), respectively. 
However, using a larger level of theory B3LYP/6-311+G (2df,p) adding f and diffuse 
functions slightly decreased the difference to 53.0 and 48.7 kJ mol-1. These differences is 
still in agreement with our previous results at the B3LYP/6-311G(d,p)//B3LYP/3-21G*. 
Therefore, our new results with larger basis sets emphasized our previous conclusion in 
which the direct formation of disulfide bond is favoured over sulfenic acid formation. 
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Figure 4.3. Potential energy surface (PES) for sulfenic acid formation pathway from 
optimization and single point calculations at several level of theory. Relative energies in 
kJ mol-1  
 
Since all previous results were obtained using the hybrid DFT B3LYP functional, we 
also considered using different functional to test if this difference is an artefact of the 
chosen method. Therefore, we also investigated the two pathways using meta hybrid DFT 
functional M062X. From previous calculations, the 6-31G(d) seems to be a reasonable 
basis set, so it has been employed. The energy difference between the two pathways at 
optimization level (M062X/6-31G(d)) gave a similar difference of -46.6 kJ mol-1, in 
favour of direct disulfide bond formation. More importantly, the sulfenic acid and 
disulfide TSs increased to 95.4 and 48.8 kJ mol-1, respectively. Furthermore, the same 
results were obtained at the M062X/6-311G(2df,p) single point calculations showing an 
energy difference between the two pathways of 66.5 kJ mol-1. Therefore, using different 
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basis sets and functionals does not change our previous conclusion; the direct disulfide 
bond formation is approximately 55 kJ mol-1 more favoured than the sulfenic acid 
intermediate formation, However both pathways are enzymatically feasible.  
 
4.3.2 QM/MM Results 
Since basis sets and functional change confirmed previous conclusions, we also 
considered investigating the effect of model choice. Therefore, we used a QM/MM model 
as described in the method section to explore both pathways starting from the sulfonium 
intermediate structure. A large QM layer around the recycling Cys440 has been chosen. 
In all our previous models we considered anionic recycling cysteine, however a neutral 
cysteine might affect the proposed mechanism. It is worth mentioning that, the pKa of the 
recycling cysteine has been experimentally suggested to be higher than 9.60 Therefore, we 
attempted to calculate the proton affinity of Cys440. However, such calculations could 
not be obtained as in all our anionic models the optimization leads to the formation of the 
disulfide bond emphasizing that a direct nucleophilic attack on Cys495 sulfur forming a 
disulfide bond upon activation of Cys440 without an energy barrier. 
 
 
Figure 4.4. Optimized structures for the direct disulfide bond formation from the 
QM/MM calculations in which the sulfonium intermediate were obtained from MsrB 
crystal structure. 
 78 
The optimized reactive complex of the neutral model shows that, the hydrogen of 
Cys440 is hydrogen bonded to Asp412 and Asp437 via several water molecules 
suggesting a new role for either of the aspartate residues to activate Cys440. It also shows 
that W1 (Figure 4.4) could act as a base as it has very strong hydrogen bonds with 
Ser438, NH backbone of Asp437 and W2 with distances of 1.68 Å, 1.99 Å and 1.51 Å, 
respectively. In addition it has a weaker hydrogen bonds to Ser444 and the backbone 
carbonyl of Pro443 with distances of 2.13 Å and 2.60 Å, respectively. Interestingly, we 
found that the activation of catalytic Cys495 occurs via a low barrier, 19.2 kJ mol-1, 
concerted TS in which proton shuttle from Cys440 to Asp412 via two water molecules. 
The TS structure (Figure 4.4) show that, a proton is shared between W1 and W2 with 
distances of 1.26 Å and 1.17 Å, respectively, In turn, the O-H distances in W2 is 
elongated to 1.07 Å in which the proton is strongly interacting with Asp412 oxygen, 1.44 
Å. Similarly, the S-H bond in Cys440 is elongated to 1.36 Å and is hydrogen bonded to 
W1 oxygen at a distance of 2.14 Å. IRC calculations shows that this TS leads to the 
activation of Cys440, however no stable intermediate was obtained as Cys440 
concomitantly attack the sulfur centre of the sulfonium cation forming disulfide bond. 
The formed disulfide intermediate is 246.6 kJ mol-1 lower than RC. 
The sulfenic acid pathway is also investigated, however to activate a water molecule 
to attack the sulfonium sulfur the Cys440 needs to be activated first and as noted before 
once Cys440 is activated it forms the disulfide bond. Therefore, we investigated a 
concomitant activation of Cys440 and the sulfenic acid water, however no such TS was 
found to occur. Furthermore, the closest water is not in a proper location to attack; as 
including the whole monomers limited the ability of having that water in a proper 
position. These results actually question the validity of the QM cluster approach in which 
the surrounding of the active site are not included allowing for water addition in several 
position, which might not be realistic as in this case. In addition the nature of the TS 
differs based on chosen computational approach, QM-cluster or QM/MM, as in the 
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former one the TS represent the S…S…S bonds formation and dissociation however, the 
QM/MM study show that this TS would occur spontaneously upon Cys440 activation. 
All previous results emphasize our original proposed mechanism were the direct 
disulfide bond formation is more favoured. As previously described we tested the choice 
of basis set, the functional and the computational approach, however all these result are 
based on the original crystal structure of MsrB in which the distance is 3.29 Å. Therefore, 
the obtained PES might be an artifact of the short distance between the two sulfurs in the 
crystal structure. Specially as discussed in the introduction that the recycling Cys440 is 
located in a flexible loop and the S…S distance in the only solved NMR structure is over 
7Å. Furthermore, in several species this distance has been found to be longer. Therefore, 
we ran an MD simulation on the sulfonium cation intermediate for 5ns and the generated 
structures were clustered and an average structure was obtained from the highest 
populated cluster. Interestingly, the S…S distance was elongated during the simulation to 
approximately 5Å. Similar to previous QM/MM the whole monomer was used and no 
atoms were kept fixed allowing for full relaxation of the system. 
The optimized structure of the average structure of the sulfonium cation shows that 
(Figure 4.5), the S…S distance is 4.88 Å. More importantly, a water molecule is now 
located below the Cys495 sulfur and the SCys495…OW1 distance is 2.44 Å. In turn, the W1 
proton is hydrogen bonded to the SCys495 sulfur with a distance of 2.29 Å. Furthermore, It 
also has several hydrogen bonds with carbonyl of Pro443 and W3 (to Arg493) with 
distances of 1.78 Å and 1.72 Å, respectively. The Cys440-H is strongly hydrogen bonded 
to W2 with a distance of 1.43Å, which in turn strongly polarized by two hydrogen bonds 
with Asp412 and Asp437 via a distance of 1.48Å and 1.66Å, respectively. This hydrogen 
bonding network emphasis our previous proposed mechanism in our previous MsrB and 
MsrA studies in which the recycling cysteine activates a water molecule forming sulfenic 
acid (Cys440 activates W1, in MsrB). Interestingly, this step was found to occur via a low 
barrier of 16.7 kJ mol-1. In this TS (Figure 4.5), Cys440 hydrogen is shared with W2 with 
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distances of 1.50 Å and 1.43 Å, respectively. In turn the W2 O-H bond is elongated to 
1.05 Å strongly interacting with Asp412, 1.78 Å. As previous no stable intermediate of 
the anionic sulfur was optimized, however the activation of Cys440 occur with 
concomitant proton transfer from W1 to Cys440 activating W1 and forming sulfenic acid. 
The generated sulfenic acid intermediate is 120.6 kJ mol-1 lower in energy than the 
sulfonium intermediate, 3Large.  
These results raise many questions about the quantum cluster approach especially in 
dealing with proteins containing flexible loops showing that misleading results might be 
obtained upon using models based on crystal structures without proper preparation. It also 
emphasizes the importance of the starting structure in determining enzymatic 
mechanisms. Such proper preparation is missing in the Quantum cluster approach as the 
models are commonly based on the crystal structure with the substrate analogue. Our 
QM/MM MD based calculations showed that a sulfenic acid intermediate is formed in the 
MsrB catalytic mechanism which is contradicting our DFT cluster approach as well as 
QM/MM crystal structure based calculations.  
 
 
Figure 4.5. Optimized structures for the sulfenic acid formation pathway from the 
QM/MM calculations in which 3large were obtained from sulfonium intermediate MD 
simulation. 
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4.3.3 Molecular Dynamics Simulations Results 
In order to confirm previous results and to understand why the S…S distance is 
different from crystal structure, we ran a series of MD simulations for several complexes 
starting from Apoenzyme to Michaelis complex, sulfonium and sulfenic acid, as 
described in the method section. We first examined the distance between the two Cys 
before substrate binding in wild type apoenzyme. A 16 ns MD simulation was enough to 
reach equilibrium as can be seen from the RMSD of the QM layer (Figure 4.6). The rmsd 
of the apoenzyme-generated structures fluctuate between approximately 0.75 Å and 1.5 Å 
indicating the stability of the system. This higher fluctuation range was investigated and 
found to be because that the recycling cysteine is located in a high flexible turn as 
previously suggested. 
 
 
Figure 4.6. RMSD's of the QM layer vs time for the four models used to represent the 
catalytic cycle (A) Apoenzyme before substrate binding, (B) substrate bound active site, 
(C) sulfonium cation intermediate, and (D) sulfenic acid intermediate. 
 
The main criterion in analyzing these simulations is the distance between the Cα's of 
Cys440 and Cys495. As can be seen in Figure 4.7, this distance fluctuate approximately 
 82 
between 7.0 Å and 9.5 Å with few exceptions where the distance increased near to 11.0 
Å, as will be seen in the following discussion. Further, the mean distance is 8.36 Å with a 
maximum distance of 11.27 Å and minimum distance of 6.76 Å. Furthermore, all 
generated structures were clustered into five clusters and the average structure for each 
were determined. The highest populated cluster represents approximately 60% of the 
simulation in which the distance in the average structure is 8.36 Å, which is agreement 
with the crystal structure, ≈7.40 Å. Furthermore, the highest and lowest distance in this 
cluster are 8.88 Å and 7.83 Å, respectively. The second populated cluster represents 
approximately 20% of the simulation. The Cα distance significantly decreased in the 
average structure to 7.31 Å. In contrast, the distance in the 3rd populated cluster average 
structure has increased to 9.4 Å. All three clusters represent more than 95 % of the 
simulation. Structures with a distance between 9.93 Å and 11.27 Å in the 4th cluster 
represented less than 2.5 %. It is also worth to mention that the average S…S distance is 
5.79 Å with a maximum distance of 11.08 and minimum distance of 3.08 Å. All these 
results show that the formation of disulfide bond is feasible with no need for 
conformational changes in the active site and the average distance is in agreement with 
crystal structure. 
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Figure 4.7. Distance change between Cα of Cys495 and Cys440 vs time the four models 
used to represent the catalytic cycle (A) Apoenzyme before substrate binding, (B) 
substrate bound active site, (C) sulfonium cation intermediate, and (D) sulfenic acid 
intermediate. Distances are in Angstrom. 
 
Since the Apoenzyme simulation shows a similar close distance, we also investigated 
the effect of the substrate binding. As shown in Figure 4.6, the rmsd of the QM layer are 
equilibrated with a fluctuation after the first 3 ns between approximately 1.0 Å and 1.4 Å. 
Similarly, the distance between the two Cys Cα fluctuate between 10-12 Å with a mean 
distance 11.12 which is significantly higher than in the apoenzyme with a huge minimum 
distance of 9.39 Å and a maximum distance of 12.83 Å. As before, the generated 
structures were clustered into five clusters, which have been further analyzed. The most 
populated cluster represents approximately 59% of the simulation with a maximum and 
minimum distances of 11.45 Å and 10.79 Å, respectively. It is important to mention a 
distance more than 11 Å does not allow for disulfide bond formation. More importantly, 
the average structure of this cluster has 11.12 Å distance between the Cα of the two 
cysteine. Furthermore, the second and third most populated clusters have a similar 
population of 19.5% with an average distance of 11.77 Å and 10.46 Å, respectively. All 
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three clusters constitute more than 97% of the simulation. Furthermore, the mean distance 
between the two sulfurs has significantly increased to 6.93 Å with a minimum of 4.72 Å 
and a maximum of 9.31 Å. Therefore, it’s obvious that substrate binding leads to active 
site conformational changes. In fact Cys440 is located on the same loop as Trp442, which 
also changes its position upon substrate binding. The strong hydrophobic interaction 
between the substrate and Trp442 is very important for substrate binding and catalysis as 
have been examined experimentally. This suggest that, as can be seen in Figure 4.8, the 
substrate binding enforce Trp442 conformational change which in turn affects the 
conformation of the whole turn including Cys440 extending the distance between the two 
sulfurs. 
In order to confirm prior conclusion, we also considered long MD simulation for the 
sulfonium intermediate in which bigger range of fluctuation in the QM rmsd between 
approximately 0.6 Å-1.3 Å; this actually an artifact of the turn flexibility and the 
sulfonium cation. It's important to mention that the positive sulfur of the sulfonium cation 
was not properly parameterized was the current force field, however its partial charges 
was correct, which might be a reason for this fluctuation. However, the current results are 
in agreement with the former one, as the distance of the Cα is equilibrated and fluctuate 
between 9.5 Å and 11.5 Å with a mean of 10.14 Å with a minimum of 8.24 Å and a 
maximum of 11.15 Å. This range is still significantly large compared to the apoenzyme 
simulation. Furthermore, the distance in the average structures of the three highest 
populated, 96%of the simulation, clusters are 10.14 Å, 9.48 Å and 10.80 Å, respectively. 
Furthermore, the mean distance between the two sulfurs is 5.80 Å with a minimum of 
3.88 Å and a maximum of 8.49 Å. These results of the longer simulation confirm our 
QM/MM MD based results were the S…S distance are larger than the crystal structure 
allowing for formation of sulfenic acid intermediate in the mechanism as experimentally 
suggested.  
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Figure 4.8. Superposition of the 4 MD's active site average structures in apoenzyme, 
Michaelis complex, sulfonium and sulfenic acid intermediates. 
 
Although earlier results explain the effect of substrate binding on the mechanism and 
its effect on the proceeding pathway, however there is still a question to be answered, 
which is how the disulfide bond is formed. Therefore we ran another 16ns MD simulation 
on the sulfenic acid structure investigating the effect of substrate removal; starting with a 
large S…S distance using the average structure of the 5ns sulfonium simulation. As shown 
in Figure 4.6, the RMSD of the QM layer is equilibrated fluctuating between 0.4 Å and 
1.0 Å. This emphasized from the distance between the two Cα of the two cysteine which 
fluctuate approximately between 8.5 Å and 10.5 Å with a mean distance of 9.48 Å with a 
minimum of 7.63 Å and maximum of 11.19 Å. Furthermore, the highest populated cluster 
represents 59% of the simulation with an average structure distance of 9.48Å which 
would allow for a direct disulfide formation with no need to any conformational changes. 
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Similarly, the distance in the average structure of the second and third most populated 
cluster is 8.89 Å and 10.08 Å, respectively. All three clusters represent more than 97.5% 
of the simulation showing that upon substrate removal the Trp442 and Cys440 turn would 
move back toward its original conformation as in the wild type simulation and crystal 
structure.  
Comparing all previous simulation results show that, before substrate binding the 
distance between the Cα of Cys440 and Cys495 in the average structure is 8.36 Å which 
then is elongated upon substrate binding to 11.12 Å showing that substrate induce 
conformational changes in the active site specially via its hydrophobic interaction with 
Trp442 which is located on the same turn as Cys440. These results were confirmed by the 
10.14 Å distance in the average structure of the sulfonium cation allowing for sulfenic 
acid formation as have been shown in the previous QM/MM section. Finally, upon 
formation of sulfenic the substrate leaves the active site allowing for a shorter interaction 
distance, 9.48 Å, between the two Cys allowing for disulfide bond formation with no 
need for any conformational changes.  
Our results emphasize the importance of starting structure preparation as well as 
question the applicability of QM cluster approach to system with flexible turns showing 
that misleading results might be obtained. Our previous QM-cluster study on MsrB 
showed that both mechanisms are energetically feasible however the direct disulfide bond 
formation is favorable. In contrast, in this study, running several MD simulations as well 
as investigating the effect of substrate binding in the active site showed that a sulfenic 
acid intermediate would occur in the mechanism. 
 
4.4 Conclusions 
In this study several computational approaches, QM cluster, QM/MM and MD 
simulations, have been employed comprehensively to reinvestigate that last step in the 
reductase step of the catalytic mechanism of MsrB. First, we investigated the effect of 
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level of theory by utilizing several basis sets for optimization and single point 
calculations. Increasing the basis set size confirmed our previous conclusion in which the 
direct disulfide bond formation is favorable over sulfenic intermediate formation.  
Furthermore, the HMGGA M062x was also used to examine the effect of functional on 
previous conclusion, however M062x emphasized previous conclusion. In addition, we 
also investigated the effect of model choice using QM/MM (ONIOM) approach including 
a large QM layer around Cys440. The QM/MM model was directly extracted from the 
crystal structure. Interestingly, deprotonating the second Cys440 leads to direct 
nucleophilic attack on Cys495 sulfur forming disulfide. Therefore we considered using a 
neutral cysteine in our model. Using neutral cysteine changed the nature of the optimized 
TS as it is now represent the activation of Cys440 leads to direct formation of disulfide 
emphasizing previous results.  
In order to eliminate the possibility that all previous results are an artifact of the used 
same crystal structure in which the S…S distance is 3.29 Å, we investigated the effect of 
the starting distance by running a 5 ns MD simulation on the sulfonium cation 
intermediate. Surprisingly, the MD simulation results shows that the distance between the 
two sulfur is significantly increased to 4.88 Å. More importantly a water molecule is 
located in a proper position for attack forming sulfenic acid intermediate. To investigate 
the mechanism from the average structure of the MD simulation, we run QM/MM using a 
similar QM layer as in previous calculations. Surprisingly, the an anionic Cys440 leads to 
direct formation of sulfenic acid intermediate. We also found the activation of Cys440 
occurs via a low barrier of 16.7 kJ mol-1 proposing a catalytic role for Asp412.  
Since Our MD results shows different distance from the crystal structure, we 
considered running long MD simulations for 16ns using several models representing 
active site changes during the catalytic mechanism. MD results show that, before 
substrate binding the distance between the Cα of Cys440 and Cys495 in the average 
structure is 8.36 Å which then is elongated upon substrate binding to 11.12 Å showing 
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that substrate induce conformational changes in the active site, especially via its 
hydrophobic interaction with Trp442 which is located on the same turn as Cys440. These 
results were confirmed by the 10.14 Å distance in the average structure of the sulfonium 
cation allowing for sulfenic acid formation as have been shown in the previous QM/MM 
section. Finally, upon formation of sulfenic the substrate leaves the active site allowing 
for a shorter interaction distance, 9.48 Å, between the two Cys allowing for disulfide  
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5.2 Introduction 
In drug design, enzymes are one of the primary therapeutic targets.1 Indeed, enzyme 
inhibitors are widely used as drugs for numerous diseases, today.1 Moreover, in the recent 
years, a new role of enzymes in drug development has become apparent, in which small 
molecules have been tested to enhance the activity of specific enzymes instead of 
inhibiting them as a new therapeutic strategy.2-4 Many enzymes have been shown to be 
activated via small molecules including glucokinase, sirtuin, AMPK and RNase.3,5-7 
Furthermore, these activation mechanisms have been classified into two main groups,2 in 
which small-molecules activators binds either directly to an allosteric site of the enzyme 
or to a regulatory subunit, leading to a conformational change and the stabilization of an 
open active sites enabling catalysis. Notably, the discovery and validation of possible 
target enzymes for activation is a very complicated process and there is no systematic 
approach to achieve this goal. In general, the activation of enzymes via small-molecules 
is actually favored over their inhibition due to: 1) allosteric sites are not conserved as 
active sites, so activators binding is considered more specific in general, 2) unlike 
inhibitors, much smaller concentration of the activators is needed to amplify the enzyme 
efficiency significantly.2  
Methionine sulfoxide reductase (Msr) is a group of ubiquitous antioxidant enzymes 
that catalyze the repair of oxidized proteins, reduction of methionine sulfoxide (Met-O) to 
methionine (Met),8 with multiple health implications, from aging to several age related 
diseases such as Alzheimer's and cancer.9,10 It is mainly consisted of two stereospecific 
classes, MsrA and MsrB. Remarkably, the overexpression of MsrA in several species has 
been shown to increase their life span as well as knocking it out leads to oxidative 
stress.11-13 Indeed, the defensive role of this enzyme against reactive oxygen species has 
been the subject of numerous studies. 
The catalytic mechanism of MsrA can be divided into two step:14,15 1) the reductase 
step, in which Met-O is reduced forming MsrA-sulfenic acid intermediate that 
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subsequently reduced forming an intramolecular disulfide bond (MsrAOx), 2) the 
regeneration step, in which the protein disulfide is reduced by thioredoxin (Trx) 
regenerating the active site (MsrARed). Recently, we have elucidated the mechanism for 
the reductase step in detail, showing that it happens via low barriers multistep.14 
Experimentally, the rate-limiting step of the overall mechanism has been shown to be 
associated with the regeneration step.15 Outstandingly, the two steps of the mechanism 
require two different conformations, switching from a closed form active site in the 
reductase step to a more open fold for the regeneration step, allowing for Trx binding.16,17  
The overall fold of MsrAOx and MsrARed does not change much and the core structure 
of the enzyme is maintained. The main difference between the two conformations is the 
unfolding of the two-stranded antiparallel β–sheet (Gln122 to Thr132). Coudevylle et al.16 
using NMR studies have shown that in the oxidized form the Gln122-Thr132 segment is 
unfolded and has no secondary structure. Indeed, the unfolding of this segment is 
essential for Trx binding and subsequent reaction to regenerate the active site. In general, 
in either conformation, the core enzyme structure is lined with N and C-terminal ends 
with no secondary structure. The C-terminal end in Escherichia coli contains the 
resolving cysteinyl residue. It is important to mention that the Gln122-Thr132 segment in 
the reduced form surrounds the MsrA active site. Similar confirmations of the reduced 
form have been found in several species using X-ray crystallography.  
Recently, Moskovitz et al.18 have shown that the activity of MsrA in rat neurons can 
be induced using a substrate mimic molecule, N-Acetyl Methionine Sulfoxide (Ac-Met-
O). In vitro and in vivo studies have shown that Ac-Met-O protects the neuron from Aβ42 
toxicity suggesting a protective role in Alzheimer's. Based on their results, the authors 
suggested that the activity of MsrA might be provoked by small molecules containing a 
sulfoxide functional group, providing a novel way to develop antioxidant drugs in 
Alzheimer's and other oxidative stress related diseases.18 Consequently, more recently, 
Frankiln et al.19 have shown that Pergolide sulfoxide (PergSO) and Pergolide (Perg) as 
 96 
well as S-adenosyl methionine (SAM) increases the activity of MsrA in neuronal cells 
suggesting similar role to Ac-Met-O. Perg is a dopamine receptor agonist that used to 
treat Parkinson's disease until 2007. Furthermore, the authors chose PergSO as it contains 
a methyl sulfoxide moiety suggesting that Perg will be first enzymatically converted to 
PergSO before activating MsrA.19 However, their results show that Perg is more potent 
than PergSO. At 10 µM concentration, Perg and PergSO increased the activity of MsrA 
by 158% and ∼130%, respectively. Interestingly, the upregulation of MsrA activity was 
partially correlated to its overexpression, suggesting that the activation occurs via an 
uncertain mechanism. In addition, SAM was found to have a less activation effect 
compared to Perg and PergSO. 
Here we investigated the mechanism of MsrA activation by Perg, PergSO and SAM, 
considering the possibility of their direct interaction with the enzyme. The binding 
pockets were identified using docking techniques. The effects of small-molecules binding 
were elucidated using a 9.5 ns MD simulations. Furthermore, virtual-screening was used 
to identify other possible activator small-molecules. 
 
5.2 Computational methods 
In order to investigate the possibility of direct interaction, the Escherichia coli NMR 
structure (PDB: 2GT3) of the reduced form of MsrA was used as a starting structure.16 In 
addition, another starting structure was also considered in which the MsrARed was 
modified manually to form MsrAOx, by forming the Cys51-Cys198 disulfide bond. In 
both cases, the enzyme structure was first solvated, up to 15 Å away from any residue, 
and minimized using AMBER12:EHT forcefield. Subsequently, both MsrARed and 
MsrAOx were docked using the three ligands Perg, PergSO and SAM. The whole enzyme 
structure was used as a receptor for docking. The MOE suite of programs was used for 
docking.20 First, the top 100 conformations for each ligand were generated using the 
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London dG scoring function. Second, using forcefield refinement method, only the top 50 
conformations were retained and analyzed.  
 
5.3 Results and Discussions  
Docking the MsrARed form has shown that the three ligands mainly bind to a 
hydrophobic pocket at the interaction between the C-terminal and the α4 secondary 
structure, in which the ligands interact with Leu207, Pro206, Ala159 and Phe156. 
Furthermore, very few conformation were found to occur at the N-terminal end along 
with β5.  
Notably, upon forming the Cys51-Cys198 bond (MsrAOx) all three ligands were found 
to constantly bind to new binding pocket at the interaction of N-terminal and more 
importantly the two-stranded antiparallel β–sheet (Gln122-Thr132 segment). These 
interactions were found to include several residues such as His130, Arg125 from Gln122-
Thr132 segment and Phe3, Lys5, Lys5 from the N-terminal. Furthermore, the binding 
score of all three ligands in MsrAOx is higher than the previously obtained for MsrARed. 
SAM was found to bind less regularly to this new pocket. Moreover, our docking 
structures show that the methyl sulfoxide moiety is not involved in these interactions; 
instead cation-π and hydrophobic interactions are the main reason for binding. 
These results raised a main question if the binding of these ligands to the Gln122-
Thr132 segment in the oxidized form might facilitate its unfolding and the subsequent 
regeneration reaction with Trx leading to MsrA direct activation, as observed 
experimentally. Therefore, using 9.5 ns molecular dynamic simulations, we investigated 
the dynamics of the Gln122-Thr132 segment upon ligand binding. Prior to MD's, we 
docked the three ligands using induced fit approach, in which the previously identified 
pocket residues were allowed to move and adjust during the simulation. The highest 10 
conformations for each ligands were retained and top three poses were used as a starting 
point for MD simulations. Furthermore, a control MD simulation of MsrAOx was also 
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performed in order to compare the obtained results. As previous MOE suite of programs 
was used to generate and analyze MD's as well as NAMD was used to run the MD 
simulations.21 
 
 
Figure 5.1. Top) docking predicted binding mode of Pergolide, bottom) schematic 
representation of Pergolide interactions in the MsrA allosteric site. 
 
Experimentally, based on previous X-ray structures of MsrARed, a main hydrogen 
bond between Asp129 (from the Gln122-Thr132 segment) and Tyr197 was though to play 
an important role in keeping the folded reduced form of the active site.17 However, in the 
used NMR structure, this hydrogen bond is broken, therefore in our analysis we also 
considered both scenarios as starting structures. Furthermore, in our analysis we 
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considered two main criteria, 1) the molecular surface of the Cys51-Cys198 disulfide 
bond and its surroundings residues as well as the disulfide exposure to the solvent, which 
reflects its subsequent reaction with Trx, 2) the root-mean-square deviation (RMSD) of 
the Gln122-Thr132 residues as well as the facing interacting residues, Gly196, Tyr197, 
Cys198 and Gly199 in the C-terminal. Although, all three ligands were investigated, in 
the following section we will mainly discuss the results obtained for Perg as it has the 
highest effect on MsrA activity. 
 
 
Figure 5.2. Molecular surface representation of the disulfide surrounding residues 
extracted from MD simulations. The surface exposure of the disulfide bond is represented 
by yellow colour. 
 
As shown in Figure 5.2, from the control MD, the disulfide bond is buried in the 
active site with a very minimal solvent exposure. Furthermore, either upon forming the 
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Tyr197…Asp129 hydrogen bond or in its absence the Gln122-Thr132 segment is still 
folded completely, covering the active site. The rmsd of the involved residues shows that 
after significant change due to annealing the rmsd were kept constant between 2-3 Å 
reflecting a small increase upon time, see Figure 5.3. It is also important to mention that 
in our previous study on MsrA mechanism we ran a 25 ns simulation of the oxidized 
structure and no significant change in the Gln122-Thr132 segment was observed.14 
Unlike the control MD, the introduction of Perg was found to increase the disulfide 
bond exposure to the solvent, dramatically, see Figure 5.2. More importantly, the Gln122-
Thr132 segment residues are no longer interacting with the Gly196-Gly199 C-terminal 
residues. The superposition of the control versus Perg structure clearly emphasize this 
finding. Indeed, this is reflected in the obtained rmsd, in which after almost 7 ns of the 
simulation a huge jump was observed to occur breaking the original interactions between 
the Gln122-Thr132 residues and the Gly196-Gly199 C-terminal, see Figure 5.3. Similar 
dynamics were also observed for PergSO and SAM. Based on the MD generated 
structures, a cation-π between Arg125 and Perg arene might be the cause of this 
dynamics, see Figure 5.1. Furthermore, using different starting structure, another 
interaction was also found to occur with His130. All these results suggest that Perg 
binding disrupt the interactions between the Gln122-Thr132 and C-terminal residues, 
which might affect the segment folding.  However, the generated structures still maintain 
the two-stranded antiparallel β–sheet.  
In order to speed up the unfolding dynamics within a moderate simulation time, we 
ran a second MD (15 ns) starting with the last structure of the Perg MD upon removing 
Perg from the allosteric site. Indeed, the rmsd of the Gln122-Thr132 segment shows 
significant increase upon time. Notably, snapshots of the MD's conformation show the 
total uncovering of the active site and the fluctuation of the Gln122-Thr132 segment from 
two-stranded antiparallel β–sheet and no secondary structure. A superposition of the MD 
generated structure and the NMR unfolded form of the enzyme (PDB:2IEM)16 
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highlighting the exposure of the active site to subsequent reaction with Trx, see Figure 
5.4. It is also important to mention that based on docking results that the binding of these 
small-molecules activators to the reduced form of the enzyme does not affect its folding 
and subsequently will not disturb the first step ( the reductase step) of the mechanism 
which require a folded active site. 
 
 
Figure 5.3. Time evaluation of root-mean-square deviation (Rmsd's) of Gln122-Thr132 
segment and Gly196-Gly199 residues with and without Pergolide binding. 
 
Previous results suggest that the activation mechanism of MsrA by Perg, PergSO and 
SAM occurs due to direct interaction with an allosteric site of the enzyme facilitating the 
unfolding of the Gln122-Thr132 segment. However, Perg cannot be longer used as a drug 
as it was withdrawn from the market due to undesirable side effects. Therefore, we also 
considered the search for other ligands, which can bind to MsrA producing similar effect. 
Using virtual-screening, we searched the subset ZIM from the ZINC drug database for 
binding in the previously identified allosteric site.22 ZIM includes all compounds have 
been in human including worldwide drugs. Using the triangle matcher placement and 
London dG scoring, we docked 11421 molecules, retaining the highest 10 poses for each 
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molecule. Based on the scoring function, the highest 292 molecules were selected for 
further analysis. In which an induced fit docking approach as well as a second refinement 
step, as described earlier, was used retaining the top highest 5 poses for each ligand. A full 
list of the 292 molecules with their docking score are included (See Appendix Table B2).  
 
 
Figure 5.4. Superimposition of the MsrAOx NMR solution structure with that of 
MsrAOx MD generated structure upon Pergolide binding and removal. 
 
In general, most of the identified systems were found to include an arene function 
group and some of them include the cation-π interaction as in Perg suggesting the 
possibility of discovering new small-molecules MsrA activators. Surprisingly, many 
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antibiotics such as Cefoperazone, Natamycin and Lymecycline were found to have high 
binding affinity to MsrA. Furthermore, many natural occurring molecules including 
NAD+, NADH and ATP were also identified as possible ligand. These results raise 
another main question, if MsrA is naturally regulated by biomolecules! Finally, part of the 
identified molecules has been found or suggested previously to have an antioxidant 
effects such as Nicardipine, folinic acid and Sildenafil.23-25 In addition, we run a short MD 
simulation (2 ns) on selected ligands including NADH, Natamycin and Cefoperazone. 
Although the short simulation time compared to control, our MD's show that the 
molecular surface of the disulfide was found to increase significantly in comparison to the 
longer 10 ns control simulation. 
 
5.4 Conclusions  
In summary, this report suggests the direct activation of MsrA via binding of small-
molecules providing an explanation of the previously recognized experimental results. 
Furthermore, our results also suggest other possible activator ligands. Further 
experimental studies to test this direct interaction as well as high-throughout screening 
will provide tools to confirm our proposed mechanism of activation and develop new 
activators with an antioxidant activity. 
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Formation of Stable Iminol Intermediate in the 
Redox Regulation Mechanism of PTP1B  
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6.1 Introduction 
Protein tyrosine phosphatases (PTP's) are a large family of enzymes responsible for 
dephosphorylating phosphorylated tyrosyl residues in proteins,1,2 a physiologically 
important post-translational modification (PTM). In particular, the sub-class PTP1B, first 
characterized in 1988,1,3,4 plays a key role in inhibiting insulin and leptin signaling.5-7 
Conversely, it has been shown to have a crucial positive role in signaling of, for instance, 
cSrc tyrosine kinases in breast cancer3,8,9 and the ubiquitous Ras proteins.10 Consequently, 
PTP1B is considered to be an outstanding drug target for the treatment of several diseases 
including diabetes, obesity and cancer.3,11-13 
PTP1B catalyzes the dephosphorylation of phosphotyrosine via a two step ping-pong 
mechanism (Scheme 1).14 In the first step, the sulfur of an active site cysteinyl (Cys215) 
nucleophilically attacks the phosphotyrosine ester to form a phosphoenzyme intermediate. 
This is accompanied by the concomitant release of the tyrosine. In the second step, 
hydrolysis of the phosphoenzyme intermediate occurs via nucleophilic attack of H2O 
upon activation by Asp181. Tiago et al.14 have previously investigated both steps using X-
Ray crystallography to characterize transition state analogs. 
To date, four different mechanisms have been identified by which the function of 
PTP1B can be regulated: phosphorylation, sumoylation, proteolysis and oxidation.3 In 
particular, in the latter, Cys215 has been experimentally observed to be reversibly 
oxidized to a sulfenic acid (Cys251SOH) by reactive oxygen species' (ROS).15 This 
modification is in part facilitated by the unusually low pKa (4.5-5.5) for the thiol of 
Cys215.1 This oxidative PTM mediates several signaling pathways. For instance, with 
regards to insulin the stimulation of trans-membrane receptor kinase (RTK) leads to the 
activation of NADPH oxidase, producing ROS that oxidize Cys215 in PTP1B, thus 
transiently inhibiting its function.1 The activity of PTP1B is restored upon reduction by an 
external thiol such as thioredoxin (Trx), dithiothreitol (DTT) or Glutathione (GSH).16 
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In general, sulfenic acid is susceptible to further and irreversible oxidation to sulfinic 
or sulfonic acid. X-ray crystallographic analysis, and pulse-chase labeling and mass 
spectrometry experiments suggested that the sulfenic acid can undergo an intramolecular 
reaction to give a seemingly unique cyclic sulfenyl-amide species; thus protecting it from 
further oxidation.15,17-19 To-date this mechanism has only been observed for PTP1B. But it 
should be noted that it has been suggested that such an intermediate may occur in other 
proteins including PTP1α, and other protein families such as organic hydroperoxide 
resistance regulator (OhrR) in Bacillus subtilis.20,21 In other enzymes sulfenic acid is 
protected via, for example, formation of a disulfide (e.g., methionine sulfoxide reductase) 
or hypervalent sulfurane species (e.g., archaeal peroxiredoxin).22,23 
Initially it was proposed that the sulfenyl-amide forms via a direct SN2 mechanism. 
Specifically, the backbone nitrogen of the neighboring serinyl (Ser216) nucleophilically 
attacks the sulfenic acid's Sγ atom with concomitant release of H2O (scheme 1).17 
Furthermore, the hydrogen bonding interaction between the Nδ1 atom of the invariant 
histidyl (His214) and the carbonyl oxygen of Cys215 was suggested to play a key role in 
enhancing the nucleophilicity of the Ser216 backbone nitrogen.17 Indeed, it has been 
shown that mutation of His214 to Asn or Ala increases the pKa of Cys215.24 Generation 
of the sulfenyl-amide intermediate induces an active site conformational change. In 
particular, formation of the S–N bond disrupts a hydrogen bond between the R-groups of 
Ser216 and Tyr46, rendering the enzyme inactive.25 Thus, there is interest in inducing or 
stabilizing this inactive oxidized form as a potential therapeutic approach for several 
diseases.25 It is noted that experimentally, several external thiols have been shown to be 
able to reduce the sulfenyl-amide, regenerating the activity of the catalytic Cys215.16 This 
restoration mechanism has been confirmed via re-soaking crystals of sulfenyl-amide with 
dithiothreitol (DTT).17 
Sarma et al.26 have previously studied, both experimentally and computationally, the 
mechanism of sulfenyl-amide formation in PTP1B using model non-protein molecules. In 
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particular, formation of sulfenyl-amide via the above proposed direct mechanism was 
calculated at the B3LYP/6-31G(d) level of theory to have a barrier of 206.2 kJ mol-1. In 
addition, they considered an alternate mechanism involving heterocyclic substitution of 
an oxazoline ortho to the sulfenic acid moiety. This modification significantly reduced the 
calculated barrier to 119.8 kJ mol-1. However, they noted that the sulfenic acid model 
used did "not effectively mimic the cyclization of protein sulfenic acids".26 Similarly, 
Sarma et al.27 examined ortho substitution effects on a small amido thiophenol molecule 
and concluded that S…N/O interactions could influence the properties of the sulfenic 
acid. Furthermore, nearby residues may have a role in the sulfenyl-amide formation. 
More recently, as part of a review, Defelipe et al.28 discussed results they had obtained for 
the mechanism of PTP1B using QM/MM. The reactive (QM) region of their chemical 
model consisted of Cys215 and Ser216. Similar to the results of Sarma et al.26 they 
concluded that the direct formation of sulfenyl amide occurs with a high barrier of 205.0 
kJ mol-1. Experimentally, however, several studies have suggested that the rate-limiting 
step in sulfenyl-amide formation is generation of the sulfenic acid, not the sulfenyl-
amide.15,20 Hence, many questions remain about the enzymatic mechanism. 
In this present study, formation of the putative sulfenyl-amide intermediate from a 
Cys215 derived sulfenic acid, within the enzyme environment, is investigated via 
complementary application of molecular dynamics simulations and extensive quantum 
mechanical/molecular mechanical (QM/MM) modeling. 
 
6.2 Computational Methods 
6.2.1 Protein Model Preparation and Molecular Dynamics Simulations 
The X-ray crystal structure preparation and the MD analysis were performed using the 
Molecular Operating Environment (MOE) software package.29 Molecular dynamics 
simulations were conducted using the NAMD Molecular Dynamics software.30 The X-ray 
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crystal structure of the Homo sapiens PTP1B in its sulfenic acid oxidation state was used 
as starting structure and obtained from the PDB structure 1OET.17 
First, problems encountered in the crystal structure were automatically corrected using 
the structural preparation applications in MOE. Second, the missing protons in the crystal 
structure were added using the protonate 3D application in MOE that assigns each residue 
ionization state by minimizing the total free energy of the system.31 Then, the enzyme 
was spherically solvated up to 15 Å beyond every protein atom. Later, the newly 
generated structure was minimized using AMBER12:EHT force field, which uses 
AMBER12 parameters for protein and Extended Hückel Theory for parameterizing small 
molecules.32-34 Finally, in order to allow for thermal relaxation and multiple conformers 
generation, the minimized structure was used as starting point for a 3 ns MD simulation.  
 
Scheme 6.1. The proposed dephosphorylation mechanism of phosphotyrosine in PTP as 
well as the oxidative regulation mechanism in PTP1B via formation of sulfenyl-amide 
and the subsequent reactivation.14,17  
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In the MD simulation, all atoms were set free to move and a time step of 2 fs was 
used. The Columbic interactions were calculated with the PME method and the short 
range van der Waals interactions were truncated at 8-10 Å. The simulation started with an 
annealing dynamics from 150 K to 300 K then to 400 K to finally 300 K at a constant 
volume for 550 ps, followed by a production run in the NPT ensemble at 300K and 1 bar 
for 2500 ps.  
 
 
Figure 6.1. Illustration of the QM/MM model used (Model I) in this study obtained from 
the average structure. The QM layer atoms are highlighted and shown in sticks 
representation to the right. 
 
All generated structures were analyzed using MOE software. Furthermore, based on 
the root mean square deviation (rmsd) of the active site residues, the generated structures 
were clustered into 5 main groups. The average structure of the highest populated group 
was selected and further minimized using AMBER12:EHT force field and the resulting 
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structure was used for further calculations using quantum mechanical/ molecular 
mechanical (QM/MM) approach. Finally, the rmsd for several active site interactions 
were also calculated to confirm the consistency of these interactions during the 
simulation. 
 
6.2.2 QM/MM Models and Calculations 
All calculations were performed within the ONIOM scheme using the Gaussian 09 
suite of programs.35 The QM/MM starting structures were acquired from the previous 
preparation steps using the whole protein. The QM high layer was described using the 
hybrid-meta-exchange-correlation functional M06-2X.36 While the MM low layer was 
described by AMBER96 force field as implemented in Gaussian.30 Optimized geometries 
were obtained using the 6-31G(d,p) basis set for the high layer. All atoms in the systems 
were kept free to move including solvent atoms. Relative energies were then obtained 
using single point energy calculations on the optimized structures at the ONIOM(M06-
2X/6-311+G(2df,p):AMBER96) level of theory. The choice of functional and basis sets 
was based on our previous benchmarking study of several biological sulfur species in 
which M06-2X was found to be one of the best functionals in describing SN bonds with 
respect to QCISD and MP2 (manuscript in preparation). Due to the models size and 
computational cost, frequency calculations were conducted only on the high layer to 
confirm the nature of the optimized structures as previously performed.37,38 In addition, 
topological analysis of the electron densities as well as natural bond orbital (NBO) 
analysis for certain intermediates were performed at the M062-X/6-311+G(2df,p) level of 
theory using AIM2000 program.39  
In model I, as shown in Figure 6.1, the QM layer is formed of the catalytic Cys215 in 
its sulfenic acid form, Ser216, His214 in protonated form, Ala217, Gly218, Ile219, 
Gly220, Arg221, Ser222 and Asn111. In addition the R group of Glu115 as well as the 
backbone of Met109 and Leu110 were included. Furthermore, 4 active site water 
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molecules were included in the high layer. Besides the previous model, we also 
considered modifying model I in which we used a neutral His214 (Model II) to confirm 
the role of the histidyl residue in sulfenyl-amide formation. 
 
6.3 Results and Discussion 
6.3.1 Insights into Reactive Complex Structures 
The MD average structure was first optimized using ONIOM approach as previously 
discussed. In model 1, the optimized structure shows that (see RC in Figure 6.4) Ser216 
amide hydrogen is strongly hydrogen-bonded to a water molecule with a distance of 2.00 
Å; the former is also found to be strongly hydrogen-bonded to Glu115, 1.67 Å. 
Furthermore, Arg221 is also found to be doubly hydrogen bonded to Glu115. The 
distance between the sulfenic acid sulfur and the amide nitrogen is quite large, 3.83 Å, 
which explains the unfeasibility of the direct mechanism.  
Since previous proposed mechanism has highlighted the role of His214 hydrogen-
bonding to Cys215 carbonyl oxygen, we investigated this hydrogen-bond in the optimized 
RC. As can be seen in Figure 6.4, His214 is weakly hydrogen bonded to Cys215; instead 
it is strongly hydrogen bonded to Asn111. Therefore, we considered optimizing new RC' 
structure upon decreasing the distance between the two residues. It is important to 
mention that mutating His214 was found to increase the pKa of Cys216.24 In model I, see 
Figure 6.4, the RC' structure was found to lie just 1.8 kJ mol-1 lower in energy than RC. 
More importantly, the His214H…O_Cys216 distance is now 2.09 Å showing strong 
interaction. Furthermore, His214 is also still hydrogen bonded to Asn111 with a distance 
of 2.10 Å. More importantly, other active site interaction remain similar to RC with 
minute differences such as the hydrogen-bond between Ser216 amide and the water 
molecule as well as the water…Glu115 have become slightly stronger with a distance of 
1.94 Å and 1.54 Å, respectively.  
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Figure 6.2. Plot of the hydrogen-bond distance between His214 and Cys215 with respect 
to time in the MD simulation. 
 
In order to rationalize our choice of RC', we analyzed the consistency of this hydrogen 
bond interaction during the MD simulation. As can be seen in figure 6.2, the distance 
between the His214 hydrogen and the carbonyl oxygen is mainly fluctuating between 2 Å 
to 3 Å with less fluctuation around 3 Å to 4 Å. This clearly shows the strength of this 
hydrogen bond, fluctuating between strong to weak but it always exists. 
 
6.3.2 Formation of Sulfenyl-Amide via Direct Mechanism 
Although as indicated in the introduction that Sarma et al.26 as well as Defelipe et al.28 
have studied the formation of sulfenyl-amide via direct mechanism showing an unfeasible 
high barrier of over 200 kJ mol-1, we first considered reexamining this possibility in 
protein environment using both models. Especially, our MD simulations and QM/MM 
optimized structure suggest the presence of a water molecule that might mediate this 
reaction via a 6 member ring TS. However, such direct reaction was not found to occur, as 
we could not optimize a transition state that correspond to this mechanism. More 
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importantly, all attempted calculations have shown that the direct proton transfer to the 
sulfenic acid oxygen did not lead to sulfenyl-amide formation instead all calculations 
collapse back to form the reactive complex. It is important to mention that the obtained 
TS in Defelipe et al. QM/MM study shows a quite large distance of 3.30 Å and 2.36 Å for 
S…N and S…O, respectively.28 
All previous results suggest the need for investigating other possible mechanisms. 
Furthermore, for the nitrogen atom of the S216 to act as nucleophile it has to be first 
deprotonated, otherwise it is considered as a poor nucleophile as the π conjugation with 
the carbonyl group lead to resonance structure with positive charged nitrogen atom.  
By investigating the MD generated structures, we found that a water molecule always 
bridge a hydrogen-bond interaction between the Ser216 amide hydrogen and Glu115 
oxygen suggesting alternative mechanism. Indeed, this interaction was found to be 
consistent during the simulation. 
 
6.3.3 Formation of Sulfenyl-Amide via Stepwise Mechanism 
As mentioned earlier, RC and RC' active site interactions as well as MD results 
suggest the possibility of activating Ser216 amide nitrogen via Glu115. This step was 
found to be enzymatically feasible in with a barrier of 46.8 kJ mol-1. Surprisingly, the TS1 
structure shows triple proton transfers in which Ser216 amide hydrogen is shared with the 
water molecule oxygen with a distance of 1.27 Å and 1.23 Å, respectively. Furthermore, 
the water molecule proton is already transferred to Glu115 that has broken one of its 
hydrogen bonds to Arg221. The third proton transfer is between His214 and the carbonyl 
oxygen. Indeed, the resulting structure, I1, shows a complete proton transfer from His214 
to Cys215 carbonyl oxygen, shifting the double bond to be between the amide nitrogen 
and carbonyl carbon forming a novel iminol intermediate. Definitely the nucleophilicity 
of the iminol nitrogen is much higher compared to the amide form. Notably, this would 
facilitate the nucleophilic attack on the sulfenic acid sulfur and the subsequent formation 
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of sulfenyl-amide intermediate. A similar mechanism of amide-iminol tutomerization has 
been recently proposed to occur in the case of succinimide formation in the C-terminal 
peptide group of aspartic acid residue.40,41 
These results suggest a new role for both His214 and Glu115 in sulfenyl-amide 
formation. The optimized structure of I1 was found to be slightly less stable than RC' with 
an energy difference of 21.3 kJ mol-1. 
The same step was reexamined starting from RC in which a weak hydrogen-bond 
interaction exists between His216 and Cys215. However, no stable I1 intermediate was 
found to exist where in the optimization the proton is transferred back to the amide 
nitrogen. 
Although the iminol N is nucleophilic in I1, the distance between the Cys215S and 
Ser216 backbone N is quite large, 3.56 Å. This implies the need for structural 
rearrangements in the active site prior to subsequent reactions. Therefore, we considered 
optimizing another intermediate (I1') which was found to be more stable than I1, 22.7 kJ 
mol-1 lower in energy with respect to I1. More importantly, the S…N distance has largely 
decreased to 2.78 Å allowing for following reaction. This rearrangement occurs upon 
changing the CCCS dihedral angle from 99.62° to 130.20°. Furthermore, the Glu115 is 
still hydrogen-bonded to the water molecule, which is now quite closer to the sulfenic 
acid oxygen allowing for proton transfer. 
Recently the non-bonded interactions in protein sulfur species are gaining more 
attention and they are implicated to play a crucial role in sulfenic acid chemistry.42 
Therefore we considered investigating the S…N interaction in I1', using Quantum Theory 
Atoms-in-Molecules (QTAIM) to gain further insights. In Bader's QTAIM theory the 
presence of critical point between two atoms reflect the existence of chemical bonding 
between them.43 Therefore, we performed AIM analysis on I1 and I1'. Indeed, the 
generated molecular graphs for I1' indicated the presence of critical bond between S…N 
with electron density ρ of 0.016. Furthermore, we also considered the Laplacian ∇ρ2 of 
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this critical point to indicate the strength of the interaction, which was found to be 0.017, 
indicating the presence of a weak interaction between the two atoms. In general, the non-
bonded electrostatic interaction between S and N atoms have been previously 
reported.44,45 The nature of this interaction has been suggested to occur due to the shift of 
electron density from the N lone pair to the S antibonding orbital (σ*). This shows the 
importance of iminol intermediate formation to allow for such interaction to occur. 
 
 
Figure 6.3. Potential energy surface obtained for the formation of sulfenyl-amide from 
sulfenic acid via iminol intermediate, see computational methods. 
 
In order to investigate this shift in electron density between the S…N, we used NBO 
analysis on I1 and I1'. The negative charge on the sulfur atom has increased upon I1' 
formation from +0.52 to +0.48 in I1 and I1', respectively. Furthermore the electron 
density on the sulfenic acid oxygen has also been increased from -0.91 to -0.94. 
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Consequently, the electron density on the N atom has decreased from -0.67 to -0.64 in I1 
and I1', respectively. This clearly indicates the charge transfer and the interaction between 
the N lone pair and the sulfur σ*. 
 
 
Figure 6.4. Stationary points obtained for model I for the sulfenyl-amide formation 
mechanism from sulfenic acid. All atoms in the high QM layer are included in the 
representation. However, only the highlighted residues are the ones involved in the 
reaction. 
 
The last step of the mechanism was found to occur in a concerted fashion as shown in 
TS2, in which the S…N bond is formed concomitantly with S…O dissociation upon a 
proton transfer from Glu115 via water molecule. In TS2, the S…N distance is reduced to 
1.97 Å while the S…O bond is elongated to 2.00 Å. Furthermore, the water molecule 
proton is partially transferred to the sulfenic acid oxygen with a distance of 1.29 Å and 
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1.14 Å with respect to molecular oxygen and sulfenic acid oxygen, respectively. The 
barrier for this step was found to be 73.3 kJ mol-1 from RC.  
Finally, the sulfenyl-amide species was found to lie –27.6 kJ mol-1 lower in energy 
with respect to RC forming a stable product as experimentally proposed. In PC, the S…N 
distance is 1.76 Å in agreement with the X-ray crystal structure, 1.7 Å.17 Furthermore, 
His214 has restored its proton form the carbonyl carbon. 
 
6.3.4 Formation of Sulfenyl-Amide using Neutral His214 
In order to confirm previous results and especially the proposed role of His214 as an 
acid/base, we also considered modifying model I in which we included a neutral His. 
However, no stable I1' intermediate was found to occur emphasizing the newly proposed 
role. It is important to mention as indicated in the introduction that the mutation of the 
invariant His increased the pKa of the catalytic Cys which suggest the presence of a 
protonated His in the active site.  
For completeness, we also considered the proton transfer from a neutral His214 with a 
concomitant abstraction of another proton from the surrounding residues. Investigating 
the surroundings of His214 suggested the possibility of hydrogen-bond network including 
the tetrad His214, Tyr124, His173 and Arg156. Therefore, we considered expanding the 
modified model I by including previous residues in the QM. However, based on our 
current model, there is no stable I1 intermediate. 
Although PTP1B has been examined extensively especially regarding to the 
dephosphorylation mechanism, less studies have been performed to understand the 
regulatory oxidation mechanism. Therefore, based on our obtained results several 
experimental results can be performed to confirm our suggested mechanism, for instance 
the effect of His214 mutation on sulfenyl-amide, sulfinic and sulfonic acid formation. 
Furthermore, the role of His214 as an acid could be confirmed by mutating His to Asn to 
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preserve hydrogen-bonding interaction with the carbonyl oxygen. In addition, pH and 
kinetic studies during the oxidation mechanism would provide useful insights.  
Our results show that the amide-iminol tutomerization is a more energetically 
favorable pathway over the unfeasible direct cyclization, which could be transferable to 
other amide nitrogen cyclization mechanisms in other PTP's as well as in proteins in 
general. Furthermore, the importance of the non-bonded interaction of cysteine sulfur in 
proteins is highlighted as a precursor to sulfenyl-amide formation. The rate-limiting step 
for this reaction is the formation of sulfenyl-amide from a stable iminol intermediate. 
 
6.4 Conclusions 
In this study the atomistic description of sulfenyl-amide formation from sulfenic acid 
in PTP1B has been elucidated. Several computational modeling techniques including 
molecular dynamics (MD), quantum mechanical/molecular mechanical (ONIOM) 
calculations and quantum theory atoms-in molecules (QTAIM) have been employed in 
cooperative fashion. More specifically, MD simulation on the solvated PTP1B sulfenic 
acid crystal structure was performed to generate potential Michaelis complexes. The MD 
generated structures were grouped into 5 main groups based on the root mean square 
deviation (rmsd) of the active site residue. The average structures of the highest populated 
clusters was selected for subsequent ONIOM calculations. Furthermore, several active 
site interactions including the indirect hydrogen bonding between Ser216 amide nitrogen 
and Glu115 via water molecule as well as the Cys215 carbonyl oxygen His214 hydrogen-
bonding were investigated during the course of the simulation to confirm the stability of 
these interactions. 
Three different models were generated from the MD average structure including 
model I which has protonated His214. For completeness, modified QM/MM structures of 
model I was also considered including a neutral His214 as well as upon increasing the 
size of QM layer.  
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The optimized structure of RC indicates the presence of a weak hydrogen bond 
between Cys215 carbonyl oxygen and His214. Therefore, another reactive complexes 
(RC') was optimized in which this hydrogen-bond become stronger. This has been 
justified by investigating the consistency of this interaction during the MD simulation. 
Furthermore, RC' was found to be slightly more stable than RC. Using both RC' and RC 
as starting structures, our calculation indicated the unfeasibility of the sulfenyl-amide 
direct formation. Instead ONIOM calculations as well as the MD results suggested the 
stepwise mechanism. In which the Ser216 amide N is first deprotonated by Glu115 with 
an energy barrier of 46.8 kJ mol-1. The formed iminol intermediates were found to lay 
slightly higher in energy with respect to RC', 21.3 kJ mol-1. The nucleophilicity of the 
generated iminol nitrogen is much higher compared to the amide form facilitating the 
nucleophilic attack on the sulfenic acid sulfur and subsequent formation of sulfenyl-
amide intermediate. The same step was also examined starting from RC. However, no 
stable I1 intermediate was found to occur proposing a new role for His214 as an acid. 
A second iminol intermediate (I1') was also considered where the S…N distance has 
largely decreased to 2.78 Å. The nature of the S…N interaction in I1' was analyzed using 
QTAIM and NBO indicating the presence of a weak interaction between the two atoms. 
Furthermore, NBO analysis confirmed the nature of this interaction in which there is a 
charge transfer between the N lone pair and the sulfur σ*. 
Finally, the S…N bond is formed concomitantly with S…O dissociation forming a 
stable sulfenyl-amide intermediate. Notably, the two modified forms of model I including 
a neutral His214 showed that no stable iminol intermediate is formed.  
Our results suggest the formation a cyclic sulfenyl-amide from sulfenic acid in 
stepwise fashion using an amide-iminol tutomerization reaction in which His214 and 
Glu115 act as an acid and base catalysts, respectively. Finally, we think this work is 
important to the field of PTP1B drug discovery, as one of the main ways to inhibit PTP1B 
is to stabilize the sulfenyl-amide inactive oxidized form. Therefore, knowing the exact 
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mechanism and the role of the active site residues would be crucial for future drug 
development. 
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7.1 Introduction 
Peroxiredoxins (Prxs), also known as thiol peroxidases, are a class of ubiquitous 
enzymes with central roles in both the regulation of signaling pathways as well as being a 
potent antioxidant.1-3 Their main function, foremost, is to catalyze the reduction of 
peroxide substrates such as hydrogen peroxide (H2O2) and alkyl-hydro-peroxide 
(ROOH).4 Notably, along with their ubiquity, these enzymes are vastly abundant in cells, 
up to 1% of the total soluble protein and reach catalytic rates in the order of ~107 M-1 S-1.1 
In fact, these remarkable catalytic efficiencies have credited Prxs to reduce ~90% of the 
mitochondrial and approaching 100% of the cytoplasmic H2O2.3,5  
Prxs are classified into 6 main groups based on sequence similarity: Prx1, Prx6, Prx5, 
Tpx, BCP and AhpE (in Mycobacterium tuberculosis).1,4 All groups contain a reducing 
thioredoxin (Trx) fold with differences in their oligomeric states, from monomer to 
dodecamer.1,6,7 In addition, they also possess high similarities in their active site 
structures including the catalytic cysteine (Cp), proline (Pro), threonine (Thr)/serine (Ser) 
and arginine (Arg).1,8,9 Furthermore, based on mechanistic differences, Prxs are further 
divided into three main groups: 1-Cys, typical 2-Cys and atypical 2-Cys.6 This 
classification is dependent mainly on the existence and location of a second mechanistic 
cysteinyl residue, known as the resolving cysteine (CR).1 For instance, 1-Cys Prxs does 
not contain CR.1,6 In typical 2-Cys Prxs (the largest class of Prxs), however, the enzyme 
function is dependent on the presence of an intact homodimer where CP and CR are 
located on different monomers.4,10 In contrast, in atypical 2-Cys Prxs, the two mechanistic 
cysteinyl residues are located on the same monomer.4,11  
All classes of Prxs have a common catalytic cycle involving three main steps:1,4 1) the 
peroxidation step, in which CP nucleophilically attacks the peroxide substrate forming 
reactive Prx-sulfenic acid (SP-OH) intermediate, 2) the resolution step, where either the 
resolving CR or external thiol in 2-Cys Prx or the 1-Cys Prx, respectively, reduce (–SP-
OH) to form an intramolecular or intermolecular disulfide bond, 3) the recycling step that 
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leads to the regeneration of the active site via the reduction of the disulfide by external 
thiol such as Trx.12  
Several X-ray structures of the Prx family reveal similarities of H2O2 (HOA–OBH 
where OA is in close proximity to CP) binding in their active sites, preserving several key 
interactions.9,13-15 More specifically, the conserved Arg always is hydrogen bonding to 
CP.6,9 This allows for the stabilization of the nucleophilic thiolate as well as it is hydrogen 
bonded to the H2O2 oxygen (OA).6,9 The conserved Pro is thought to protect CP from 
interacting with solvent. In addition, the Thr residue acts as a hydrogen bond acceptor 
with respect to OA.6,9 Furthermore, the H2O2 molecule has been shown to be well 
positioned for attack via the previously described hydrogen bonds and two other H-bonds 
with the backbone amide of CP and its neighboring residue.6,9  Although existing X-ray 
structures highlights the roles of the active site residues, their specific roles in catalysis 
remains vague.9 More importantly, the nature of the proton donor needed to neutralize the 
hydroxide-leaving group is unknown.9 
In general, sulfenic acids are fundamental intermediates for numerous redox processes 
in proteins.16 It is highly reactive and can undergo several reactions as a nucleophile or 
electrophile.16,17 Thus it can be readily overoxidized to sulfinic and subsequently sulfonic 
acids in the presence of H2O2 or other oxidizing agents.16,17  This modification, in general, 
is considered irreversible and leads to protein deactivation.18 Notably, the second step of 
the mechanism that is characterized by the reduction of –SP-OH by CR, is competing with 
its overoxidation especially under oxidative stress.4,19 In Prx, the overoxidation of the 
typical 2-Cys occurs at a higher rate than the atypical 2-Cys or 1-Cys subclasses.20 
Notably, this occurs as a result of the location of the CR on the adjacent monomer which 
requires large structural rearrangement before sulfenic reduction allowing for –SP-OH 
interaction with a second peroxide.4 Fortunately, a unique enzyme (sulfiredoxin) was 
found to reduce typical 2-Cys Prx sulfinic acid back to sulfenic.20-22 This enzyme was 
only found in eukaryotic organisms and was found to be highly specific to the typical 2-
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Cys Prx implying the presence of alternative mechanisms to protect the typical 2-Cys in 
bacteria and archaea as well as in 1-Cys Prx from overoxidation and subsequently their 
inactivation.20  
In Archaea, the typical 2-Cys Prx (ApTPx) was recently proposed, based on X-ray 
crystallography, to been protected from overoxidation via a unique hypervalent sulfurane 
intermediate.23 Nakamura et al.23 characterized an X-ray structure at high resolution of 
1.77 Å for a unique intermediate with an electron density representing a covalent 
interaction between S of CP50 and the Nδ1 of His42 of approximately 2.2 Å. Small 
models calculations were performed at the B3LYP/6-31G* level in the absence of the 
active site residues in order to describe the chemical nature of this interaction.23 In result, 
two possible sulfurane intermediates were suggested to occur where the CP50 sulfur was 
covalently bound to His42, a hydrogen ligand and a hydroxyl group.23 The two proposed 
structures differ only by the ionization state of His42. Their calculations show that the 
removal of hydrogen ligand from the CP sulfur leads to the disappearance of S…N 
interaction.23 However, recently we assessed the performance of several density 
functional theory methods in dealing with hypervalent sulfur species in biological 
systems using different size basis set; our calculations show that the removal of hydrogen 
ligand does not break the interaction using other DFT functionals (manuscript in 
preparation). Furthermore, after characterizing the chemical structure of the intermediate 
the authors also investigated the mechanism of its formation. They suggested that 
sulfurane could not be formed from the direct interaction of sulfenic acid with an 
imidazole as the obtained barrier was found to be 215.9 kJ mol-1.23 Thus, an alternative 
mechanism where a thiol, a poor nucleophile, reduces the peroxide directly was proposed 
forming the sulfurane intermediate in concomitant step.23 It is important to mention that a 
similar interaction with a histidinyl residue was previously reported in the human 1-Cys 
Prx (hORF6) however the S…N distance was suggested to reflect hydrogen-bonding 
interaction.24 In addition, this histidyl residue is not conserved in all Prxs.23 
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Recently, there has been several hypervalent sulfur species reported in biological 
systems. For instance, in methionine sulfoxide reductase (Msr), a different sulfurane 
intermediate has been suggested computationally to occur.25 In addition, in Srx 
mechanism, two-hypervalent sulfur-based intermediate have been also suggested 
experimentally.26 More recently, a pseudo-hypervalent divalent sulfur species has been 
shown to play a critical role in protein architecture and functions.27 This type of weak 
interaction (S…X) between divalent sulfur and oxygen, nitrogen or sulfur atoms is quite 
similar to halogen-bonds.28 This σ hole bonding originates from a positive electrostatic 
potential on the sulfur center allowing for orbital interaction between the X lone pair and 
the anti-bonding orbital of the sulfur atom, nX→σ*S.29 Iwaoka et al. have characterized 
this weak interactions in four proteins: phospholipase, ribonuclease A, insulin and 
lysozyme, suggesting their importance in proteins in general.27 
In this study we first used the hybrid quantum mechanical/molecular mechanical 
calculations (QM/MM) calculations to elucidate the first step of the mechanism. This 
revealed thermodynamics and the roles of active site residues during the reduction of 
peroxide and sulfenic acid formation. Second, we investigated the pathway of formation 
of the currently proposed hypervalent sulfurane in ApTPx. Third, using QTAIM and 
NBO analysis we identified the degree of covalency of the S…N interaction in the 
enzyme's active site. Fourth, we also considered the formation of this intermediate in 
hORF6 to determine if this is feasible to occur in similar enzymes as a general intrinsic 
precaution to over oxidation. Finally, details into the overoxidation mechanism of Prx-
sulfenic acid to sulfinic acid have been determined. 
 
7.2 Computational Methods 
7.2.1 Structural Preparation and Molecular Dynamic Simulations. 
The Molecular Operating Environment (MOE) software package was used to prepare 
the starting X-ray structures for MD simulations as well as to analyze the simulations 
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results.30 The NAMD molecular dynamic software was used to run the MD simulations.31 
For ApTPx, the H2O2 bound X-ray of the C207S mutated crystal structure was obtained 
form the protein data bank (PDB: 3A2V)13 and used as starting configuration for 
simulation using one monomer of the decameric form. In addition, one monomer of the 
human 1-Cys Prx (hORF6) Prx-sulfenic acid X-ray structure (PDB:1PRX)24 was used as 
starting structure. 
Prior to MD simulations, errors in both crystal structures were automatically corrected 
using the structural preparation application in MOE. In ApTPX, the position of His42 was 
modified manually allowing for His42…Cys50 interaction. The protonated 3D application 
in MOE was used to add the missing protons in the crystal structures. For the active site 
residues especially Cys50 and His42 the protonation states were determined based on 
their pKa values obtained via PROPKA program.32,33 The generated structures were 
solvated up to 10 Å beyond every protein atom. Then, were minimized using 
AMBER12:EHT force field.34,35 Later, the minimized structures were used as starting 
points for 500 ps equilibration MD simulations to generate thermally relaxed structures in 
similar protocol as previously used.36,37 In the MD, 2 fs time step was used. The PME 
method was used to calculate columbic interactions and the van der Waals interactions 
were truncated at 8-10 Å.  
In hORF6, the S…O bond in the sulfenic acid intermediate was broken to generate the 
reduced form of the enzyme. The peroxide substrate was manually docked in the active 
site prior to simulation. In addition, a third MD simulation was performed to simulate the 
overoxidation mechanism. First, the QM/MM optimized structure of ApTPx sulfenic 
intermediate was used as starting structure. Second, peroxide substrate was also manually 
docked in the active site. The Cys50…H2O2 distance was restrained during the 
minimization to 3 Å allowing for substrate binding adjustment in the active site. Later, 
similar solvation, minimization and MD simulation protocols were used as described 
above. 
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Figure 7.1. Illustration of the ApTPx QM/MM model used obtained from MD average 
structure. The QM layer atoms are highlighted and shown in sticks representation. 
 
7.2.2 QM/MM Models and Calculations. 
All calculations were performed within the ONIOM formalism using the Gaussian 09 
suite of programs.38 The last structures of the previous MD simulations were used as 
starting structures for QM/MM calculations.39 The QM atoms were optimized at the M06-
2X/6-31G(d,p) which was selected based on previous assessment of several level of 
theories to optimize the proposed intermediates in ApTPx (manuscript in preparation).40 
The rest of the monomer was calculated using the AMBER96 forcefield as implemented 
in Gaussian09.35 Frequency calculations were used to confirm the nature of the optimized 
stationary points using the QM layer only, due to model size as previously used.36,37 
Relative energies were obtained using the ONIOM electronic embedding formalism using 
single points calculations at the ONIOM(M06/6-311+G(2d,p):AMBER96) In addition, 
other basis sets were also tested such as 6-311G(2d,p), 6-311+G(2df,p) and 6-
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311++G(3df,3pd) using the M06 functional as well as ONIOM(MP2/6-
31G(d,p):AMBER), (See Appendix Figure A7). 
Three QM/MM models structures were generated from the last conformer of the 
equilibrated MD simulations. All MM atoms 15 Å away from Cys50 sulfur were kept 
fixed in the optimization. For ApTPx, the QM layer included H2O2, Cys50, Pro48, Thr47, 
the backbone of Val40 and the R groups of His42, Asp45, Asp45, Arg126 and Arg149, 
see Figure 7.1. For ApTPx overoxidation state of sulfenic acid, the previously described 
residues were included in the QM layer as well as H2O2, Pro43, Ala44 and a water 
molecule (See Appendix Figure A8). Finally for hORF6, the QM was formed of H2O2, 
Cys47, backbone of Val46, Pro45, Thr44, His39, Pro40, part of Ser38 backbone and the 
R groups of Arg132, Arg155, Glu50 and 3 water molecules (See Appendix Figure A8). 
In order to investigate the nature of the S…N interaction, the Quantum Theory Atoms-
in-Molecules (QTAIM) was employed using AIM2000 program.41 Furthermore, natural 
bond analysis (NBO) was also used to determine the atomic partial charge of the 
optimized structures. 
 
7.3 Results and discussion 
7.3.1 Sulfurane intermediate formation in ApTPx. 
In ApTPx, the QM/MM optimized reactive complex (RC) structure revealed similar 
interactions to X-ray structure9 as discussed in the introduction. Based on estimated pKa's, 
our MD starting structure contained a neutral His42 and Cys50. However, in the QM/MM 
optimization Cys50 was found to be deprotonated, by transferring a proton to His42 that 
in turn transferred its proton to Asp45. Thus, the RC is formed of anionic Cys50, neutral 
His42 and Asp45, see Figure 7.2. 
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Figure 7.2. Illustration of the QM/MM optimized reactive complex of ApTPx. Only the 
QM layer is shown. 
 
The nucleophilic Cys50 anionic sulfur is stabilized via four hydrogen bonds with 
Arg126, His42 and Thr49. Furthermore, the H2O2 binding in the active site was found to 
involve several strong hydrogen bonds including OB...HNVal49, OA...HNCys50, OA...Arg126 
and OAH...Thr49. Notably, these hydrogen bonds destabilize the H2O2 in the active site 
promoting catalysis as experimentally suggested. NBO analysis was used to compare the 
substrate's charges in the active site and in the absence of the active site using both in gas 
phase and protein environment (dielectric= 4). In absence of active site, the negative 
charge on H2O2 two oxygen’s were found to be symmetric with values of -0.47 and -0.48 
in gas phase and protein environment, respectively. In the active site the O–O bond is 
polarized with charges of -0.49 and -0.52 for OB and OA, respectively. The ∠H-OB-OA-
H dihedral angle is reduced from 179.9° to 112.0°. In addition, Cys50 anionic sulfur has a 
charge of -0.63 and the Cys50S...OA distance is 3.2 Å. 
 135 
The first step in the proposed mechanism is the reduction of the peroxide. By 
investigating this step, our calculations show that this can readily occur via a barrier of 
82.1 kJ mol-1, see Figure 7.3. In TS1, the H2O2 OA...OB bond is elongated to 1.80 Å. 
Notably, the Cys50S...OA is reduced to 2.21 Å. Two intermediate were optimized from TS1, 
sulfenic acid (I1) and sulfenate intermediates (I2). However, I2 was found to be lower in 
energy than I1 by 15.0 kJ mol-1. In I1, see Figure 7.4, a proton is being transferred from 
Arg126 to OA. In addition, Thr47 is now hydrogen bonded to sulfenic acid oxygen with a 
distance of 1.71 Å. I1 is 88.9 kJ mol-1 more stable than RC. In I2, a sulfenate, the S...O 
bond is slightly reduced with respect to I1 from 1.66 Å to 1.64 Å. Additionally, the 
charge on the oxygen has increased from -0.93 in I1 to -1.09 in I2. Notably, the oxyanion 
is stabilized with three strong hydrogen bonds with Thr47, Arg126 and the formed water 
molecule with distances of 1.56 Å, 1.43 Å and 1.93 Å, respectively. I2 is 103.9 kJ mol-1 
more stable than RC. Since TS1 leads to the formation of either sulfenic or sulfenate, we 
considered optimizing TS2 to represent the interchange between the two possible 
intermediates. From I1, I2 can be readily formed via a low barrier of 4.8 kJ mol-1. In TS2, 
a proton is being shared between Arg126 and sulfenic acid with distances of 1.27 Å and 
1.20 Å, respectively.  
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Figure 7.3. Potential energy surface obtained for the formation of pseudo-sulfurane 
intermediate in ApTPx. 
 
In order to form the proposed sulfurane intermediate and allow for Cys50S...NHis42 
interaction, His42 needs to lose its proton. Thus, based on His42 interactions in I2, this 
can only be achieved by transferring a proton to sulfenate sulfur to form sulfenic acid 
tautomer. In I2, the His42H...SCys50 distance is 2.70 Å which allows for direct transfer. This 
step was found to occur via TS3 with a low barrier of 16.5 kJ mol-1. In TS3, a two proton 
transfer was found to occur in which the His42H is transferred to SCys50 and Asp45 to 
His42. The optimized structure shows that the latter proton is 1.14 Å and 1.47 Å from 
His42 and Asp45, respectively. From TS3, a sulfenic acid tautomer (I3) was found to 
occur and be more stable than I2 by 11.5 kJ mol-1 and lower than RC by -115.4 kJ mol-1. 
In I3 optimized structure, the S...O bond is reduced to 1.58 Å. As in I2, the sulfenic acid 
tautomer oxygen is stabilized by three hydrogen bonds. Notably, there is a weak 
interaction between His42N...SCys50 with a distance of 2.76 Å. This weak interaction 
(nN→σ*S) was analyzed using QTAIM in which a critical point was found to connect 
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His42 and Cys50 with electron density ρ of 0.020 and Laplacian ∇ρ2 of 0.017. NBO 
analysis of I3 shows that there is a positive charge on the Cys50 sulfur of 1.05 as well as a 
negative charge on the His42 nitrogen with a value of -0.63. The ∠ N–S–O angle is 
164.1°, which is close to X-ray structure.13 
Although I3 represents a pseudo hypervalent structure similar to the X-ray obtained,13 
the His42N...SCys50 distance is still large. Therefore, we considered a subsequent reaction 
that may strengthen this interaction. This was found to occur via TS4 with a barrier of 
25.2 kJ mol-1. In TS3, a proton is transferred form His42 to Asp45 in which the H...His42 
and H...Asp45 distances are 1.20 Å and 1.36 Å, respectively. For this TS, the His42N...SCys50 
was found to be slightly reduced to 2.75 Å. The following intermediate (I4) was found to 
contain anionic His42 and neutral Asp45. Indeed, in I4, His42N...SCys50 distance is reduced 
to 2.58 Å which is in agreement with crystal structure. In addition, the sulfenic S...O 
distance was slightly increased to 1.58 Å. The ∠N–S–O angle is increased to 166.1°. As 
previous, the nature of His42...Cys50 interaction was investigated further using QTAIM. 
Our analysis was found to still reflect His42...Cys50 weak interaction. However, the 
calculated density at critical point was found to be strengthened with respect to I3, 
ρ=0.030, as well as the Laplacian ∇ρ2=0.023. NBO analysis shows the increase of the 
negative charge on the sulfurane oxygen from -1.09 in I3 to -1.10. The charge on the 
sulfurane N was also found to increase to -0.68. In general I4 was found to be less stable 
than I3 by 43.7 kJ mol-1. However, I4 is still more stable than RC by -71.7 kJ mol-1. 
We also considered investigating a final intermediate (I5) upon transferring a proton 
from Arg126 to sulfurane oxygen via TS5, however this intermediate was found to be 
high in energy compared to I3 with a value of 15.2 kJ mol-1. The energy difference 
between I3 and I5 was found to be 130.6 kJ mol-1, which is unfeasible in enzymatic 
systems. More importantly, our QTAIM analysis shows that the His42...Cys50 interaction 
is still noncovalent (ρ=0.086 and ∇ρ2=0.083) indicating that the X-ray obtained 
hypervalent sulfurane in ApTPx is formed due to noncovalent interactions. 
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Figure 7.4. Stationary points obtained for the pseudo-sulfurane formation mechanism. 
Shown atoms represent the QM layer. However, only the highlighted are directly 
involved in the reaction. 
 
The previous described mechanism provides a detailed mechanism to the formation of 
hypervalent sulfurane (I4) from sulfenic acid via low barriers multistep. Furthermore, in 
order for the last step in ApTPx to occur, which is the formation of disulfide bond, the 
formation of sulfurane has to be reversible allowing for sulfenic acid reduction. Our 
obtained potential energy surface shows that the sulfurane (I4) can be readily reduced 
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back to sulfenate (I2) or sulfenic acid (I1) via maximum barriers of 28.0 kJ mol-1and 31.3 
kJ mol-1, respectively. 
 
7.3.2 Sulfenic acid oxidation mechanism in ApTPx. 
Since the formation of sulfurane intermediate is proposed to protect sulfenic acid from 
oxidation, we also considered investigating the overoxidation mechanism in the active 
site. As indicated in the methods section, the sulfenic acid QM/MM optimized structure  
(I1) was used as starting point for equilibrated MD simulation. Two models were used in 
which His42 was neutral/protonated. However in our discussion, only the neutral His42 
based model will be discussed in details as the obtained barrier for the protonated form 
shows unfeasible barrier of 183.3 kJ mol-1. 
In the MD simulation, the binding of H2O2 was found to only occur upon the rotation 
of the ∠Cα–Cβ–S–O dihedral angle, as experimentally suggested.42 In fact this might 
explains the role of sulfurane formation as the presence of His42...Cys50 noncovalent 
interaction would prevent such rotation and subsequently overoxidation. In the optimized 
QM/MM structure (RCOx), similar H2O2 interactions were found to occur including 
OB...HNVal49, OA...HNCys50, OA...Arg126 and OAH...Thr49 with the following distances 1.99 
Å, 2.06 Å, 2.57 Å and 1.68 Å, respectively. More importantly, the sulfenic acid S...OA 
distance is 3.09 Å. Furthermore, the sulfenic acid is hydrogen bonded to His42, see 
Figure 7.5. 
 The overoxidation mechanism was found to occur via TSOx in which similar 
interactions to TS1 were observed. In TSOx the OB...OA distance is increased to 1.87 Å as 
well as the Cys50S...OA distance is reduced to 2.05 Å. The obtained barrier for this step was 
found to be 121.6 kJ mol-1. The optimized sulfinic acid product (PCOx) was found to be 
much more stable than sulfenic acid with energy difference of -179.4 kJ mol-1. This is in 
agreement with experiment and explains the irreversibility of the overoxidation.16,17 
 140 
Indeed, comparing the energetics of the overoxidation mechanism with the sulfurane 
formation shows that sulfurane formation is extremely favorable over sulfinic acid.  
 
 
Figure 7.5. Illustration of the optimized stationary points for sulfenic acid overoxidation 
to sulfinic acid including their relative energies. Shown atoms represent the QM layer. 
However, only the highlighted are the ones involved in the reaction. 
 
7.3.3 Sulfurane formation in human hORF6. 
Finally, we investigated the possibility of pseudo-sulfurane formation in other 
enzymes in the Prx family. As discussed in the introduction, 1-Cys Prxs lack the presence 
of a second cysteine,1 which suggests a sulfenic acid protective mechanism. In human 1-
Cys hORF6, an X-ray structure shows that His39 nitrogen is 3.0 Å away from Cys47 
sulfur indicating hydrogen bonding. Thus we elucidated the possibility of sulfurane 
formation in hORF6. In order to form this intermediate, as in ApTPx, a base is needed to 
deprotonate His39. From MD simulation, a water molecule was always found to connect 
His39 to Glu50 implying the possibility of sulfurane formation. Thus we optimized 
several intermediates along the reaction pathway. 
In hORF6, the QM/MM optimized reactive complex (RChORF6) was found to show 
similar H2O2 binding interactions including OB...HNVal46, OA...HNCys47, OA...Arg132 and 
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OAH...Thr44 with distances of 2.08 Å, 2.02 Å, 2.29 Å and 1.59 Å, respectively. The 
Cys47S...OA is 3.42 Å as well as the anionic Cys47 sulfur is stabilized by four hydrogen 
bonds with His39, a water molecule and two hydrogen bonds with Arg132 with distances 
of 2.02 Å, 2.02 Å, 2.39 Å and 2.27 Å. Based on approximated pKa's, our model contained 
a neutral His39 and Cys47, however during the optimization an anionic Cys47 and 
protonated His39 was formed. The protonated His39 was found to be strongly hydrogen 
bonded to a water molecule, 1.52 Å. In turn this water is strongly hydrogen bonded to 
Glu50 with a distance of 1.48 Å.  
 
 
Figure 7.6. Illustration of the optimized stationary points for pseudo-sulfurane formation 
mechanism in hORF6, including their relative energies. Shown atoms represent the QM 
layer. However, the only highlighted are the ones involved in the reaction. 
 
Subsequently, we optimized the sulfenic acid intermediate (I1hORF6) which was found 
to be more stable than RChORF6 by -111.3 kJ mol-1. Upon sulfenic acid formation His39 
was found to donate its proton to Glu50 via the water molecule. Furthermore, as in 
ApTPx, sulfenic acid is formed with proton transfer from the neighboring arginine 
residue Arg132. The His42...Cys50 distance has increased to 2.36 Å. In addition, His39 is 
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still strongly hydrogen bonded to a water molecule, 1.79 Å, which subsequently is 
hydrogen bonded to the now neutral Glu50, 1.50 Å.  
As previous, in order for His39 to noncovalently bound to Cys47, His39 has to lose its 
proton. Based on X-ray and optimized QM/MM structure, this can be only achieved via 
sulfenic acid tautomer formation similar to ApTPx. Thus, we optimized the tautomer 
structure in which it was found to be lower in energy than RChORF6 and I1hORF6 by -166.4 
kJ mol-1 and -55.1 kJ mol-1, respectively. Notably, His39N...SCys47 is now reduced to 2.87 Å 
and the QTAIM calculation indicate the presence of noncovalent interaction with a 
ρ=0.017 and ∇ρ2=0.015. Furthermore, the optimized structure shows that His39 is now 
neutral upon proton transfer from Glu50. Similarly, sulfenic acid donates its proton to 
Arg132.  
Finally, we also considered forming an anionic His39 to strengthen the S...N 
interaction as in ApTPx. Indeed in I3hORF6, the His39N...SCys47 is reduced to 2.78 Å and the 
electron density and the Laplacian at the critical point was increased to ρ=0.022 and 
∇ρ2=0.017, respectively. Notably, our calculations show that a pseudo-sulfurane 
intermediate could form in 1-Cys Prx protecting sulfenic acid from overoxidation. The 
presence these noncovalent interaction between His nitrogen lone pair and Cys sulfur σ* 
orbital prevent the ∠Cα–Cβ–S–O dihedral angle rotation and subsequently H2O2 binding.   
Previous results might suggest the generality of this protective mechanism in Prxs. 
Therefore, we also considered investigating the current X-ray structures in the protein 
data bank. As in hORF6, another 1-Cys Prx in Arenicola Marina shows that a histidynyl 
residue is 3.96 Å away from the Cp in the C45S mutated X-ray structure (PDB:2V32).43 
Surprisingly, several structures of human PrxV were found to include histadinyl residues 
in close proximity to the catalytic Cys with an approximate distance of 5 Å.44-46 Although 
PrxV is an atypical 2-Cys Prx, the distance between the two cysteinyl residues are over 13 
Å and require large conformational change before disulfide bond formation which might 
imply the need for sulfenic acid protective mechanism.47  
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In human PrxIV, typical 2-Cys Prx similar to AtPTx, a threonyl residue was found to 
be located beneath the catalytic cysteine (PDB: 3TKS) similar to previous discussed 
histidinyl with a distance of approximately 3 Å.48 This suggests the occurrence of 
noncovalent interaction between Thr...Cys to form a novel sulfurane intermediate. Indeed, 
similar to nitrogen atom in His, the oxygen lone pair of Thr could form a noncovalent 
interaction with cysteinyl sulfur atom. As indicated in the introduction similar O...S 
interactions have been characterized in several proteins.27 
Finally, we also investigated the possibility of S...X noncovalent interaction formation 
in other enzymes. By investigating several X-ray structures including sulfenic acid, we 
found similar electrostatic interactions to occur. For instance, SUMO protease crystal 
structure indicate the presence of His residue 3.61 Å from sulfenic acid sulfur 
(PDB:2HKP).49 Earlier, it was suggested that SUMO proteases is regulated by H2O2.49 
Similar interaction was also found in E coli Gsp amidase with His...Cys distance of 3.7 
Å.50 These structures as well as our results might suggest the generality of noncovalent 
interactions to stabilize sulfenic acid in proteins and their protection from overoxidation. 
 
7.4 Conclusion 
In this study the mechanistic details of pseudo-hypervalent sulfurane species in 
ApTPx and hORF6 have been investigated using molecular dynamics simulations (MD) 
and quantum mechanical/ molecular mechanical (ONIOM) calculations. The chemical 
nature of the obtained intermediates was also revealed using quantum theory atoms in 
molecules (QTAIM) and natural bond orbital analysis (NBO). Furthermore, the atomistic 
details of hydrogen-peroxide reduction mechanism in ApTPx have been elucidated. 
First, MD and ONIOM calculations have shown that the binding of the substrate in the 
active site is similar to previous X-ray structures. Structural and NBO analysis of the 
reactive complex suggest the polarization of the OA...OB bond allowing for catalysis. The 
catalytic CP was also found to exist as anionic sulfur upon substrate binding and stabilized 
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with four hydrogen bonds. The substrate was found to be reduced forming 
sulfenic/sulfenate and water molecule via a barrier of 82.1 kJ mol-1. This step was found 
to be the rate-limiting step of the mechanism. Arg126 was found to act as an acid in case 
of sulfenic acid formation. However, the sulfenate intermediate was found to be more 
stable in the active site in which the oxyanion is stabilized by three strong hydrogen 
bonds.  
The experimentally proposed hypervalent species was found to occur via a low barrier 
multistep reaction in which Asp45 was found to play a crucial role in alternating the 
ionization state of His42.The first step in this reaction was found to occur via the 
formation of sulfenic acid tautomer from sulfenate upon proton transfer from His42. 
Indeed, the neutral His42 nitrogen is now 2.76 Å from Cys50 sulfur. QTAIM analysis 
confirmed the presence of weak interaction between the two residues. This interaction 
was found to be strengthening upon the formation of anionic His42 upon proton transfer 
to Asp45. The S...N distance in the formed intermediate is in agreement with the X-ray 
structure. Another step was also considered in which the sulfenic acid tautomer oxygen 
abstract a proton from Arg126. However, this was found to be energetically unfeasible. 
Second, we also considered investigating the overoxidation mechanism of sulfenic to 
sulfinic acid. This was found to occur upon another peroxide binding in the active site 
upon sulfenic acid dihedral rotation as suggested by previous experiment. The mechanism 
was found to occur via a high barrier, still enzymatically feasible, of 121.6 kJ mol-1. 
Indeed the formation of pseudo hypervalent sulfurane is much more favorable over 
sulfinic acid formation emphasizing the role of sulfurane formation in protecting ApTPx 
sulfenic acid. 
Third, we also considered investigating the possibility of similar hypervalent species 
in huamn 1-Cys hORF6. MD and ONIOM results suggested that Glu50 could act as an 
acid/base catalyst as in ApTPx. In order to investigate the mechanism, we optimized 
several intermediate along the reaction pathway. Notably, a similar reaction was found to 
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occur as in ApTPx. Although the S...N distance in hORF6 pseudo hypervalent species is 
larger than ApTPx, QTAIM suggest there is a presence of a weak interaction between the 
two residues.  
Finally, we also considered investigating the protein data bank X-ray structures for 
similar possible interactions. Similarly to hORF6, the 1-Cys Prx in Arenicola Marina 
have a histidinyl residue. Remarkably, several structures of human PrxV were found to 
include histidinyl residues in close proximity to the catalytic Cys with an approximate 
distance of 5 Å. Furthermore, in the typical 2-Cys human PrxIV, a threonyl residue was 
found to 3 Å away from CP suggesting the possibility of a novel sulfurane formation. We 
also considered investigating sulfenic acid X-ray structures in other proteins. In SUMO 
protease a His residue was found to be located 3.61 Å from sulfenic acid sulfur. Similarly, 
in E coli Gsp amidase a His residue was found to be in close proximity.  
Our MD, ONIOM, QTAIM, NBO and X-ray structure analysis suggest the generality 
of sulfenic acid sulfur noncovalent interactions forming pseudo hypervalent as protective 
mechanism against overoxidation in Prxs and other proteins. It also emphasizes the role 
of weak interaction in restricting dihedral rotation and subsequently in catalysis. Several 
studies can be conducted in order to confirm the generality of these mechanisms in 
protein sulfenic acid chemistry. 
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Chapter 8 
QM/MM Investigation of the Reduction 
Mechanism of Cysteine Sulfinic Acid in 
Peroxiredoxin via Sulfiredoxin 
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8.1 Introduction 
Elevated levels of reactive oxygen species (ROS), such as hydrogen peroxide (H2O2), 
have been known for their abilities of modifying several cellular components including 
proteins, DNA and lipids leading to cell damage.1,2 Such oxidative stress in cells has been 
highly related to aging and age related diseases including cancer and Alzheimer's.2-5 
Dissimilarly, low levels of H2O2, under subtoxic concentration, are essential for a variety 
of cellular functions including proliferation, differentiation, adhesion and migration by 
stimulating signal transduction.6-8 Indeed, H2O2 fulfills the requirement to act as a second 
messenger as it is rapidly produced and controlled via antioxidant enzymes.9 However, 
for H2O2 to act as a signaling molecule its concentration has to reach and to maintain a 
certain threshold level. 10 
In cells, H2O2 is reduced via two main mechanisms;9 1) It is being reduced by one 
electron reduction mechanism using transition metal such as in catalases or,11 2) it is 
reduced by the two electron nucleophilic substitution reaction by protein cysteinyl or 
seleno-cysteinyl residues, forming sulfenic/selenenic acid and water molecule such as in 
thiol and glutathione-peroxidases.12-14  
Peroxiredoxin (Prxs), also known as thiol peroxidases, are ubiquitous thiol-dependent 
enzymes that reduce H2O2 as well as other ROS species.12,15 It is highly abundant within 
cells and it represents the main enzyme for reducing H2O2 with a catalytic rate constant of 
107 M-1 s-1.15 Previous studies have shown that Prxs can readily reduce all cytoplasmic 
and nearly 90% of the mitochondrial H2O2 emphasizing its role in regulating low levels of 
H2O2 and its subsequent signaling.10  
In general, Prxs are categorized into three main classes, 1-Cys, typical 2-Cys and 
atypical 2-Cys, based on the number and location of the catalytic cysteinyl residues as 
well as the formation of inter or intra disulfide bond in the mechanism.16 For example, in 
1-Cys there is only one catalytic cysteinyl residue. In both 2-Cys classes two catalytic 
cysteinyl residues are involved in the mechanism.12 The first step of the H2O2 reduction 
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via Prxs is similar in which a conserved catalytic cysteinyl residue, known as peroxidatic 
cysteine, (Cys-SPH) attacks the H2O2 molecule forming a highly reactive sulfenic acid 
intermediate (Cys-SPOH).12 Subsequently, the later molecule is reduced using a resolving 
cysteinyl residue (Cys-SRH) forming a disulfide bond. In the atypical 2-Cys, the resolving 
Cys is located on the same monomer.17 Dissimilarly, in the typical 2-Cys, Cys-SRH is 
located on the adjacent monomer of the Prxs dimer. Ultimately, an external thiol reduces 
the sulfenic acid intermediate in 1-Cys or the disulfide bond in 2-Cys restoring the 
catalytic activity of the enzyme as the formation of sulfenic acid or disulfide transiently 
stops the peroxidatic activity.12 
In eukaryotic cells, the reduction of sulfenic acid, in the typical 2-Cys, by the adjacent 
monomer Cys-SRH requires large structural rearrangements decreasing the rate of 
disulfide formation.18,19 Notably, this can lead to the overoxidation of the highly reactive 
sulfenic acid by a second H2O2 molecule forming a sulfinic acid (–SO2H) intermediate.19 
Subsequently, under oxidative stress sulfinic acid is overoxidized to sulfonic acid (–
SO3H).20 The formation of sulfinic acid in Prxs was found to not only inactivate the 
peroxidatic activity allowing for the increase in the peroxide level and signal stimulation 
but also it leads to the formation of high molecular mass Prxs aggregates with a 
chaperone activity.21,22 In addition to typical 2-Cys, the oxidation of sulfenic acid has 
been found to occur in 1-Cys and in the atypical 2-Cys but at slower rates.23 It is 
important to mention that this overoxidation mechanism has been found to occur in other 
proteins such as protein tyrosine phosphatases 1B (PTP1B) and carbonic anhydrases.24,25 
In general, theses overoxidation states of sulfenic acid are considered irreversible, leading 
to the inactivation of the enzyme.26,27 Furthermore, the formation of sulfinic and sulfonic 
acid has been found to be associated with multiple disorders including cancer and age 
related diseases.22,28-30 Fortunately, the overoxidation of the typical 2-Cys Prxs to sulfinic 
acid is reversible by sulfiredoxin (Srx) via a unique mechanism.22 
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Srx was first identified in 2003 in Saccharomyces cerevisiae in which a disulfide bond 
was formed between Srx and 2-Cys Prx.31 The reduction mechanism was found to be 
dependent on the presence of ATP and magnesium.31 Later several studies have indicated 
the conservation of Srx in eukaryotic organisms.22 In human, Srx is mainly localized in 
the cytosol allowing for the restoration of the peroxidatic activity of PrxI and PrxII as 
well as the mitochondrial PrxIII and the ER PrxIV.22 Therefore, Srx can bind to all human 
typical 2-Cys Prxs and reverse the oxidation to sulfinic acid. However, previous studies 
have also shown that the Srx-Prx reduction mechanism is inefficient, with catalytic rate 
constant of 0.1 to 1.8 min-1, emphasizing the role of Srx in regulating 2-Cys Prxs and 
subsequently H2O2 signaling.22,32 Wood et al.31 have proposed a floodgate hypothesis in 
which transient intracellular peroxide burst increases the level of peroxide leading to the 
rapid inactivation of 2-Cys Prx allowing for H2O2 to act as messenger interacting with 
other proteins. However, in the presence of high concentration of Prx peroxide signaling 
would be stopped. Hence this overoxidation/reduction mechanism is essential for 
peroxide signaling as well as Prxs chaperon activity.21,23 
The molecular basis of this unique interaction of Srx-Prx has been investigated using 
several techniques including structural, mutational and mass spectrometry studies.22 
However, the exact mechanism is debatable. Originally, Biteau et al.33 proposed that the 
mechanism would occur in two steps in which Srx act as a phophotransferase and 
thioltransferase. First, the sulfinic acid is phosphorylated forming a novel sulfinic acid 
phosphoryl ester intermediate, see scheme 8.1. This reaction is reminiscent and is known 
to occur in several enzymes for the activation of a carboxylic group by phosphorylation 
such as in glutamine synthetases.34 However, this reaction is unique for sulfur chemistry. 
Then, the activated phosphoryl ester intermediate might reacts with a conserved Srx 
cysteinyl residue (Cys99) forming Srx-Prx thiosulfinate intermediate,33 see scheme 8.1. 
Finally, an external thiol, such as Trx, reduces the thiosulfinate intermediate restoring the 
Prx activity. 
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Scheme 8.1. The proposed regulation mechanism of typical 2-Cys Prx via Srx upon the 
hyperoxidation of Prx sulfenic acid by hydrogen peroxide. 
 
 
On the contrary, Jeong et al.19 proposed different mechanism in which the Srx 
conserved Cys is first phosphorylated similar to the phosphorylation mechanism of 
PTP1B active site cysteinyl residue.35 Followed by the transfer of the phosphate group to 
the sulfinic acid oxygen forming the sulfinic acid phosphoryl ester. Later the intermediate 
is directly reduced via thiol molecule (RSH). Furthermore, their mutation studies 
indicated that Arg50, Asp57 and Asp79 are essential for substrate binding.19 It is 
important to mention that the mutation of Cys99 was found to terminate the reductase 
activity of Srx.33 
Jönsson et al.32,36,37 have performed several crystallographic studies to investigate the 
nature of the formed intermediates in the mechanism. Their results support the original 
mechanism, see scheme 8.1, in which Srx performs bifunctional roles. Since their 
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obtained crystal structure of Srx-Prx complex as well as the quaternary structure of Srx-
Prx in the presence of ATP and Mg2+ shows that the distance between the γ-phosphate and 
Cys99 sulfur is nearly 5 Å.36 Notably, the position of Cys99 does not allow for in line 
nucleophilic attack. On the contrary, the Prx Cys52Asp oxygen is in a perfect position for 
in line nucleophilic attack with a distance of 4.3 Å from the phosphate group.36 In 
addition, in their Srx, ATP and Mg2+ crystal structure the γ-phosphate was found to point 
toward the solvent.37 Furthermore, the formation of the thiosulfinate intermediate has 
been proven in both human and yeast in previous studies.38,39 The role of the Mg ion was 
also investigated in which it was found to ligate to the three phosphate groups of ATP 
resulting in directing the γ-phosphate toward the Prx Cys-Sp.22 Finally crystal structure 
indicated the unfolding of the Prx to allow for its interaction with Srx.32 
Until now, this unique sulfur reaction has not been investigated neither using small 
molecules nor within the Srx-Prx active site. Therefore in this study the reduction 
mechanism of Prx sulfinic acid via Srx is investigated in details using quantum 
mechanical/ molecular mechanical (QM/MM) modeling approach based on the Srx-Prx 
ATP and Mg2+ bound protein crystal structure. Computational chemistry is now 
established as a main tool for investigating catalytic mechanisms and has been 
successfully used to gain atomistic details of the enzymatic mechanisms including 
intermediates, transition states and energetics.40-43 
 
8.2 Computational Methods 
8.2.1 Protein Model Preparation 
The X-ray crystal structure preparation and the MD analysis were accomplished using 
the Molecular Operating Environment (MOE) software package.44 Molecular dynamic 
simulation was performed using the NAMD Molecular Dynamics software.45 The initial 
coordinates were taken form the X-ray crystal structure of human Srx in complex with 
typical 2-Cys Prx (PrxI), ATP and Mg2+, PDB: 3HY2. 36 
 156 
 
Figure 8.1. The QM/MM model for the Srx-Prx Michaelis complex used to investigate 
the first step of the mechanism. The QM layer atoms are highlighted in sticks to the right 
of the Figure. 
 
First, the PrxI Cys52Asp was mutated to sulfinic acid. Second, the missing protons in 
the crystal structure were added using the protonate 3D application in MOE that assigns 
each residue ionization state by minimizing the total free energy of the system.46 Then, 
the two enzymes complex structure was spherically solvated up to 15 Å beyond every 
protein atom. The distance between the γ-phosphate and one of the sulfinic oxygen's was 
restrained to 3–3.5 Å. Subsequently, the protein complex was minimized using 
AMBER12:EHT force field in which AMBER 12 parameters are used for protein and 
Extended Hückel Theory for parameterizing small molecules.47,48 Finally, in order to 
allow for thermal relaxation especially after introducing sulfinic acid in the structure, the 
minimized structure was used as starting point for a short 500 ps MD simulation at 300 K 
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similar to previous studies.49 Finally, the final structure of this short simulation was 
chosen as the starting structure for further calculations. 
In order to investigate the second step of the reaction, a second 500 ps MD simulation 
was also performed to model possible arrangements in the active site upon sulfinic acid 
phosphoryl ester intermediate formation. The starting structure for this simulation was 
obtained from the QM/MM optimized structure of the intermediate. The distance between 
sulfinic acid phosphoryl ester sulfur and the Srx Cys99 sulfur was restrained to 2.5–3 Å in 
order to allow for subsequent reaction. The same protocol was used as in the first 
simulation and the last structure of the simulation was chosen as the starting point for 
QM/MM calculations. 
 
8.2.2 QM/MM Models and Calculations 
All calculations were performed within the ONIOM scheme using the Gaussian 09 
suite of programs.50 The QM/MM starting structures were taken from previous steps 
using the whole protein Srx-Prx complex. The QM high layer was described using the 
hybrid-meta-exchange-correlation functional M06-2X.51 While the MM low layer was 
described by AMBER96 force field as implemented in Gaussian. Optimized geometries 
were obtained using the 6-31G(d,p) basis set for the high layer. Due to computational cost 
as well as to keep the integrity of the protein-protein interaction all atoms 15 Å away 
from the γ and β phosphate linking oxygen were kept frozen in the calculations. Relative 
energies were then obtained using a single point energy calculations on the optimized 
structures at the ONIOM(M06-2X/6-311+G(2df,p):AMBER96) level of theory within the 
electrostatic embedding (EE) formalism.52 The EE formalism accounts for the 
polarization of the core layer by the low layer at the QM level of theory. The choice of 
functional and basis sets was based on our previous benchmarking study of several 
biological sulfur species in which M06-2X was found to be one of the best functionals 
with respect to a benchmarking QCISD and MP2 calculations (manuscript in 
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preparation). Frequency calculations were performed on the high layer only to confirm 
the nature of the optimized structures as previously conducted.53,54 
 
 
Figure 8.2. The QM layer residues included in model II to study the second step of the 
reduction mechanism converting sulfinic acid phosphoryl ester into thiosulfinate. 
 
As can be seen in Figure 8.1, the Michaelis complex structure included only the 
cysteinyl sulfinic acid residue (Csd52) from PrxI. Besides several residues from the Srx 
protein as the ATP molecule is mainly bonded to the Srx active site, similar to 
experimental results, including the conserved Cys99, His100, Lys61, Arg101, Gly97 and 
Gly98. Furthermore, in addition to ATP and Mg2+, several active site water molecules 
were also added to the high layer. 
For the second step of the reaction, the QM layer of the sulfinic acid phosphoryl 
intermediate was slightly increased allowing for better description of the sulfinic acid 
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phosphoryl ester surroundings interaction. As can be seen in Figure 8.2, the used model 
included Csd52, Pro53 and Thr54 from PrxI. In addition, the same Srx residues as in 
model I were included beside Ser55 and Arg51 as well as the R group of His100. 
 
 
Figure 8.3. Potential energy surface obtained for the formation of sulfinic acid 
phosphoryl intermediate and ADP from Prx-sulfinic acid and ATP via a concerted 
mechanism. 
 
8.3 Results and Discussion 
8.3.1 Formation of sulfinic acid phosphoryl ester 
The total active site interactions of the optimized structure of the reactive complex 
(RC) are similar to the Srx-Prx X-ray structure. The phosphate groups of the ATP 
molecule is stabilized and bound to the Srx proteins by several hydrogen bonding's with 
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Srx residues including Lys62, Arg101, Cys99 and the backbone amide of His100, Cys99 
and Gly98. Previous mutational studies have confirmed the role of these residues in ATP 
binding. In addition, as in the crystal structure the Mg2+ ion is coordinated to the three 
phosphate of the ATP molecule. Besides Mg2+ ion coordination to the phosphate groups, it 
is also coordinated to three water molecules with an average distance of 2.06 Å. this 
octahedral interactions of the Mg2+ ion direct the γ-phosphate toward the Prx sulfinic acid 
(Csd52). 
The Srx-Cys99 sulfur is 3.85 Å from the γ-phosphate atom. More importantly, the 
distance between the Prx-Csd52 oxygen and the γ-phosphate atom is 3.08 Å, see Figure 
8.4. Therefore, the position of Prx-Csd52 is in a better position for direct in line 
nucleophilic attack as previously proposed. Furthermore, the Prx-Csd52 second oxygen is 
sharing a proton with one of the Mg ion bound water molecule in which the proton is 1.39 
Å and 1.09 Å from the water oxygen and the sulfinic acid oxygen, respectively. In 
addition, the Mulliken population analysis shows that the sulfinic acid oxygen has a 
negative charge of -0.54 and the γ-phosphate atom has a positive charge of 1.28. 
Based on structural arrangement and charge distribution, we investigated the first step 
of the mechanism in which a direct in line nucleophilic attack of Prx-Csd52 oxygen to 
form sulfinic acid phosphoryl ester. This step was found to occur via a low barrier of 16.3 
kJ mol-1. In TS1, the Prx-csd52 oxygen is 2.13 Å form the γ-phosphate atom. Similarly, 
the γ-phosphate…O bond is elongated to 2.14 Å showing that phosphoryl transfer is 
happened via a concerted mechanism. Other interactions in the active site remain similar 
to the reactive complex.  
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Figure 8.4. Schematic representation of the optimized stationary points for the overall 
reaction, from sulfinic acid to thiosulfinate product formation. All atoms in the QM layer 
are included however, we only highlighted the atoms included in the reaction as balls and 
sticks. 
 
The energy of the sulfinic acid phosphoryl intermediate (I1) is quite similar to RC 
with a difference of -0.5 kJ mol-1. Indeed in the I1 optimized structure, see Figure 8.3, the 
phosphoryl group is already transferred to the sulfinic acid in which the Prx-Csd52 
oxygen…phosphorus distance is 1.7 Å. Furthermore, the phosphoryl group is totally 
dissociated from the ATP forming an ADP molecule with a P…O distance of 2.88 Å. 
Furthermore, the dissociated ADP oxygen is now hydrogen bonded to Srx-Cys99 and the 
backbone amide of His100. The Mg2+ ion is still coordinated to the three phosphate 
groups. In I1, the distance between the Srx-Cys99 sulfur and the sulfinic acid phosphoryl 
intermediate sulfur is quite long for subsequent reaction, 5.70 Å. This indicates the need 
for structural rearrangements of the active site upon formation of I1. Therefore, as 
 162 
indicated in the computational method section, we performed a second MD on the I1 
optimized structure allowing for the following interaction to happen. It is important to 
mention that previous study indicated the change of the two sulfur's distance to 
approximately 3 Å upon sulfinic acid phosphoryl ester formation. 
 
8.3.2 Formation of thiosulfinate intermediate 
The obtained MD structure of I1' was optimized as in the previous step however, a 
larger QM layer was included to better describe new interactions in the intermediate, see 
computational section. Several new interactions were obtained in the QM/MM optimized 
I1' upon allowing for structural rearrangements such as Mg2+ ion is now coordinated to 
two oxygen of the sulfinic acid phosphoryl ester as well as three oxygen from the ADP 
molecule in addition to a water molecule keeping its octahedral structure. The second 
oxygen of the Csd52 is double hydrogen bonded to Prx-Thr54. In addition several water 
molecules are hydrogen bonded to the phosphoryl moiety of the sulfinic acid ester. 
Furthermore, the Srx-Cys99 is strongly hydrogen bonded to the sulfinic acid phosphoryl 
ester, 2.06 Å, see Figure 8.4. More importantly, the distance between the Srx-Cys99 
sulfur and the sulfinic acid sulfur is now 3.33 Å allowing for subsequent reaction. 
Furthermore, the Mulliken population analysis shows that the sulfinic acid phosphoryl 
ester has a positive sulfur center of 0.152. In contrary the Srx-Cys99 sulfur has a negative 
charge of -0.312. 
The second step of the reaction involving thiosulfinate formation was also found to 
occur in a concerted mechanism with an energy barrier of 81.6 kJ mol-1 with respect I1', 
see Figure 8.5. The optimized transition state for this reaction (TS2) shows that the Srx-
Cys99 is already activated forming a better nucleophile by the phosphoryl sulfinic acid 
ester oxygen. Notably the S…S distance is reduced to 2.64 Å with a concomitant 
elongation of the S…OPO3H bond to 2.02 Å. This indicates that the reaction would occur 
via an SN2 mechanism as in the first step. Furthermore, in TS2, the Mg2+ ion losses one of 
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its coordination with the now protonated oxygen of the phosphoryl moiety, replacing it 
with a second water molecule. The now nucleophilic Srx-Cys99 sulfur is currently 
stabilized by hydrogen bonding with Srx-Arg51 as well as a water molecule.  
The formation of the disulfide bond forming the thiosulfinate product complex and 
phosphoryl group (PC) is found to lay 66.2 kJ mol-1 higher in energy than I1'. Indeed, the 
PC optimized structure shows the cleavage of the S…OPO3H bond with a distance of 2.71 
Å.  More importantly, the Srx-Cys99 sulfur is bounded to Prx-Cys52 with a distance of 
2.14 Å. Furthermore, the Mg2+ ion has restored its double coordination with the released 
phosphoryl group.  
 
 
Figure 8.5. Potential energy surface obtained for the formation of thiosulfinate product 
complex via the interaction of Prx-sulfinic acid phosphoryl ester and Srx-Cys99 via a 
concerted mechanism. 
 
In general, our results support the previously suggested reduction of Prx-sulfinic acid 
via ATP and Srx. Additionally, our obtained energies suggest that the rate-limiting step of 
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this part of the reduction mechanism is the formation of the thiosulfinate intermediate. 
Our obtained energies also suggest that the inefficiency and the slow catalytic rate for this 
reaction is mainly due to the final step in which an external thiol reduces the thiosulfinate 
intermediate. In fact this is in agreement with several enzymatic mechanisms including 
external thiol such as Trx. For example in methionine sulfoxide reductase Msr's where the 
reduction of the disulfide by Trx is the rate-limiting step.43 Finally, our results provide a 
detailed mechanism for sulfinic acid reduction, which could open the door to design new 
antioxidants capable of reducing such irreversible modifications of proteins. 
 
8.4 Conclusions 
The atomic description of the reduction mechanism of Prx-sulfinic acid via ATP and 
Srx has been elucidated in details using the hybrid quantum mechanical/ molecular 
mechanical (QM/MM) approach, within the ONIOM formalism. The Srx-Prx protein-
protein starting model was first obtained from the X-ray structure of the Prx-Cys52Asp 
mutated structure with Srx, ATP and Mg2+. Prior to QM/MM calculation, first, the Prx-
Asp52 was modified to sulfinic acid. Subsequently, the whole structure was solvated and 
minimized using AMBER12:EHT force field. Then the minimized structure was 
thermally relaxed using short molecular dynamics simulation for 500 ps allowing for 
equilibration of the active site upon modifications. Finally, the last MD structure was 
chosen as a starting structure for the QM/MM calculations. 
The previously proposed mechanism for sulfinic acid reduction via direct formation of 
sulfinic phosphoryl ester and finally thiosulfinate was examined. The Srx-Prx complex 
was divided into two layers in which the high layer included only the active site residues 
and their calculations were performed using the M06-2X, DFT functional. The rest of the 
complex was optimized using AMBER96 force field. 
The first step of the mechanism was found to occur via a direct concerted mechanism 
forming sulfinic phosphoryl ester with a small activation energy of 16.3 kJ mol-1.  In TS1, 
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the Prx-csd52 oxygen perform an in line nucleophilic attack on the γ-phosphate as 
previously suggested forming a slightly stable sulfinic acid phosphoryl intermediate with 
respect to RC. The I1 optimized structure shows that the phosphoryl group is already 
transferred to the sulfinic is dissociated from the ATP forming an ADP molecule. In I1, 
the distance between the Srx-Cys99 sulfur and the sulfinic acid phosphoryl intermediate 
sulfur indicated the need for structural rearrangements of the active site upon the 
intermediate formation allowing for subsequent reaction. 
A second MD on the sulfinic acid phosphoryl ester was performed allowing for 
structural rearrangements. The last MD structure was chosen for subsequent QM/MM 
calculations as in the previous step. A larger QM layer was included in the starting 
structure of the second step allowing for better description of the active site. The QM/MM 
optimized of I1' shows several structural rearrangements in the active site, such as the 
Mg2+ ion double coordination the sulfinic acid phosphoryl moiety. Notably, the distance 
between the Srx-Cys99 sulfur and the sulfinic acid sulfur is 3.33 Å allowing for 
subsequent reaction.  
The second step of the mechanism was also found to occur in a concerted mechanism 
with an activation energy of 81.6 kJ mol-1. In TS2, the Srx-Cys99 is first activated 
forming a better nucleophile followed by nucleophilic attack on the sulfinic acid sulfur 
with a concomitant cleavage of the S…O bond via an SN2 mechanism. The formed 
thiosulfinate product complex was found to lay 66.2 kJ mol-1 higher in energy than I1'. 
Our results suggest that the rate-limiting step of this part of the reduction mechanism is 
the formation of the thiosulfinate intermediate indicating that the rate limiting–step of the 
overall reaction is related to the reduction of the thiosulfinate intermediate via an external 
thiol as in other proteins.  
Finally, this study set up the basis for understanding the chemistry behind this 
fascinating sulfur reaction in Srx which could open the door to design Srx ATP mimic 
antioxidants as new hope to fight oxidative stress which is hallmark for many diseases. 
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9.1 Introduction 
For biomolecules, structure and function are often intimately inter-related. 
Consequently, their chemical and physical diversity is an essential factor for life as it 
enables them to exhibit numerous differentiated and highly specific functionalities.1 
This range of functionality arises not only from the use of dissimilar molecules but 
also from geometrical isomers of the same molecule.2 For example, L-glutamate is a 
building block of proteins and has a role as an essential neurotransmitter in all 
complex living organisms.3 Its stereoisomer D-glutamate, however, does not share 
these functionalities; for example, it is instead a key component in bacterial cell wall 
synthesis.4 Cells can also differentiate between isomers of exogenous molecules such 
as therapeutic drugs, e.g., the enantiomers of thalidomide in which one is an effective 
treatment for morning sickness while the other causes birth defects.5,6 
Cis-trans isomerization (CTI) is an important approach for generating geometrical 
isomers,7 and is involved in many biochemical phenomena such as protein folding.8 
Such reactions require the breaking of a double bond, which typically has a high 
activation barrier. However, they can be chemically-facilitated by, for example, the 
use of metal ions, nucleophilic attack or acid/base catalysis.8,9 Alternatively, photo-
excitation can lead to isomerization via π-π* singlet and triplet excited states.10-12 
A number of enzymes that catalyze CTI have been examined experimentally and 
theoretically, revealing a wide range of mechanisms. For example, the glutathione 
(GSH)-dependent enzyme maleylacetoacetate isomerase, converts maleylacetoacetate 
to fumarylacetoacetate via transient covalent modification.13 The related enzyme 
maleylpyruvate isomerase utilizes a similar mechanism.14 In contrast, the mechanism 
by which retinal isomerases converts 11-trans-retinal to 11-cis-retinal proceeds via a 
radical intermediate.15 The peptidyl-prolyl cis-trans isomerase family catalyzes the 
interconversion of cis/trans peptide bonds that involve prolyl. Notably, they have been 
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proposed to use a variety of different mechanistic approaches including nucleophilic 
and proton addition.16,17 
Asp/Glu racemase superfamily members share several structural features including 
a pseudosymmetrical active site-containing domain, carboxylate-containing substrate, 
dioxyanion hole to help stabilize the carboxylate,18 and in most members, two 
catalytic cysteinyls.4 The catalytic role of the latter two residues has been 
experimentally confirmed using site directed mutagenesis,9,19,20 and two mechanisms 
have been proposed for their activation. In particular, in some members such as 
glutamate racemase (GluRs) the catalytic Cys may be activated by a conserved His 
and Asp residues.21 In contrast, a previous study on proline racemase (ProRs), 
involving molecular dynamics (MD) simulations suggested that activation may occur 
via a water or the substrate itself.18 Regardless of such differences, however, the 
catalytic mechanism of all members is believed to involve formation of an enediolate 
intermediate.18,22 
Maleate cis-trans Isomerase (MI) is a member of the Asp/Glu racemase 
superfamily found in bacteria that collectively exhibit a diverse range of functions 
including catalyzing the conversion of L-amino acids to D-amino acids during cell wall 
biosynthesis.19,23,24 MI is a key enzyme in the metabolic degradation pathway of 
nicotinic acid.25 Notably, it is utilized by many microorganisms such as Pseudomonas, 
Alcaligenes, Serratia and Proteus to catalyze the geometric isomerization of maleate 
to fumarate (Scheme 1).6,26 The latter is an essential intermediate in the citric acid 
cycle.27 In addition, it is also an important industrial target as it is involved in aspartic 
and L-maleic acid production.28,29 Recently, there has also been increasing attention in 
using MI for degradation of tobacco waste.30 Hence, there is great interest in gaining a 
better understanding of the mechanism and properties of MI and its related 
enzymes.23,29,31,32 
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Scheme 9.1. Illustration of the overall isomerization reaction catalyzed by Maleate 
cis-trans Isomerase (MI). 
 
 
Maleate cis-trans Isomerase (MI) is a cofactor-independent member of the 
Asp/Glu racemase superfamily.26,33 Recently, X-ray crystal structures of both wild-
type MI from Nocardia farcinia and the corresponding C194A mutant with a 
succinyl-cysteine intermediate trapped within the active site has been determined.34 In 
the same study, site directed mutagenesis studies showed that mutation of Cys194 to 
Ala results in enzyme inactivation.34 Furthermore, substitution of either active site 
cysteinyl Cys194 or Cys76 by serine reduces the rate of reaction of MI by 8000 and 
1474-fold, respectively.34 In addition, it was noted that as with other Asp/Glu 
racemase members several residues form a dioxyanion hole to help stabilize reaction 
intermediates.9,34 However, the more hydrophobic nature of MI's active site likely 
results in a less effective stabilization.34 
Based in part on these studies, two possible isomerization mechanisms have been 
proposed as shown in Scheme 2. Both involve an initial direct nucleophilic attack of 
deprotonated Cys76 (i.e., Cys76S–) at the maleate substrate's C2 carbon centre. 
Notably, it is as yet still unclear how Cys76 is deprotonated (i.e., activated) so that it 
can more readily act as a nucleophile.34 Furthermore, this nucleophilic role is 
distinctly different to that observed in other superfamily members such as GluR and 
arylmalonate decarboxylase (AMD) in which the active site cysteinyls act as acids 
and/or bases and do not form a covalent enzyme-substrate complex.18,35 Importantly, 
in one pathway (A) this occurs with concomitant transfer of the Cys194 thiol proton 
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onto the substrate's C3 carbon centre to form a succinyl-cysteine-type intermediate 
(Scheme 2A). It is important to mention that this intermediate has been observed using 
X-ray crystallography in the C194A mutant structure at high resolution and it was also 
confirmed using mass spectrometry.34 In the alternate pathway, however, Cys194 acts 
simply as a hydrogen bond donor to one of the substrate carboxylates throughout the 
mechanism, stabilizing its anionic charge (Scheme 2B). That is, pathway B proceeds 
via an enediolate-type intermediate. Despite these differences, the next step in both 
proposed mechanisms is rotation around the newly formed C2–C3 single bond to give 
a fumarate-like structure. In the succinyl-Cys pathway (Scheme 2A), the Cys76S–C2 
bond dissociates concomitantly with deprotonation of -C3H2- by Cys194S–, thus 
forming fumarate with regeneration of a neutral Cys194SH. In contrast, in the 
enediolate pathway (Scheme 2B), cleavage of the Cys76S–C2 bond leads directly to 
formation of fumarate. 
Scheme 9.2. Proposed mechanisms for the maleate/fumarate isomerization reaction 
catalyzed by MI via an (A) succinyl-Cys or (B) enediolate intermediate.34
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Computational chemistry has been shown to provide detailed insights into 
biological systems, and in particular, enzymatic mechanisms.36-39 In this present study, 
density functional theory-based QM-cluster and ONIOM QM/MM methods have been 
used to investigate the initial substrate-bound active site complex and protonation 
states of key residues, as well as the catalytic mechanism of Maleate cis-trans 
Isomerase (MI). 
 
9.2 Computational Methods 
All docking and molecular dynamics simulations were performed using the 
Molecular Operating Environment (MOE) program,40 while all QM-cluster and 
ONIOM QM/MM calculations were performed using the Gaussian 0341 and 0942 suite 
of programs. The density functional theory method B3LYP, a combination of Becke’s 
three parameter exchange functional43 and Lee, Yang and Parr’s correlation 
functional44 as implemented in the Gaussian programs, was the QM method used in 
the present calculations. 
 
9.2.1 DFT-Small Model Studies 
A series of initial studies were done in order to help determine an appropriate basis 
set to use in the larger studies (see below), and to examine the effects of the 
environment's polarity on the protonation state and properties of the substrate, 
mechanistic intermediates and product. More specifically, optimized geometries were 
obtained of maleic acid, its mono- and di-anionic deprotonated derivatives, succinate 
and succinyl-methylthiol using the B3LYP method in combination with basis sets 
ranging from 6-31G(d) to 6-311+G(2df,p). Effects of a polar environment were 
included by use of the integral equation formalism polarizable continuum model (IEF-
PCM) as implemented in Gaussian.41,42 In particular, dielectric constants (ε) of 4 and 
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10 were used to model a protein environment as previously suggested,45,46 while 
ε=78.39 was used to model an aqueous environment. 
 
9.2.2 QM-Cluster Studies 
All structures were optimized at the B3LYP/6-31G(d,p) level of theory. Relative 
energies were obtained via single points at the B3LYP/6-311+G(2df,p) level of theory 
on the optimized structures with the inclusion of the corresponding solvation 
correction obtained at the IEF-PCM (e=4.0)-B3LYP/6-31G(d,p) level of theory. 
Frequency calculations were used to characterize transition structures as first-order 
saddle-points. 
A suitable chemical model was derived using the X-ray crystal structure of 
Nocardia farcinia, NfMI (PDB ID: 2XEC).34 Specifically, dianionic maleate was 
docked into the active site of NfMI; all residues within 10 Å of the catalytic cysteine 
(Cys76) being considered as the active site. In the above crystal structure the R-group 
of Cys76 points away from the active site pocket and therefore was manually 
reoriented prior to docking and MD simulations. Docking was performed using the 
London dG scoring function followed by optimization of the top 100 generated 
structures using a force field refinement method using AMBER99. The best 30 
scoring structures were then examined visually to choose the most suitable starting 
structure for further calculations. The active site of the chosen structure was then 
solvated up to 10 Å from the substrate. The solvated enzyme-substrate complex was 
then allowed to thermally relax by performing an MD simulation for 1 ns with a time 
step of 2 fs as has been previously used.47,48 A cluster analysis was then performed 
based on the distance between the sulfur of Cys76 and maleate's -C2H2- carbon in 
order to obtain an average structure, which was then optimized using the AMBER99 
force field.49 From this optimized structure, the active site-bound substrate model 
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shown in Scheme 3 was obtained for use in the QM-cluster studies. In particular, it 
included appropriately truncated models of Cys76, Cys194, Val78 and Gln196 as they 
are known or have been suggested to be catalytically important.34 In addition, the R-
groups of Tyr133, Asn14, and Asn163 were included as they directly interact with the 
substrate, e.g., via hydrogen bonding. Finally, Leu77 and Val195, both modelled as 
alanyls, were also included. As is common practice50 when using QM-cluster models, 
in order to maintain the integrity of the model, a minimum number of atoms, remote 
from the reactive region, were kept fixed at their MM optimized coordinates and are 
highlighted in red in Scheme 3. 
 
Scheme 9.3. The active site-bound substrate chemical model of NfMI used for the 
QM-cluster studies (atoms fixed at their MM optimized coordinates are highlighted in 
red and atom numbering used for Maleate carbons is also shown). 
 
 
9.2.3 QM/MM Studies 
The hybrid quantum mechanics/molecular mechanics (QM/MM) method as 
implemented in the ONIOM formalism in Gaussian 0942 was used for all QM/MM 
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calculations.51 The reactive region, high (QM)-layer, was described using the same 
level of theory and basis set size as per the above QM-cluster approach, B3LYP/6-
31G(d,p). The rest of the chemical model, the low (MM)-layer, was described using 
the AMBER96 MM force field. Relative energies were obtained via single points at 
the ONIOM(B3LYP/6-311+G(2df,p):AMBER96) level of theory on the above 
optimized structures. 
 
Scheme 9.4. Schematic illustration of the chemical model, derived from the X-ray 
crystal structure PDB ID: 2XED, used in the ONIOM QM/MM calculations. The 
inner circle represents the high (QM)-layer while the outer represents the low (MM)-
layer. 
 
 
A suitable chemical model for use in the QM/MM calculations was obtained from 
the X-Ray crystal structure of the Cys194Ala NfMI mutant enzyme with a covalently 
active site-bound succinyl-cysteine intermediate (PDB ID: 2XED).34 A wild-type 
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Michaelis complex was generated by mutating Ala194 to Cys and cleaving the 
enzyme-substrate covalent bond. The structure was then minimized using the 
AMBER99 force field. The resulting minimized structure was then truncated to 
include all residues within 15 Å of the substrate and is shown in Scheme 4. Within 
this, the QM-layer was chosen to contain all residues previously used in the QM-
cluster chemical model as well as the Gln196–Met197 and Val78–Ala79 peptide 
bonds. All other residues were placed in the MM-layer. In order to help maintain the 
model’s integrity, and since a large QM-layer was selected, most MM-layer atoms 
were held fixed at their minimized (see above) positions.52 The QM-cluster and 
QM/MM optimized reactive complexes (RCs) were compared to verify consistency in 
their structures. Notably, their RMSDs were determined to have only quite negligible 
differences. In addition, the QM/MM optimized succinyl-Cys intermediate was 
compared to the corresponding chemical region of the crystallized intermediate (i.e., 
PDB ID: 2XED)34 and found to have minor RMSDs of just 0.29 Å. 
 
9.3 Results and Discussion  
9.3.1 DFT-small model studies on isomerization 
As noted in the Introduction, both proposed mechanisms involve nucleophilic 
attack of a cysteinyl thiolate at the C2/C3 position of dianionic maleate.34 However, 
one proceeds via a succinyl-Cys and the other an enediolate intermediate. The former 
occurs with protonation of the adjacent =CH- while the latter does not (see Scheme 2). 
To help obtain additional insights into factors that may influence maleate to fumarate 
isomerization, a series of DFT-small model studies were performed. Specifically, we 
considered formation of these intermediates for all 3 possible ionization states of the 
substrate; di- (the most common form in aqueous solution)53 and monoanionic 
maleate, and neutral maleic acid (Scheme 5). The HOMO and LUMO of each species 
 180 
was also determined, where those of maleate are shown in Figure 9.1. 
 
Scheme 9.5. Schematic illustration of the gas-phase optimized structures of the 3 
possible substrate states (∠C1-C2-C3-C4 = 0.0º in each). 
 
 
The gas-phase optimized structure of dianionic maleate has a ∠C1-C2-C3-C4 
dihedral angle (φ) of 0.0º with the two carboxylates almost perpendicular to each other 
(Supporting Information: Table S1). The C3–C4 bond (1.543 Å) is slightly elongated 
with respect to C1–C2 (1.537 Å) as the HOMO lies mainly on the C1 carboxylate 
which lies more in the plane of the carbon backbone. Notably, C2 has only a small 
contribution to the HOMO orbital while to the LUMO it makes the largest 
contribution (Figure 9.1). Thus, it would be expected to be the carbon centre most 
susceptible to nucleophilic attack as has been proposed.34 Increasing the polarity of 
the environment to 4.0 and 10.0, values commonly used to model the internal 
environment of a protein, the HOMO and LUMO of maleate had negligible change. It 
is noted that decreasing the charge in maleate via sequential protonation of the 
carboxylates has only quite minor effects (-0.003 and -0.002 Å respectively) on the 
C2=C3 bond length. Notably, however, the carboxylate/carboxylic groups now lie 
more in the plane of the carbon backbone (see Scheme 5). 
For maleate and monoanionic maleate, nucleophilic attack of a methylthiolate 
(CH3S–) at C2 without concomitant protonation of C3 does not give a stable species 
for all environmental polarities (ε values) considered (ε = 1.0, 4.0, 10.0 and 78.39 
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(water)). Specifically, formation of an enediolate is unstable with respect to 
dissociation of the S–C2 bond. The same occurs for monoanionic maleate when 
CH3S– attacks at C3 (C3C4COOH) instead of C2. 
 
 
Figure 9.1. The (a) HOMO and (b) LUMO of dianionic maleate in the gas-phase (ε = 
1). 
 
In contrast, for maleic acid nucleophilic attack of CH3S– at C2 gives a stable 
enediolate structure. This occurs with marked lengthening in the C2–C3 bond from 
1.343 to 1.471 Å, respectively. Simultaneously, a significant increase in the ∠C1-C2-
C3-C4 angle (φ) occurs from 0.0º to 57.6º, respectively. Furthermore, such changes 
are observed for all values of ε; i.e., regardless of the environments polarity. 
A stable succinyl-cysteinyl type intermediate was obtained for all 3 ionization 
states of the substrate. However, its nature was sensitive to the environment and the 
ionization state of the substrate. For example, for dianionic maleate, gas-phase 
formation of such an intermediate occurred with significant increases in both the C2–
C3 bond length from 1.35 to 1.53 Å, and the dihedral φ from 0.0º to 159.7°. However, 
as e was increased to 4.0, 10.0 and higher, the magnitude of rotation decreased. In 
contrast, for maleic acid φ in the resulting intermediate was reasonably consistent at 
approximately 60.0° for all values of e. 
Thus, it appears that both the ionization state of the substrate and the polarity of 
the environment can have significant effects on the stability and nature of possible 
mechanistic intermediates. 
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9.3.2 The ionization states of Cys76, Cys194 and the substrate 
As described in the Introduction, in both proposed mechanisms, Cys76 acts as the 
nucleophile while Cys194 acts as a proton or hydrogen bond donor.34 In order for 
Cys76 to act as a more effective nucleophile it must be deprotonated, as assumed in 
the mechanisms.34 Knowing the likely initial ionization state of both active site 
cysteinyl residues is central for understanding their roles and the preferred reaction 
pathway. Consequently, the proton affinities (PAs) of the Cys76S– and Cys194S– 
thiolates within the various possible ionization states of the apo-enzyme and substrate-
bound active site were examined using the present QM/MM models. The results 
obtained are shown in Figure 9.2. 
 
 
Figure 9.2. The calculated proton affinities (see Computational Methods) of C76S– 
and C194S– before and after substrate binding, and the PA of the substrate in the 
active site. 
 
The proton affinity (PA) of methylthiolate (model for deprotonated cysteine) in 
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aqueous solution is calculated to be 1514.7 kJ mol-1 at the present level of theory (see 
Computational Methods). For the active site cysteinyl thiolates (i.e., C76S– and 
C194S–), their PAs were first calculated within the apo-enzyme active site for both 
possible scenarios; where the other cysteinyl is (i) anionic or (ii) neutral. For the first 
case the PA of C76S– is 1541.4 kJ mol-1 while that of C194S– is 1448.5 kJ mol-1. That 
is, the PA of C76S– has increased while that of C194S– has decreased compared to 
CH3S– in aqueous solution. In contrast, in the case where the other cysteinyl is kept 
neutral the PAs of both C76S– and C194S– decrease significantly to 1418.3 and 
1325.2 kJ mol-1, respectively. Interestingly, in both scenarios the PA of C194S– is 
lowest. This may reflect the fact that as seen in the X-ray crystal structure (PDB ID: 
2XED),34 C194 is surrounded by more possible hydrogen bond donors than C76, thus 
any anionic charge on the former is likely to be better stabilized. 
From Figure 9.2 it can be seen that upon binding the dianionic substrate (Sub=), 
the proton affinity of both C76 and C194 has increased markedly from their 
corresponding values in all possible apo-enzyme active sites. In contrast, in all 
substrate-bound active sites containing one or more neutral cysteinyls, the PA of Sub= 
has decreased from its calculated value in aqueous solution (1877.3 kJ mol-1; not 
shown). Importantly, however, despite these decreases, in those cases where only one 
of the cysteinyls is neutral, the PA of Sub= remains higher than that of the ionized 
cysteinyl. For instance, when C194 is neutral the PA of Sub= is 1811.1 kJ mol–1 while 
that of C76S– is 19.0 kJ mol–1 lower at 1792.1 kJ mol–1. Similarly, when C76 is 
neutral, the decreased PA of Sub= (1785.0 kJ mol–1) is still 71.7 kJ mol–1 higher than 
that of C194S– (1713.3 kJ mol–1). Thus, in either system Sub= will be preferentially 
protonated over the ionized active site cysteinyl. 
Indeed, the proton affinity of Sub= when both cysteinyls are neutral is 1546.6 kJ 
mol–1, while that of the ionized cysteinyl in C76S–/Sub–/C194SH and C76SH/Sub–
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/C194S– is 1527.7 and 1475.0 kJ mol–1, respectively. It is noted that in the latter 
system the PA of C194S– is also lower than that of methylthiolate in aqueous solution. 
These results thus suggest that the substrate-bound active site prefers to exist as 
having a monoanionic maleate and ionized Cys194 (i.e., C194S–), but a neutral Cys76 
(i.e., C76SH). This further suggests that the substrate itself may be able to play a role 
in activating an active site cysteinyl, specifically Cys194, to be the required 
nucleophile, while Cys76 may instead act as the proton or hydrogen bond donor. 
 
 
Figure 9.3. PES obtained using a QM-cluster approach (see Computational Methods) 
of the catalytic mechanism of MI in which Cys76 acts as a nucleophile. 
 
9.3.3 Cys76-pathway: mechanism with Cys76 as the nucleophile 
In both of the experimentally proposed mechanisms the thiol of Cys76 is 
deprotonated and acts as a nucleophile to attack the C2 position of dianionic maleate, 
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while Cys194 is neutral. Such possible catalytic mechanisms were thus considered 
using a QM-cluster approach. The potential energy surface (PES) obtained is shown in 
Figure 9.3 while the corresponding optimized stationary point structures, with selected 
distances, are shown in Scheme 9.6. 
In the optimized structure of the reactant complex, RCQM, the substrate’s 
carboxylates are each stabilized by multiple hydrogen bonds. More specifically, -
C1OO– forms hydrogen bonds with the R-groups of Cys194 and Tyr133, and the 
backbone –NH– moieties of Leu77 and Val95. The -C4OO– carboxylate, in contrast, 
is stabilized by only three hydrogen bonds formed with the R-groups of Asn14 and 
Asn163, and the backbone –NH– of Gln196. Meanwhile, the Cys76S– forms just a 
single hydrogen bond with the backbone –NH–of Val78. 
 
Scheme 9.6. Schematic illustration of the optimized structures obtained using a QM-
cluster approach (see Computational Methods) for the mechanism in which Cys76 
acts as nucleophile  
 
 
 186 
Using the QM-cluster approach no mechanism involving an enediolate-
intermediate could be characterized. However, an alternate possible pathway 
involving a succinyl-Cys type intermediate was obtained. The latter begins with 
nucleophilic attack of the Cys76S– at the substrate's C2 center with a concomitant 
proton transfer from the thiol of Cys194 onto C3. This step occurs via TS1QM with a 
markedly high relative energy barrier of 142.0 kJ mol-1. In the optimized structure of 
TS1QM (Scheme 6) the Cys76S…C distance has shortened considerably to 2.36 Å 
while the C3…H…SCys194 distances are 1.74 and 1.53 Å, respectively. These 
distances further illustrate the concomitant formation of the Cys76S—C2 bond and 
proton transfer from Cys194. Notably, during formation of the succinyl-Cys 
intermediate the ∠C1-C2-C3-C4 (φ) increases from 1.1º to 68.0º while the C2—C3 
bond has lengthened to 1.42 Å; it now has significantly reduced double bond 
character. That is, IC1QM resembles more a fumarate-like structure. 
The resulting intermediate (IC1QM) formed lies 88.5 kJ mol-1 lower in energy than 
RCQM. The dihedral angle φ has significantly increased to 210.8 (-149.2)º while the 
C2—C3 bond has lengthened to 1.53 Å, i.e., is now essentially a single bond with a 
trans-like orientation of the substrate's carbon backbone. The hydrogen bond network 
between the substrate and active site residues is generally retained, with only some 
minor differences. For example the Gln196 –NH– backbone now hydrogen bonds to 
the thiolate of Cys76 instead of the substrates’ –C4OO– group. 
In the next and final step the Cys76S–C2 bond is cleaved while concomitantly the 
-C3H2- moiety transfers a proton onto the Cys194S– thiolate. This concerted step 
proceeds via TS2QM with a barrier of 81.8 kJ mol–1 with respect to RCQM; 160.3 kJ 
mol-1 with respect to IC1QM. That is neither step 1 or 2 are likely to be enzymatically 
feasible.54,55 In TS2QM, the Cys76S…C2 bond has elongated to 2.60 Å; while the 
Cys194S…H…C3 distances are 1.68 and 1.52 Å, respectively. As a result the C2—C3 
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bond now has regained some double bond character. Furthermore, the dihedral angle φ 
is now 182.9º. The product complex (PCQM) lies 28.5 kJ mol-1 lower in energy than 
RCQM. Notably, the C2—C3 bond is now formally a double bond with a distance of 
1.34 Å while φ has increased slightly to 191.9º. 
 It is noted that the corresponding "succinyl-Cys" mechanism in which the proton 
transfers involving Cys194 occurred via a H2O moiety was also examined. However, 
the relative energies with respect to RCQM of TS1QM and TS2QM increased 
significantly to 123.0 and 193.9 kJ mol-1, respectively. 
An ONIOM(QM/MM) approach (see Computational Methods) was then used to 
further examine possible mechanisms in which Cys76 may act as the nucleophile. In 
particular, mechanisms in which Cys76 and Cys194 may initially be neutral, as 
suggested by the above PA calculations, were considered. The PES obtained is shown 
in Figure 9.4 while the corresponding optimized structures, with selected distances, 
are shown in Scheme 9.7. 
Again, in the reactant complex the –C1OO– carboxylate is stabilized via multiple 
strong hydrogen bonds with the side chain hydroxyl of Tyr133 and the backbone –
NH– functionalities of Ala79, Leu77 and Val195. Similarly, the -C4OO– group is 
again stabilized via three strong hydrogen bonds with the side chains of Asn14 and 
Asn163, and the backbone–NH– of Gln196. It is noted that the thiol of Cys194 forms 
a weak hydrogen bond with –C1OO–; r(SH…O) = 2.52 Å. 
 
 188 
 
Figure 9.4. PES obtained using an ONIOM(QM/MM) approach (see 
Computational Methods) of the catalytic mechanism of MI in which Cys76 acts as a 
nucleophile.  
As noted, Cys76SH is proposed to act the nucleophile after it has been activated, 
i.e., deprotonated. Unfortunately, Cys76 is situated in a hydrophobic region with no 
suitable candidate base residue to cause its activation. However, an alternate 
possibility is that the substrate may be able to facilitate such a process due to its 
carboxylates. Indeed, the PA calculations described above suggest that the substrate 
may have a suitably high-enough PA compared to Cys76SH. 
In RC, the Cys76SH proton is 2.85 and 3.70 Å from the nearest oxygen of the –
C1OO– and –C4OO– groups, respectively Table S2). The first step of the overall 
mechanism is transfer of the thiol proton of Cys76 via the –C1OO– moiety onto the –
C4OO– group. This occurs via TS1 with a barrier of 80.2 kJ mol–1 with respect to RC 
(Figure 9.4). In TS1 (Scheme 7) the proton being transferred is essentially on the –
C1OO– group; r(C1OO–…H+) = 1.05 Å. Simultaneously, however, it lies about 
midway between the Cys76 thiolate sulfur and the nearest oxygen of the –C4OO– 
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moiety with distances of 2.31 and 2.15 Å, respectively (see Scheme 7). It is noted that 
no intermediate was obtained with the Cys76SH proton on the –C1OO– group. This 
may reflect that this carboxylate already makes stronger and more hydrogen bonds 
with active site residues than the –C4OO– group. Thus, the –C1OO– group's anionic 
character is better stabilized than that of the –C4OO– group. The Cys76S– thiolate now 
appears suitably positioned to attack C2 (Scheme 7). 
In the resulting intermediate formed, IC1, the proton from Cys76SH has been 
transferred fully to the –C4OO– group. That is, the substrate is now a monoanionic 
maleate with a neutral Cys194. Meanwhile, the anionic Cys76S– forms a single weak 
hydrogen bond (2.57 Å) with the backbone –NH- of Val78. More importantly the 
Cys76S…C2 distance has shortened to 2.75 Å while the C2–C3 bond has elongated 
from 1.35 to 1.37 Å. IC1 lies lower in energy than RC by just 9.1 kJ mol-1. 
As suggested by the DFT-small model studies (see above), a stable enediolate 
intermediate could not be obtained within the active site using the QM/MM model. 
Rather, the next step is nucleophilic attack of the thiolate of Cys76S– at the C2 carbon 
centre of the substrate. Concomitantly, the thiol of Cys194 transfers its proton onto the 
substrate's adjacent C3 center. This concerted step proceeds via TS2 at a cost of 52.4 
kJ mol-1 with respect to IC1. This is illustrated by the fact that in the optimized 
structure of TS2 the Cys76S…C2 distance has shortened significantly to 1.96 Å. 
Meanwhile, the Cys194SH proton now lies between the Cys194 sulfur and C3 with 
distances of 1.51 and 1.80 Å, respectively. 
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Scheme 9.7. Schematic illustration of optimized structures obtained using an 
ONIOM(QM/MM) approach (see Computational Methods) for the mechanism in 
which Cys76 acts as nucleophile. 
 
 
The resulting succinyl-Cys intermediate formed, IC2, lies significantly lower in 
energy than RC by 91.5 kJ mol-1. Also, the C2–C3 bond distance is now 1.54 Å. 
Notably, it corresponds to the crystallographically obtained "intermediate" in a 
Cys194Ala mutant MI enzyme.34 
The next step is likely rotation about the C2–C3 bond (1.52 Å) to give an enzyme-
bound fumarate-like intermediate IC3. Such a species similarly lies considerably 
lower in energy than RC by 75.6 kJ mol–1. Unfortunately, no TS (TS3) for such a 
rotation could be optimized at the present level of theory. However, the barrier is 
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expected to be feasible as observed in the Cys194-pathway discussed below (see 
Figure 9.5).  
The subsequent and final step is then formation of the product complex PC; an 
active site-bound fumarate. This concerted step, involving both cleavage of the C2—
SCys76 bond and a proton transfer from the substrate's -C3H2- group to Cys194, 
occurs via TS4 at a cost of 119.2 kJ mol-1 with respect to IC3. Notably, the energy 
difference between IC2 and TS4 is 135.1 kJ mol-1; which has been suggested to be 
thermodynamically greater than that which is enzymatically feasible.54,55 This also 
represents the largest difference between any minimum and TS along this possible 
mechanism, and is likely the rate limiting step for such a mechanism. The apparent 
considerable energy required for IC2 to either proceed to product or back to reactant 
(requires 171.7 kJ mol–1) may provide insights into the ability of experimentalists to 
obtain an X-ray crystal structure of such an intermediate in a Cys194Ala mutant 
enzyme. Notably, the detection of the succinyl-Cys in C194A suggests the presence of 
an alternate proton-transferring agent that helps stabilize the intermediate. However, 
the absence of a suitable mechanistic base (i.e., loss of Cys194S–) does not allow for 
product formation. 
The final product complex, PC, lies slightly higher in energy than RC by 10.9 kJ 
mol-1, indicating that the overall mechanism is endothermic. The C2–C3 double bond 
is 1.37 Å, further indicating the formation of the fumarate product.  
 
 192 
 
Figure 9.5. PES obtained using an ONIOM(QM/MM) approach (see 
Computational Methods) of the catalytic mechanism of MI in which Cys194 acts as a 
nucleophile. 
 
9.3.4 Cys194-pathway: mechanism with Cys194 as the nucleophile 
As noted above, the PA calculations suggested that rather than Cys76, Cys194 
may in fact be preferably ionized within the substrate-bound active site. Hence, 
possible catalytic mechanisms in which Cys194 may act as the nucleophile were 
investigated. The resulting PES obtained is shown in Figure 9.5 while the 
corresponding optimized stationary point structures are illustrated in Scheme 8. 
Beginning from the same RC as for the above mechanism in which Cys76 acts as 
the nucleophile, the first step is the analogous substrate facilitated activation of 
Cys194. This step, however, proceeds via TS1' at a cost relative to RC of only 40.1 kJ 
mol-1 (Figure 9.5). This is half that required to activate Cys76 via an analogous 
pathway (cf. Figure 9.4). Furthermore, unlike that observed for activation of Cys76, 
the Cys194 thiol proton is transferred directly onto an oxygen of the -C4OO– group 
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with r(Cys194S…H) and r(H…OOC4) distances in TS1' of 1.63 and 1.24 Å, 
respectively (Scheme 7). The resulting intermediate formed IC1', lies lower in energy 
than RC by 62.4 kJ mol-1. Notably, this is 53.3 kJ mol-1 lower in energy than IC1 on 
the Cys76-pathway (cf. Figure 9.4). This is likely due in part to the fact that in 
contrast to the single weak stabilizing hydrogen bond observed in IC1, in IC1' the 
Cys194S– thiolate forms three hydrogen bonds. Specifically, it forms two with the 
backbone –NH–'s of Gln196 and Met197, and one with the amide side chain of 
Asn163 via a water molecule. Meanwhile, as in IC1, the proton from Cys194 is 
wholly transferred onto the substrate's –C4OO– group and now forms an 
intermolecular hydrogen bond with the –C1OO– moiety. Also, the C2–C3 bond in 
IC1' (1.35 Å) remains little changed from that obtained for RC, in contrast to that 
observed for IC1 in the alternate Cys76-pathway. 
As for the Cys76-pathway the subsequent step is formation of a succinyl-Cys type 
intermediate (IC2'). Again this involves nucleophilic attack of the thiolate, though 
now it is Cys194S–, at the substrates C2 center, with concomitant transfer of the thiol 
proton from the second active site cysteine (now Cys76) onto the adjacent C3 center. 
No stable enediolate intermediate could be found. This step occurs via TS2' with a 
barrier of 19.0 kJ mol–1 with respect to RC, or 81.4 kJ mol-1 relative to IC1'. The 
resulting succinyl-Cys intermediate IC2' lies lower in energy than RC by -39.4 kJ 
mol-1. However, notably, this is in fact 52.1 kJ mol–1 higher in relative energy than the 
same corresponding intermediate IC2 of the Cys76-pathway (cf. Figure 9.4). The C2–
C3 bond has now elongated to 1.55 Å; that is, it is now a single bond. 
 At the heart of the isomerization mechanism is rotation about the C2—C3 
bond, i.e., the cis-trans isomerization. In contrast to the seemingly one-step 
isomerization upon formation of a succinyl-Cys intermediate for the Cys76-pathway, 
a multi-step process was obtained on the Cys194-pathway (Figure 9.5). This process 
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itself can be thought to occur in 3-stages. In the first, the intramolecular -C4OOH…–
OOC1- hydrogen bond is broken. Instead, the -C4OOH group now forms a strong 
hydrogen bond with the thiolate of Cys76S–; r(C4OOH…–SCys76) = 1.84 Å. This 
step occurs via TS3' with a low barrier of just 12.7 kJ mol-1 to give the alternate 
succinyl-Cys type intermediate IC3'. The latter in fact lies slightly lower in energy 
than IC2' by 8.6 kJ mol–1. More importantly, the ∠C2-C3-C4-O increases from 44.8° 
to 71.8°. Notably, the twist about the C2—C3 bond, i.e., ∠C1-C2-C3-C4 (f), has 
slightly changed from that observed in IC2', -294.3º to 306.0º in IC3'. 
The next step is essentially the twist from a cis conformation to trans. This occurs 
via TS4' with a barrier of 41.9 kJ mol–1 relative to RC or 89.9 kJ mol–1 with respect to 
IC3'. In the resulting alternate succinyl-Cys type intermediate IC4', lying just slightly 
higher in energy than IC3' by 5.3 kJ mol–1, ∠C1-C2-C3-C4 (f), has increased 
significantly to 137.2º. All active site-substrate interactions observed for IC3' are 
maintained (and the C2–C3 bond length stays the same as in IC3'). Importantly, this 
represents the rate-limiting step along the Cys194-pathway having both the highest 
barrier for a single reaction step and relative to RC. Furthermore, it is in good 
agreement with the barrier of ~70 kJ mol-1 calculated using experimental kinetics 
measurements.34 In addition, it is significantly lower than the 135.1 kJ mol–1 required 
for the rate-limiting step of the alternate Cys76-pathway: going from IC2 to PC. 
The third stage is cleavage of the Cys76S–…HOOC4 hydrogen bond. This step 
occurs via TS5' at a cost of 52.0 kJ mol-1 with respect to IC4', or 9.3 kJ mol–1 relative 
to RC. In the resulting alternate succinyl-Cys type intermediate formed, IC5', the C2–
C3 bond has shortened by 0.02 Å to 1.53 Å, while the dihedral angle ∠C1-C2-C3-C4 
is now 160.4°. More importantly, the C4OH group now forms a quite strong hydrogen 
bond of length 1.80 Å with an active site water molecule (Scheme 8). It should be 
noted that this latter water simultaneously forms a weak hydrogen bond (2.45 Å) with 
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the sulfur of Cys194 (Scheme 8). In addition, the distance between the thiolate sulfur 
of Cys76 and the nearest -C3H2- proton has now decreased from 3.05 Å in IC4' to 
2.45 Å in IC5'. Thus, the Cys76 now seems well-positioned relative to the substrate to 
abstract a proton. Thermodynamically, IC5' has an energy relative to RC of 9.4 kJ 
mol-1, 0.1 kJ mol–1 above that of TS5'. This is a common artefact of single-point 
energy calculations on a flat PES and indicates that the reverse reaction, IC5' to IC4', 
essentially occurs without a barrier. 
The final step is proton abstraction by the thiolate of Cys76 from the substrates -
C3H2- moiety, with concomitant cleavage of the Cys194S—C2 bond. However, 
unlike the Cys76-pathway where the analogous step occurred with a high barrier, on 
the Cys194-pathway this step proceeds via TS6' at a very low cost of only 29.9 kJ 
mol-1 relative to IC5'. The concerted nature of this step is highlighted by the fact that 
in TS6' the Cys194S…C2 bond has elongated to 1.97 Å, while the C3H…SCys76 and 
C3—HSCys76 distances are now 1.65 and 1.50 Å, respectively. The final product 
complex PC, in which fumarate is now non-covalently bound within the active site, is 
25.5 kJ mol-1 lower in energy than RC with a C2–C3 bond of 1.35 Å. Thus, unlike that 
calculated above for the Cys76-pathway, this alternate mechanism in which Cys194 
acts as the nucleophile is thermodynamically favoured. 
 
9.4 Conclusions 
In this study the mechanism by which the enzyme maleate isomerase catalyzes the 
cis-trans interconversion of maleate and fumarate has been computationally 
investigated. Specifically, DFT methods in combination with small chemical models 
were used to gain fundamental insights into the nature of possible mechanistic 
intermediates, while QM-cluster and ONIOM(QM/MM) methods have been used to 
examine the nature of the substrate-bound active site and the catalytic mechanism. 
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The feasibility of the formation of proposed enediolate and succinyl-Cys type 
intermediates from a neutral, monoanionic or dianionic maleate substrate was initially 
examined using DFT-small chemical model studies For both neutral and monoanionic 
maleate an enediolate intermediate, formed by nucleophilic attack of methyl thiolate 
(CH3S–) at their C2 center, was unstable, i.e., dissociated back to the original 
substrates. In contrast, the  succinyl-Cys type intermediate, formed by concomitant 
thiolate addition to C2 and protonation of C3, was stable for all 3 ionization states of 
the initial maleate. Furthermore, for dianionic maleate the formation of succinyl-Cys 
leads to a barrierless rotation about the substrates central C2—C3 bond. Increasing the 
polarization of the environment was observed to decrease the angle of rotation. In 
order to understand the driving force for rotation, the LUMO and HOMO were also 
examined. 
The ionization state of the active site cysteinyl's (Cys76 and Cys194) and the 
substrate were examined using an ONIOM(QM/MM) based approach for both the 
apoenzyme and the substrate-bound active site. The results suggest that the proton 
affinity (PA) of Cys76S– is higher than that of Cys194S– in both the apo-enzyme and 
when the dianionic maleate substrate is bound within the active. Furthermore, the 
combined results suggest that upon substrate binding the preferred initial state of the 
substrate-bound active site contains a monoanionic maleate substrate, an ionized 
Cys194 (i.e., Cys194S–) and a neutral Cys76 (i.e., Cys76SH). 
Two possible mechanistic pathways were investigated using QM-cluster and/or an 
ONIOM(QM/MM) approach. The first pathway corresponds to that previously 
experimentally proposed in which the active site residue Cys76 acts as the mechanistic 
nucleophile that attacks the substrates sp2 C2 centre; the Cys76-pathway. In the 
alternate pathway Cys194 acts as the required nucleophile; the Cys194-pathway. 
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Scheme 9.8. Schematic illustration of optimized structures obtained using an 
ONIOM(QM/MM) approach (see Computational Methods) for the mechanism in 
which Cys194 acts as nucleophile. 
 
 
 In both pathways the Cys76 or Cys194 thiol, can be deprotonated via proton 
transfer onto the maleate substrate's carboxylate positioned nearest Asn14 and 
Asn163. However, the barrier for this step on the Cys194-pathway (40.1 kJ mol–1) is 
only half that of the analagous step on the Cys76-pathway (80.2 kJ mol–1). This is due 
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in part to greater stabilization of Cys194S– than Cys76S– by hydrogen bonding within 
the active site. 
The subsequent step in these pathways is the nucleophilic attack of the thiolate at 
the maleate substrate's C2 centre. Additionally, this occurs with concomitant proton 
transfer from the R-group thiol of the second active site cysteinyl to give a succinyl-
Cys intermediate (IC2 and IC2', respectively). Importantly, in the case of the Cys76-
pathway such an intermediate (IC2) lies significantly lower in energy than the initial 
reactant complex (RC) by 91.5 kJ mol–1. Furthermore, subsequent rearrangement and 
reaction of IC2 to give the final product complex (PC) requires a considerable amount 
of energy; 135.1 kJ mol–1. This is in fact the rate-limiting process of the Cys76-
pathway. In contrast, for the Cys194-pathway the resulting succinyl-Cys intermediate 
(IC2'), while lower in energy than the RC, is not as significantly stabilized, lying just 
39.4 kJ mol–1 lower in energy than RC. It is able to undergo a series of relatively low-
energy rearrangements and reactions to give the final product complex (PC'). The 
rate-limiting step along the Cys194-pathway is the step in which a twist from a cis 
conformation to trans occurs. The calculated barrier for this step if 89.9 kJ mol–1 is in 
good agreement with the barrier calculated using experimentally determined kinetics; 
~70 kJ mol-1.34 
Thus, the present results suggest that the overall catalytic mechanism of Maleate 
Isomerase is initiated by a substrate-assisted activation of the active site cysteinyl 
Cys194. This is followed by the concerted formation of a succinyl-Cys intermediate in 
which Cys76 acts as an acid. Thus, Cys194 is the mechanistic nucleophile while 
Cys76 instead acts as an acid/base along the mechanism. The desired rotation about 
the C2—C3 bond occur via multiple relatively low-barrier steps with assistance of the 
anionic Cys76S–, generated during formation of a succinyl-Cys intermediate. Finally, 
cleavage of the Cys194S–C2 bond concomitant with proton abstraction by Cys76S– 
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from the intermediates C3H2 group leads to the formation of the fumarate product. 
The conserved nature of the active site in the racemase superfamily suggests possible 
transferability of the mechanism outlined to other species in the family. 
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In this thesis the redox chemistry of sulfur in several enzymes has been investigated 
using various computational approaches. Particularly, previously proposed mechanisms 
for sulfenic acids formation and reduction/overoxidation pathways have been examined. 
In Chapter 3, the catalytic mechanism of MsrA in Mycobacterium tuberculosis, in 
which S-methionine sulfoxide (Met-O) is reduced to Methionine (Met), has been 
investigated using docking, molecular dynamics (MD) simulations and ONIOM 
(QM/MM) methods. In addition, the roles of specific active site residues including an 
aspartyl (Asp87) near the recycling cysteine, tyrosyl's (Tyr44 and Tyr92) and glutamyl 
(Glu52) have been examined, as well as the general effects of the protein and active site 
on the nature and properties of mechanistic intermediates. The mechanism is initiated by 
proton transfer from the catalytic cysteine's thiol (Cys13SH) via a bridging water to the 
R-group carboxylate of Glu52. The now anionic sulfur of Cys13 nucleophilically attacks 
the substrate's sulfur with concomitant proton transfer from Glu52 to the sulfoxide 
oxygen, generating a sulfurane. The active site enhances the proton affinity of the 
sulfurane oxygen which, can readily accept a proton from the phenolic hydroxyls of 
Tyr44 or Tyr92 to give a sulfonium cation. Subsequently, Asp87 and the recycling 
cysteine (Cys154) can facilitate nucleophilic attack of a solvent water at the Cys13S 
center of the sulfonium to give a sulfenic acid (Cys13SOH) and Met. For the subsequent 
reduction of Cys13SOH with intramolecular disulfide bond formation Asp87 can help 
facilitate nucleophilic attack of Cys154S at the sulfur of Cys13SOH by deprotonating its 
thiol. This reduction is found to likely occur readily upon suitable positioning of the 
active site hydrogen bond network and the sulfur centers of both Cys13 and Cys154. The 
calculated rate-limiting barrier is in good agreement with experiment. 
In Chapter 4, the last step in the reductase step of the catalytic mechanism of MsrB 
(MsrA sister enzyme) was re-investigated using several computational approaches. Our 
previous DFT cluster paper showed that two possible mechanisms could occur, however 
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the direct formation of disulfide from sulfonium cation was favored over sulfenic acid 
formation. In contrary, experimental studies suggest sulfenic acid formation. Therefore, 
first, we investigated the effect of level of theory, which confirmed previous conclusion. 
In addition, the effect of model choice was also investigated using ONIOM including a 
large QM layer around Cys440. Interestingly, deprotonating Cys440 leads to direct 
nucleophilic attack on Cys495 forming disulfide. Second, to eliminate the possibility that 
all previous results are an artifact of the used crystal structure in which the S…S distance 
is 3.29 Å, we ran a 5 ns MD simulation on the sulfonium cation intermediate. 
Surprisingly, our results show that the distance between the two sulfur is significantly 
increased to 4.88 Å. More importantly a water molecule is located in a proper position for 
nucleophilic attack. QM/MM calculations shows that sulfenic acid is formed via low 
barrier of 16.7 kJ mol-1. Finally, the effect of substrate binding on the two Cys's distance 
were investigated via running several MD simulations of possible intermediates, showing 
that substrate binding induces conformational changes increasing the sulfur's distance 
which is decreased upon substrate removal upon sulfenic acid formation. These results 
question the applicability of QM cluster approach in systems including flexible turns. It 
also emphasizes the importance of proper preparation of the starting structure. 
Both Chapters 3 and 4, show that the same mechanism occurs in MsrA and MsrB 
despite their active sites structural differences. As future direction, it would be interested 
to investigate the mechanism in the 1-Cys Msr, which contains only one Cys residue in 
the active site, particularly the stabilization mechanism of sulfenic acid in the active site 
against overoxidation. Furthermore, in human, MsrB reduction mechanism uses an active 
site selenocysteine (Sec) residue. Therefore, mechanistic difference between Cys and Sec 
in MsrB could be revealed.  
In Chapter 5, Docking and Molecular dynamic simulations were synergistically used 
to elucidate the mechanism of MsrA activation via small molecules. Experimentally, 
Pergolide (Perg) and Pergolide-sulfoxide (PergSO) have been shown to increase the 
! 207!
activity of MsrA via an unknown mechanism. In this study we investigated the possibility 
of MsrA induction via direct molecular interaction. Our docking calculations show that 
Perg and PergSO as well as S-adenosyl methionine (SAM) bind to a novel allosteric site 
of the oxidized form of the enzyme. MD simulations have also shown that the binding of 
these molecules disrupts the interaction between the Gln122-Thr132 segment and C-
terminal residues facilitating the binding of thioredoxin and the regeneration step in the 
mechanism. These finding represent for the first time a direct mechanism to activate 
MsrA providing a novel therapeutic pathway. Furthermore, virtual screening was used to 
screen the subset ZIM from the drug database ZINC against our identified allosteric site. 
Several ligands were identified to bind with high affinity to MsrA. Several following 
studies are needed to verify the proposed activation mechanism. For instance, the direct 
interaction hypothesis could be tested experimentally. Furthermore, identified possible 
ligands can also be tested to select lead compounds. Subsequently, quantitative structural 
relationship studies could be used to optimize the lead ligands. 
In Chapter 6, the formation mechanism of sulfenyl-amide intermediate from sulfenic 
acid in protein tyrosine phosphatase 1B (PTP1B) has been investigated. Using a wide 
array of computational modeling techniques including MD simulations and high-level 
ONIOM calculations possible catalytic pathways has been investigated. Several potential 
reactive complexes were considered in the calculations. The only feasible mechanism was 
found to occur in a stepwise fashion, in which a stable iminol intermediate is formed. 
This step has an activation energy of 48.6 kJ mol-1. Later, a much more stable iminol 
intermediate is formed in which a noncovalent electrostatic interaction of the sulfenic acid 
sulfur anti-bonding orbital with the iminol nitrogen lone pair was found to occur. 
Subsequently, a cyclic sulfenyl-amide is formed with a concomitant proton transfer from 
Glu115 to the sulfenic acid oxygen. Our results suggest that Glu115 and His214 play a 
crucial role in the mechanism. These results could contribute to the discovery of PTP1B 
inhibitors and the stabilization of the enzyme oxidized form. 
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In Chapter 7, mechanistic details for the reduction of hydrogen peroxide and the 
formation of a proposed hypervalent sulfurane species in ApTPx have been elucidated via 
the synergistic use of MD simulations and ONIOM. Our results show that the reduction 
mechanism is driven by the destabilization of the peroxide substrate in the active site, 
facilitating the nucleophilic attack from the peroxidative cysteine. Following the reduction 
of hydrogen peroxide, a pseudo hypervalent sulfurane intermediate is suggested to form 
with a weak interaction between His42 and the oxidized Cys50. This interaction was 
confirmed using QTAIM and NBO analysis. Indeed, the formation of the sulfurane was 
found to be energetically favorable over the overoxidized sulfinic acid species and thus 
would provide a mechanism protecting sulfenic acid from overoxidation. A similar 
intermediate was discovered for the first time in the human 1-Cys hORF6. Moreover, by 
comparing X-ray structures with several different Prxs and other proteins we suggest this 
intermediate may be generally formed when sulfenic acid is involved in protein 
chemistry. This can be tested via synergistic use of computational and experimental 
techniques to elucidate sulfenic acid interactions in PrxV and PrxIV as well as other 
proteins such as SUMO proteases and Gsp amidase.  
In Chapter 8, the reduction of typical 2-Cys perxoiredoxins (Prxs) sulfinic acid to 
sulfenic acid via a repair enzyme known as sulfiredoxin (Srx) has been investigated. 
Molecular modeling techniques including MD simulations (MD) and ONIOM approach 
were used to elucidate the atomistic details of this unique reaction in sulfur chemistry. 
Our results support the previous experimentally proposed mechanism in which the 
sulfinic acid oxygen perform an in line direct nucleophilic attack on the γ-phosphate of 
ATP forming sulfinic acid phosphoryl ester intermediate and ADP, via a low barrier of 
16.3 kJ mol-1.  Subsequently, the formed intermediate is directly reduced via an SN2 
mechanism by the Srx-Cys99 forming thiosulfinate. Our results suggest that the rate-
limiting step of the reduction mechanism is associated with the reduction step of the 
thiosulfinate intermediate. Notably, this work improves the current knowledge of this 
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unique reaction, which could contribute to the discovery of new groups of antioxidants 
capable of reducing this irreversible overoxidized state in other proteins. 
In Chapter 9, the maleate isomerase (MI) catalyzed isomerization of maleate to 
fumarate has been investigated using a wide range of computational modeling techniques, 
including small model DFT calculations, QM-cluster approach, ONIOM and MD 
simulations. Several fundamental questions regarding the mechanism were answered in 
detail, such as the activation and stabilization of the catalytic Cys in a rather hydrophobic 
active site. The two previously proposed mechanisms were considered, where either 
enediolate or succinyl-Cys intermediate forms. Small model calculations as well as an 
ONIOM-based approach suggest that an enediolate intermediate is too unstable. 
Furthermore, the formation of succinyl-Cys intermediate via the nucleophilic attack of 
Cys76– on the substrate C2 (as proposed experimentally) was found to be energetically 
unfeasible in both QM-cluster and ONIOM approaches. Instead, our results show that 
Cys194, upon activation via the substrate, acts as a nucleophile and Cys76 acts as an 
acid/base catalyst, forming a succinyl-Cys intermediate in a concerted fashion. Indeed, 
the calculated PA of Cys76 is always higher than that of Cys194 before or upon substrate 
binding in the active site. Furthermore, the mechanism proceeds via multiple steps by 
substrate rotation around C2–C3 with the assistance of the now negatively charged 
Cys76, leading to the formation of fumarate. Finally, our calculated barrier is in good 
agreement with experiment. These findings represent a novel mechanism in the racemase 
superfamily. With!the!fast!growing!number!of!X:ray!identified!sulfenic!acids!in!proteins,!more!computational! studies! are! needed! to! further! elucidate! sulfenic! acid! chemistry!specially! their!protective!mechanism!and! interactions.! In!addition,! the!role!of!non:covalent! interactions! in! stabilizing! sulfur! species'! needs! further! investigation.! ! In!addition!the!transferability!of!any!of!our!studied!mechanism!to!other!proteins!would!improve!our!understanding!of!these!reactions.!Although!our!studies!do!not!discuss!
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all! aspect!of! sulfur/sulfenic! chemistry,! it! gave!some! important! insights! that!enrich!our!knowledge!about!sulfur!chemistry.!!!
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